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Abstract 
The cell cycle is a highly orchestrated developmental process that eventually leads to 
the reproduction of a cell. In metazoans, it is driven by the successive activation of 
cyclin-dependent kinases (Cdk) and proper coordination of cell cycle transitions and 
processes ensure genomic stability. DNA replication takes place during S phase to 
faithfully duplicate a cellʼs genetic material. In eukaryotes, S phase onset involves the 
initiation of numerous licensed replication origins across the genome and requires the 
activities of two protein kinases, S phase-Cdk and Cdc7. In this thesis, I present work 
relating to the role of the S phase-promoting kinases in DNA replication and S phase 
regulation.  
 
Using the cell-free system of Xenopus egg extracts, a small molecule inhibitor of Cdc7 
was characterised. PHA-767491 was then used to demonstrate that Cdc7 executes its 
activity early in S phase before the Cdk-dependent step. Cdc7 is not rate limiting for the 
progression of the replication timing programme once its essential function has been 
executed, unlike S-Cdk whose activity is required throughout S phase. Protein 
Phosphatase 1 (PP1) was identified as a modulator of Cdc7 activity in egg extracts, 
which rapidly reverses Cdc7-dependent phosphorylation of chromatin-bound Mcm4 
and likely functionally lowers Cdc7 activity during an etoposide-induced checkpoint 
response. This provides a novel mechanism for regulating Cdc7 by counteracting its 
activity on essential replication substrates in the event of replicative stress.  
 
In the second part of the thesis, the design strategy for generating a Cdc7-conditional 
knockout mouse (cko) is outlined and results from the screen for a transgenic founder 
are presented. A Cdc7-cko mouse will be a valuable tool to further dissect Cdc7 
function and regulation in mammalian cells. In the final section, S phase entry and 
progression in mouse embryonic fibroblasts lacking both Cdk1 and Cdk2 was 
examined. Contrary to expectations, Cdk1/Cdk2 double knockout cells can enter S 
phase in the absence of detectable S phase-Cdk activity. S phase progression, 
however, was inefficient. Cdc6 and cyclin E1 proteins were found to accumulate in high 
levels in these cells although the exact function(s) and mechanism(s) for these 
observations remain to be discovered. With this work, I hope to provide additional 
insight into the roles and regulation of S phase kinases in eukaryotic DNA replication. 
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Chapter 1 – Introduction 
 
1.1  The cell division cycle 
The cell cycle is a highly orchestrated developmental process that eventually leads to 
the reproduction of a cell. In eukaryotic cells, it is classically divided into four phases in 
which genetic material is first duplicated during S (Synthesis) phase and then 
segregated during M (Mitosis) phase. S and M phase may each be preceded by a gap 
phase, the G1 and G2 phase respectively. Faithful replication of chromosomes 
followed by accurate segregation of sister chromatids are crucial to ensure that the two 
daughter cells each inherit a perfect copy of the genetic material that was originally 
carried in the mother cell, thus ensuring continued genomic stability (Blow and Dutta, 
2005). For sustained cell proliferation, this chromosomal cycle is tightly coordinated 
with the growth cycle in which other cell constituents are also duplicated and divided 
into daughter cells (Nasmyth, 2001). Adaptions to the four-stage cell cycle also occur in 
nature, for instance, rapid cleavage cycles consisting only of alternating S and M 
phases take place during embryogenesis in order to produce large numbers of cells 
within a short span of time (Duronio, 2012). 
 
1.1.1  A short history 
The mechanisms underlying the cycle of cell growth and division remained largely 
unknown until the 1970s and 80s, when development of techniques in molecular 
biology quickly allowed advances to be made in the areas of cell biology, biochemistry 
and genetics. Details about basic control components and mechanisms revealed that 
processes are highly conserved across eukaryotic organisms (Nurse et al., 1998). 
 
Cell cycle genetics was pioneered by Hartwellʼs seminal work in screening 
temperature-sensitive mutants of Saccharomyces cerevisiae (Hartwell et al., 1970). In 
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a series of papers published in the early 70s, Hartwell isolated and characterised the 
cdc (cell division cycle) collection of mutants, setting the stage for the discovery of 
important regulators of the eukaryotic cell cycle (Culotti and Hartwell, 1971; Hartwell, 
1971a, b; Hartwell et al., 1970; Hartwell et al., 1973). Because a yeast cellʼs bud grows 
as it goes through the cell cycle, bud size provides a convenient measure of cell cycle 
position. Yeast mutants that were defective in passage through the chromosome or 
division cycle would arrest with characteristic shapes. By studying mutant yeast 
morphology after a shift to the restrictive temperature, it was then possible to determine 
a period of the cell cycle during which a particular temperature-sensitive event occurs 
at the permissive temperature, termed the execution point of this event, before the 
mutant finally arrested at the termination point with a distinctive morphology (Hartwell 
et al., 1970). Successful cell division only occurred when cell cycle events occur in the 
proper sequence. The orderly manner in which earlier events are successfully 
completed before later events can take place showed that there was great 
interdependence in between the events controlled by various cdc genes (Hartwell et al., 
1974).  
 
Inspired by Hartwellʼs work with the budding yeast, genetic studies in the fission yeast 
Schizosaccharomyces pombe by Nurse and colleagues soon led to other key insights 
to the cell cycle. Measurement of cell length could be conveniently used as a gauge of 
cell growth in fission yeast owing to its cylindrical shape and growth by lengthwise 
extension. Nurse and Thuriaux initially identified several fission yeast cdc mutant 
strains that divided at half the normal cell size at a restrictive temperature, which they 
named the “wee” mutants (Nurse, 1975; Thuriaux et al., 1978). One such mutant, the 
wee2-1 strain was found to be allelic to the fission yeast cdc2 gene and encodes a key 
regulator required for mitosis (Nurse and Thuriaux, 1980). Based on these features, 
Nurse suggested that cdc2 must be a critical cell cycle regulator because while 
necessary for mitotic entry, if mutated, it could also accelerate this process. Evidence 
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that cdc2 was central to cell cycle regulation was also supported by the discovery that it 
was required for G1/S as well as G2/M progression (Nurse and Bissett, 1981). 
Subsequent work identified the cdc2 gene product to be a protein kinase (Simanis and 
Nurse, 1986). With the advent of cloning techniques by complementation, S. pombe 
cdc2 was discovered to be the homologue of budding yeast CDC28 (Beach et al., 
1982). This finding suggested for the first time that the cellular mechanisms of cell 
cycle were conserved. The degree of conservation leapt from yeast to humans when 
the human homologue of CDC28 and cdc2 was isolated by heterologous 
complementation using a mammalian cDNA library (Lee and Nurse, 1987).  
 
At the same time, important discoveries were also made using biochemical 
approaches. A protein-like substance termed the maturation promoting factor (MPF) 
had been purified from amphibian oocytes which could drive oocyte maturation (Masui 
and Markert, 1971). Since this involves progression through meiosis during maturation, 
this meant that MPF was able to induce the onset of M phase in a cell (Nurse, 1998). 
Development of an in vitro system derived from Xenopus laevis eggs (Lohka and 
Masui, 1983) provided the assay system required for biochemical purification of MPF, 
leading to the observation that MPF was made up of two proteins with molecular 
masses of 32 kDa and 45 kDa (Lohka et al., 1988). Meanwhile, a protein had been 
discovered in sea urchin embryos whose abundance oscillated in synchrony with cell 
division; this protein was named cyclin, the first of its family to be discovered (Evans et 
al., 1983). This report by Hunt and his colleagues was the first to describe periodic 
protein degradation over the course of the cell cycle. Cyclin genes were cloned and 
sequenced shortly after (Swenson et al., 1986). It was not long before the two 
components of MPF were identified as cyclin B and Cdc2, a cyclin-dependent kinase 
(Cdk) (Gautier et al., 1990; Gautier et al., 1988; Labbe et al., 1989). 
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Subsequent studies eventually led to an understanding that these cyclin-dependent 
kinases, whose activities fluctuate cyclically as a result of periodic cyclin transcription 
and degradation, are essential regulators of the cell cycle (Glotzer et al., 1991; Minshull 
et al., 1989a; Minshull et al., 1989b; Murray and Kirschner, 1989; Murray et al., 1989). 
From these early stages, starting from different approaches and using a variety of 
model organisms, the study of cell cycle regulation has since grown to encompass 
much greater complexity as more components are identified and greater molecular 
definition add layers of controls to existing mechanisms.  
 
In the next sections of this Introduction, aspects of eukaryotic DNA replication will be 
discussed in some detail (Section 1.2), with a focus on the S phase-promoting kinase, 
Cdc7 (1.3) and ending with an overview of metazoan Cdk control of cell cycle 
transitions (1.4). 
 
1.2  Chromosome replication  
1.2.1  Eukaryotic DNA replication 
Much of cell cycle research had focused on the mechanisms that drive the 
chromosome cycle rather than the growth cycle (Nasmyth, 2001). The physiological 
significance of a requirement for perfect fidelity in DNA replication is emphasised by the 
types of human genetic diseases that may result from under- or over-replication, 
including cancers, birth defects, developmental abnormalities and a group of diseases 
collectively known as the “chromosome instability syndrome” which result from defects 
in proteins for the assembly and monitoring of the replication fork (DePamphilis, 2006; 
Sclafani and Holzen, 2007). Regulatory mechanisms exist that enforce the strict 
alternation of DNA replication and chromosomal segregation and allow DNA replication 
to take place only once in each cell cycle. 
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DNA replication in eukaryotic cells occurs in a series of ordered events that begins with 
origin selection, followed by assembly of pre-replicative complexes around origins (pre-
RC) (Section 1.2.2) and initiation of licensed origins (Section 1.2.3). Replication origins 
are chromosomal elements that bind initiator proteins, which promote local unwinding 
of the DNA double helix and recruitment of additional protein components, eventually 
leading to the assembly of the replisome at origins. It is now known that a common set 
of initiation proteins assembles at origins whose activities are regulated by specific 
kinases. Following replication initiation, two sister replication forks are established at 
each origin. Each strand of DNA is then replicated in a semi-conservative manner as 
replisomes progress bi-directionally away from the origin. Replication forks terminate 
when they encounter another fork head-on in the opposite direction (Bell and Dutta, 
2002; Blow and Dutta, 2005; Kelly and Brown, 2000; Sclafani and Holzen, 2007).  
 
1.2.2  Licensing DNA origins 
Due to the large sizes of eukaryotic genomes, ranging from 107 to more than 109 base 
pairs (bp), replication is simultaneously initiated from numerous origins located on 
multiple chromosomes, typically spaced 30 – 100 kilobases (kb) apart (Bell and Dutta, 
2002; Blow and Dutta, 2005; Kelly and Brown, 2000; Sclafani and Holzen, 2007). In 
order that this process is not only fast but also accurate, replication must be strictly 
regulated to ensure that no segment of the chromosome is duplicated more than once 
per cell cycle.  
 
The early cell fusion experiments of Rao and Johnson first established that cells in 
different phases of the cell cycle differ in their capacity to undergo the initiation reaction 
(Rao and Johnson, 1970). When a G1 phase cell was fused to a G2 phase cell, the 
unreplicated G1 nucleus entered S phase directly while the DNA of G2 cell did not 
replicate again until the hybrid cell had undergone mitosis. Fusion of an S phase cell to 
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a G1 cell accelerated the latterʼs progress into S phase; this was not observed in the 
S/G2 hybrid. These results indicate that initiation of DNA replication required a positive, 
diffusible S phase-promoting signal that a cell in G1 but not G2 phase can respond to 
(Arias and Walter, 2007; Blow and Dutta, 2005). Working with the cell-free system of 
Xenopus egg extract, a “licensing” model was subsequently proposed, in which a 
licensing factor is required for replication initiation, binding to chromatin during late 
mitosis to G1 that is later removed as DNA is replicated (Blow and Laskey, 1988). This 
model effectively divides the process of DNA replication into two mutually exclusive 
stages, the first of which is permissive to licensing and the second to initiation. 
 
The idea that DNA exists in two distinct states was validated when in vivo foot-printing 
experiments in yeast showed that origins formed a “pre-replicative” pattern in G1 cells, 
in contrast to origins that exhibited a “post-replicative” pattern from initiation until the 
end of mitosis (Diffley et al., 1994). Other experiments had in the meantime provided 
evidence that in fission yeast, Cdk activity is required to limit DNA replication to a single 
round in each cell cycle and that inhibition of Cdk activity in G2 causes origins of 
replication to revert to a pre-replicative state that is amenable to re-initiation (Broek et 
al., 1991; Hayles et al., 1994). These experiments neatly set DNA replication back into 
the broader context of the cell cycle, such that two-step initiation model is closely 
correlated to the oscillations of Cdk activity. The first step, licensing, occurs soon after 
M phase as Cdk activity decreases upon mitotic exit while replication initiation is 
triggered when S phase Cdk activity rises at the G1/S transition.  
 
In molecular terms, origin selection occurs when the Origin Recognition Complex 
(ORC) binds to DNA. ORC serves as a landing pad for two other proteins, Cdc6 and 
Cdt1, to assemble onto origins which then coordinately load a head-to-head double 
hexamer of the mini-chromosome maintenance 2-7 (Mcm2-7) protein complex around 
origin DNA to form the pre-replicative complex (pre-RC) (Figure 1.1A) (Evrin et al., 
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2009; Gambus et al., 2011; Gillespie et al., 2001; Remus et al., 2009). In Xenopus egg 
extracts, the Mcm2-7 complex remains bound to DNA even if ORC and Cdc6 are 
subsequently removed. Since DNA replication can proceed under these circumstances, 
this suggests that the essential functions of the ORC complex and Cdc6 in initiation are 
completed upon Mcm2-7 recruitment to DNA (Hua and Newport, 1998; Rowles et al., 
1999). Indeed, following Cdt1 and Mcm2-7 association to chromatin, ATP hydrolysis 
followed by dissociation of Cdc6 triggers dissociation of Cdt1, stimulating the tight 
binding of Mcm2-7 to DNA (Randell et al., 2006). This stable association of Mcm2-7 
complex on DNA is referred to as licensing. ATPase activity from the ORC is essential 
for iterative loading of Mcm2-7 to support pre-RC formation (Bowers et al., 2004).  
 
Pre-RC assembly is restricted to late M and G1 phase, in the presence of low Cdk 
activity, whereas Mcm2-7 activation can only occur in the presence of high Cdk activity, 
which also serves to prevent de novo pre-RC assembly. Since the loading of the 
Mcm2-7 complex constitutes origin licensing, the displacement of Mcm2-7 from 
chromatin as replication forks proceed along DNA means that the “licence” is never 
associated with DNA that has already been replicated (Arias and Walter, 2007; Blow 
and Dutta, 2005). Upon entry in to S phase, multiple mechanisms ensure that no new 
pre-RCs can form and no re-replication takes place. In budding yeast, these depend 
largely on Cdk-dependent phosphorylation of pre-RC components (Arias and Walter, 
2007; Chen and Bell, 2011; Nguyen et al., 2001), whereas in metazoans a major 
pathway to prevent relicensing is the inhibition of Cdt1 activity through degradation or 
by its inhibitor geminin (Li and Blow, 2004; Wohlschlegel et al., 2000). Although the 
mechanisms to ensure once-per-cycle chromosomal duplication differ between yeasts 
and metazoans, the outcome centers on the inhibition of Mcm2-7 rebinding to 
replicated DNA. This provides a molecular basis to the original licensing hypothesis. 
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Figure 1.1. Licensing and initiation of replication origins in S. cerevisiae. 
(A) In G1 phase of the cell cycle, origin selection begins by the binding of ORC to chromatin. Cdc6 
and Cdt1 subsequently bind to ORC and then recruit Mcm2-7 to origins, forming the pre-RC. 
Stable loading of a double hexamer of Mcm2-7 is known as licensing. (B) At the G1/S transition, 
the activity of Cdc7 and S-Cdk are required to phosphorylate several components of the pre-RC 
and recruit other replication factors, including Cdc45 and GINS, to form the replisome. In budding 
yeast, Sld2 and Sld3 have been identified as the minimum set of Cdk targets essential for DNA 
replication. Initiation of origins results in the formation of a pair of replication forks moving 
bidirectionally away from the origins, replicating DNA in a semi-conservative manner. Adapted from 
(Labib, 2010). 
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1.2.3  Initiation of licensed origins 
The initiation of licensed origins to trigger active DNA replication requires the activity of 
two S phase promoting kinases: Cdk and the Dbf4/Drf1-dependent, Cdc7 kinase (DDK) 
(Figure 1.1B) (Jares and Blow, 2000; Pacek and Walter, 2004; Walter, 2000). The 
actions of these protein kinases stimulate the recruitment and stable association of 
other protein components, including Cdc45 and the GINS complex, with the Mcm2-7 
complex, which is important for in vivo helicase function (Labib, 2010).  
 
While the Mcm2-7 complex consists of six ATPase subunits like other DNA replicative 
helicases and the sub-complex of Mcm4-6-7 possesses limited helicase activity in 
several eukaryotic species (Ishimi, 1997; Lee and Hurwitz, 2000; You et al., 1999), 
evidence suggests that Mcm2-7 only unwinds DNA as part of a larger functional unit in 
vivo. Cdc45, first identified in budding yeast, was shown to be required for the 
progression of the replication fork together with Mcm2-7 (Aparicio et al., 1997; Tercero 
et al., 2000). This was later found to be true also for its orthologue in Xenopus (Pacek 
and Walter, 2004; Shechter et al., 2004). Subsequent work determined that Cdc45 
actually binds Mcm2-7 as part of an even larger assembly, together with the GINS 
complex, forming a Cdc45-Mcm-GINS (CMG) complex, at origins (Aparicio et al., 2006; 
Ilves et al., 2010; Moyer et al., 2006). The stable association of Cdc45 with an origin 
coincides with its temporal order of initiation and as such, Cdc45 recruitment is a 
marker of origin activation (Aparicio et al., 1999; Zou and Stillman, 2000). The GINS 
(Go-Ichi-Nii-San or 5-1-2-3, referring to the component subunits Sld5, Psf1, Psf2 and 
Psf3) complex is required to maintain the association of Mcm2-7 and Cdc45 within the 
CMG complex (Gambus et al., 2006). CMG complexes isolated from extracts of early 
Drosophila embryos were found to have DNA helicase activity and components of the 
CMG complex were among the components identified in a replicative helicase on 
replicating DNA in Xenopus extracts (Moyer et al., 2006; Pacek et al., 2006). These 
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lines of evidence suggest that the CMG complex is the active form of the eukaryotic 
helicase. With its ATPase activity, Mcm2-7 serves as the engine in this molecular 
machine to unwind origin DNA (Ilves et al., 2010). 
 
1.2.3.1  S-Cdk activity is required for replication initiation 
Early work in the cell cycle has shown that Cdk activity is required for DNA replication 
in eukaryotes. Xenopus extracts depleted of Cdks and yeast mutants of Cdks and 
cyclins cannot initiate DNA replication (Blow and Nurse, 1990; Hartwell, 1971a; Nurse 
and Bissett, 1981). It was first shown in budding yeast and the later in metazoans that 
Cdk activity is required throughout S phase for the activation of replication origins 
(Donaldson et al., 1998b; Thomson et al., 2010). However, the essential Cdk 
substrates for replication initiation have only been recently determined in S. cerevisiae, 
thereby allowing for a mechanistic description of Cdk requirement in this process 
(Figure 1.1B). The Sld2 and Sld3 proteins are proposed to be the “minimum set” of Cdk 
targets (Tanaka et al., 2007; Zegerman and Diffley, 2007). Upon Cdk phosphorylation 
Sld2 binds to the C-terminal pair of the four BRCT (BRCA1 C terminus) repeats of the 
Dbp11 protein (Masumoto et al., 2002; Tak et al., 2006), while Cdk phosphorylation of 
Sld3 promotes its association to the N-terminal pair of BRCT repeats of Dbp11 (Tanaka 
et al., 2007; Zegerman and Diffley, 2007). Previous work had shown that Sld3 and 
Cdc45 may associate with origins weakly during G1 and Sld3 is subsequently 
displaced from origins and is not required for the elongation process (Kamimura et al., 
2001; Kanemaki and Labib, 2006). A model was thus proposed that Sld3 first 
associates with a component at origins, helping to recruit Cdc45, while Dbp11 then 
acts a bridge for phosphorylated Sld2 and Sld3, leading to the recruitment of GINS 
(Araki, 2010; Heller et al., 2011). This model is supported by the observation that yeast 
cells expressing a phosphomimetic mutant of Sld2 and a fusion of Sld3 to the C-
terminal pair of BRCT repeats of Dbp11 can replicate DNA in the absence of Cdk 
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activity (Zegerman and Diffley, 2007). A mutated Cdc45 allele can also replace the 
Sld3-Dbp11 fusion protein in a similar assay (Tanaka et al., 2007). Based on sequence 
similarity, the metazoan homologue of Sld2 may be RecQL4 (Sangrithi et al., 2005) 
while three proteins, DUE-B (DNA unwinding element) (Casper et al., 2005), 
Treslin/ticrr (TopBP1-interacting, replication-stimulation protein) (Kumagai et al., 2010) 
and GEMC1 (Geminin coiled-coil-containing protein 1) (Balestrini et al., 2010) have 
been postulated to be the functional equivalent of yeast Sld3. Treslin/ticrr shares 
sequence similarity with Sld3 and its interaction with TopBp1 (metazoan Dbp11) is 
Cdk-dependent (Boos et al., 2011; Kumagai et al., 2011; Sanchez-Pulido et al., 2010).  
 
1.3  The Cdc7 kinase 
The other S phase-promoting kinase required for replication initiation is Cdc7, an 
essential serine/theonine kinase that is conserved from yeast to humans. cdc7 was 
identified to encode a gene product involved in controlling the cell cycle in the original 
search for temperature sensitive cdc mutants in S. cerevisiae (Hartwell et al., 1970) 
and was determined to be required for the initiation of DNA synthesis (Hereford and 
Hartwell, 1974). Cdc7 was demonstrated to be a kinase capable of phosphorylating 
serine and/or threonine residues (Hollingsworth and Sclafani, 1990). Its fission yeast 
homologue, Hsk1 (homologue of Cdc-seven kinase 1), and homologues in Xenopus, 
mouse and human were isolated subsequently (Kim et al., 1998; Masai et al., 1995; 
Sato et al., 1997). Depleting Cdc7 from the cell-free system derived from Xenopus 
eggs resulted in the complete loss of DNA replication, indicating an essential role of 
Xenopus Cdc7 for replication activity (Jares and Blow, 2000; Walter, 2000). Cdc7 
activity is also essential in mammalian cells (Jiang et al., 1999; Kumagai et al., 1999) 
and the deletion of muCdc7 results in early embryonic lethality in mice (Kim et al., 
2002).  
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In the following sections, the activators (Section 1.3.1) and substrates (1.3.2) of Cdc7 
will be discussed, as well as its roles in the replication timing programme (1.3.3.1), 
intra-S checkpoint (1.3.4), other chromosome transactions (1.3.5) and its relevance to 
clinical applications (1.3.6). 
 
1.3.1  Cdc7 regulators – Dbf4 and Drf1 
The activity of the Cdc7 kinase is regulated by association with its activation subunits. 
In yeasts, only one regulator has been identified – Dbf4 (dumbbell forming 4) in S. 
cerevisiae and Dfp1 (dbf four in pombe 1) in S. pombe. In budding yeast, the Dbf4 
protein accumulates during S phase and is targeted for ubiquitin-mediated degradation 
by the anaphase-promoting complex at the end of mitosis (Ferreira et al., 2000; Oshiro 
et al., 1999; Weinreich and Stillman, 1999). While Cdc7 is expressed at an 
approximately constant level throughout the cell cycle, kinase activity peaks in at the 
G1/S transition when it binds to and is activated by Dbf4/Dfp1 (Jackson et al., 1993; 
Kitada et al., 1992; Masai et al., 1995; Takeda et al., 1999). In human cells, the 
correlation between Cdc7/Dbf4 complex formation and oscillation of Cdc7 kinase 
activity has also been observed (Jiang et al., 1999; Kumagai et al., 1999). In human 
and Xenopus, a second regulator of Cdc7 has been identified. Drf1 (Dbf4-related factor 
1) is a Dbf4-related protein which also activates Cdc7 (Montagnoli et al., 2002; 
Takahashi and Walter, 2005; Yanow et al., 2003; Yoshizawa-Sugata et al., 2005) and 
is important for promoting DNA replication (Silva et al., 2006; Takahashi and Walter, 
2005). The active Cdc7/Dbf4 and Cdc7/Drf1 kinase complexes are collectively referred 
to as the Dbf4/Drf1-dependent kinase (DDK). The significance of two Cdc7 regulators 
in vertebrates is currently unclear. Experiments in Xenopus egg extracts indicate that 
both Dbf4 and Drf1 are only found in complexes with Cdc7 and that Cdc7/Drf1 is found 
in greater abundance over the Cdc7/Dbf4 complex (Silva et al., 2006; Takahashi and 
Walter, 2005). The expression of XDrf1 and XDbf4 is differentially regulated during 
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development and the primary Cdc7-binding partner that drives replication in early 
Xenopus embryos appears to be Drf1 (Silva et al., 2006; Takahashi and Walter, 2005). 
In human cells, both components accumulate and regulate the kinase activity of Cdc7 
during the cell cycle (Yoshizawa-Sugata et al., 2005). Based on these observations, it 
may be possible that two regulators are required to fine-tune Cdc7 kinase activity 
temporally or in different biological processes, analogous to cyclin specification of Cdk 
activity in metazoans. 
 
1.3.2  Cdc7 substrates for replication initiation 
It has been shown that Cdc7 is able to phosphorylate several components of the 
replicative machinery, including multiple subunits of the Mcm2-7 complex (Jares and 
Blow, 2000; Jiang et al., 1999; Lei et al., 1997; Masai et al., 2000; Sato et al., 1997), 
Cdc45 (Kihara et al., 2000; Nougarede et al., 2000) and DNA polymerase α (Weinreich 
and Stillman, 1999). Of these proteins, Mcm2-7 appears to be the essential Cdc7 
target during DNA replication. Genetic and biochemical data indicate that Cdc7 initiates 
DNA replication by binding to Mcm2-7 at origins of replication and phosphorylating 
several subunits of the hexamer. Evidence for the interaction between Cdc7 and the 
Mcm2-7 complex was first provided by the isolation of bob1, a mutant allele of MCM5 
in yeast, as a bypass suppressor for cdc7 and dbf4 (Hardy et al., 1997). It was 
proposed that Cdc7 phosphorylation results in a conformational change that activates 
the helicase, while mcm5-bob5 mutations produce several protein conformations of 
which one is permissive for origin firing, thus bypassing a requirement for Cdc7 kinase 
activity though at reduced initiation efficiency (Hoang et al., 2007).  
 
It was shown that yeast Mcm2 is an important downstream target of Cdc7/Dbf4 kinase 
(Brown and Kelly, 1998; Lei et al., 1997) and a dbf4 mutant was identified as an allele-
specific suppressor of the temperature sensitive mcm2-1 allele (Lei et al., 1997). 
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Studies reported that Mcm2 is efficiently phosphorylated in vivo and in vitro by Cdc7 in 
fission yeast, mammalian cells as well as Xenopus egg extracts (Masai and Arai, 2002; 
Masai et al., 2006). The phosphorylation of Mcm2, classically detected as differential 
mobility in SDS-PAGE, appears to occur in a cell cycle-dependent manner. Though 
several S phase regulating kinases are known to phosphorylate Mcm2, mapping of 
specific phospho-sites on the human Mcm2 protein revealed that the observed cell 
cycle-dependent phosphorylations coincided almost exactly with Cdc7-dependent 
positions (Montagnoli et al., 2006). A similar study by Tsuji et al. showed that Mcm2 
phosphorylation by Cdc7/Dbf4 is essential for the initiation of DNA replication in human 
cells (Tsuji et al., 2006). In Xenopus egg extracts, Cdc7 is specifically recruited to 
chromatin containing Mcm2-7, and this recruitment is mediated by its activating subunit 
(Jares and Blow, 2000; Jares et al., 2004; Walter, 2000). A docking region for Cdc7 
has been reported in Mcm2 and that phosphorylation of Mcm2 by Cdc7 is essential for 
replication (Bruck and Kaplan, 2009). Mcm3 and Mcm7 have also been reported to be 
phosphorylated by Cdc7 in vitro (Weinreich and Stillman, 1999); Mcm5 is the only Mcm 
subunit that has not been shown to be a substrate of Cdc7 in S. cerevisiae and other 
species (Labib, 2010).  
 
The N-terminus of eukaryotic Mcm2, Mcm4 and Mcm6 contain relatively unstructured 
extensions of up to a few hundred amino acids, which may be major substrates for 
Cdc7, as well as for Cdk (Labib, 2010). In Xenopus, Mcm4 hyper-phosphorylation was 
found to be Cdc7-dependent (Pereverzeva et al., 2000; Takahashi and Walter, 2005). 
Putative Cdc7 phosphorylation sites have been reported in the N-terminal tails of Mcm4 
and Mcm6 in human cell lines and these sites may play important but overlapping roles 
in recruiting Cdc45 to chromatin. Full length Mcm4 protein is a better Cdc7 substrate 
than shorter fragments of the Mcm4 N-terminal tail, indicating that the kinase may 
require a docking site in this region (Masai et al., 2006). Such a Cdc7 docking region 
was described in the budding yeast N-terminal structured sequence adjacent to the 
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unstructured NSD (N-terminal Ser/Thr-rich domain) of eukaryotic Mcm4, known to 
contain multiple targets for Cdc7 phosphorylation (Sheu and Stillman, 2006). Hyper-
phosphorylated Mcm4 was found enriched in the Cdc45-Mcm2-7 complex, suggesting 
that this is the activated form of the helicase. In a more recent study by the same 
group, it was proposed that the essential function of Cdc7 phosphorylation is to relieve 
an inhibitory activity residing in the N-terminal tail of Mcm4 (Sheu and Stillman, 2010). 
In cells lacking this inhibitory region, Cdc7 activity is no longer required for viability. 
However, these cells grew slowly, as did the mcm5-bob1 mutants, suggesting that the 
formation or stability of the Cdc45-Mcm2-7 complex may be defective. The NSD may 
therefore have additional positive roles in promoting cell survival. Cells that lacked the 
entire NSD region were viable but defective in S phase in the absence of Cdc7 (Sheu 
and Stillman, 2010).  
 
While the Mcm2-7 complex is likely the physiological target of Cdc7 for DNA 
replication, it is also phosphorylated by Cdk (Masai et al., 2000; Tenca et al., 2007). 
Consequently, mechanisms should exist that coordinate Cdk- and Cdc7-dependent 
events (Heller et al., 2011). Several studies indicate that sequential phosphorylation 
events target Mcm2 during the cell cycle in the budding yeast and that the proper pre-
phosphorylation of the specific protein residues is required for Cdc7/Dbf4 to utilise 
Mcm2 as a substrate (Francis et al., 2009; Kihara et al., 2000; Lei et al., 1997). Using 
Xenopus egg extracts, it was determined that DNA replication can only occur when 
chromatin is sequentially exposed first to Cdc7 and then to the Cdk2 kinase. Cdc7 
activity can be completed in the absence of significant Cdk activity whereas Cdk2 
cannot execute its function before Cdc7 (Jares and Blow, 2000; Walter, 2000). 
Subsequent experiments using extracts from budding yeast gave results consistent 
with this (Heller et al., 2011). However, the preference of Cdc7 for serine and threonine 
residues in an acidic context may be fulfilled by having substrates located adjacent to a 
Cdk phosphorylation sites (Cho et al., 2006; Masai et al., 2000; Masai et al., 2006; 
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Montagnoli et al., 2006). Prior phosphorylation by Cdk may prime these substrates, 
thereby enhancing Cdc7 activity. It has been shown that Cdk modification can create 
Cdc7 target sites (Masai et al., 2006; Wan et al., 2008), indicating close coordination 
between the two S phase-promoting kinases in initiating origins of replication. In 
Xenopus egg extracts, pre-phosphorylation of Mcm2-7 by Cdks may occur during the 
preceding mitosis (Pereverzeva et al., 2000).  
 
1.3.3  The replication timing programme 
DNA replication initiates at numerous origins throughout the eukaryotic genome and 
subsets of origins become sequentially activated through S phase, following a temporal 
progression. In budding yeast, activation of pre-RCs proceeds in a genetically 
determined order on the chromosome and early- and late-firing origins have been 
clearly identified. Origins located near telomeres fire late, possibly as a result of 
differences in chromatin structure. Specific sequences have been well defined that can 
cause early replicating origins to fire late (Czajkowsky et al., 2008; Ferguson and 
Fangman, 1992; Friedman et al., 1996; Raghuraman et al., 2001; Stevenson and 
Gottschling, 1999). In contrast, the regulation of replication timing in metazoans is less 
well understood. Local chromatin environment, nuclear positioning of chromosome loci, 
patterns of histone modifications, transcriptional regulation and checkpoint regulation 
have been found to be related to the determination of replication timing (Chagin et al., 
2010; Zink, 2006). Experiments in budding yeast indicate that replication origins 
become established as late-firing during G1 phase in the cell cycle (Raghuraman et al., 
2001). This programming event appears to be similar to the “timing decision point” 
described in metazoans, which is a time in early G1 phase after which somatic cells 
can replicate according to a normal temporal programme if driven into S phase by 
Xenopus egg extracts in vitro (Dimitrova and Gilbert, 1999). 
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Analyses of the dynamics of DNA replication at a cellular level became possible when 
methods of labelling on-going DNA synthesis were developed to detect sites of DNA 
replication within the nucleus. Radioactive thymidine and antibodies against 
halogenated thymidine analogues were first used to analyse nuclear structures of 
replication (Aten et al., 1992; Gratzner, 1982; Milner, 1969; Nakamura et al., 1986; 
Nakayasu and Berezney, 1989; O'Keefe et al., 1992). Subsequently, fluorochrome-
conjugated nucleotides and the expression of replication factors tagged to fluorescent 
markers provided ways to observe the progress of DNA replication through live cell 
microscopy (Cardoso et al., 1997; Leonhardt et al., 2000; Schermelleh et al., 2001). 
With these approaches, DNA replication was determined to occur at sub-nuclear sites 
termed replication foci, which accumulate replication factors and cell cycle proteins 
(Cardoso et al., 1997; Cardoso et al., 1993). Sequential patterns of DNA replication can 
be observed over the course of S phase, which can be categorised into five different 
phases of replication (named Type I – V) (O'Keefe et al., 1992). These characteristic 
spatial-temporal patterns are formed when replication foci localise to characteristic 
regions of the nucleus during specific times in the S phase. They remain stable over 
multiple cell divisions, indicating a close relationship between the spatial positioning of 
DNA in the nucleus and its replication timing in during S phase (Zink, 2006). Chromatin 
modification of the regions surrounding replication origins may play a part in the 
establishing the timing programme (Thomson et al., 2010). 
 
Profiles of origin initiation have been characterised across the entire genome of the 
budding yeast (Raghuraman et al., 2001), fission yeast (Eshaghi et al., 2007; Hayashi 
et al., 2007; Heichinger et al., 2006; Mickle et al., 2007), Drosophila (MacAlpine et al., 
2004; Schübeler et al., 2002) and mammalian cells (Cohen et al., 2006; Farkash-Amar 
et al., 2008; Hiratani et al., 2008; Jeon et al., 2005; White et al., 2004; Woodfine et al., 
2005; Woodfine et al., 2004). These genomic approaches have identified relatively 
large domains of contiguous DNA that replicate at characteristic times over S phase 
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(Hiratani et al., 2008; Watanabe et al., 2002; Woodfine et al., 2004). Such timing 
domains are functionally compartmentalised replication zones that span several 
megabases in size. Their sizes suggest that they are comprised of one or several 
adjacent replicon clusters, which are groups of one to ten origins that initiate 
synchronously (Berezney et al., 2000; Gillespie and Blow, 2010; Hiratani et al., 2008; 
Jackson and Pombo, 1998; MacAlpine and Bell, 2005; Zink, 2006).  
 
The exact relationship between (1) replication foci – subcellular structures observed 
through visualisation of cells undergoing replication, (2) replicon clusters – functional 
groups of initiating origins and (3) timing domains – zones defined by genomic analysis 
of replication timing, remains unclear, as does the understanding of their regulation 
during S phase (Gillespie and Blow, 2010). In higher eukaryotes, replication timing 
appears to be regulated at a global level, so that the loss of a single origin does not 
affect the overall timing programme (Hayashida et al., 2006). According to one model, 
origin firing is stochastic and can produce the defined patterns of replication observed 
on average in cells, if origins inherently have different relative firing probabilities and if 
the firing probabilities of all origins increase during S phase (Rhind, 2006; Rhind et al., 
2010). Other studies show that checkpoint signalling pathways may modulate the 
extent to which the initiation of certain origins is delayed in response to DNA damage 
or replicative stress in a perturbed S phase (Santocanale et al., 1999; Shirahige et al., 
1998), or by regulating origin activation differentially at the level of replication clusters 
depending on whether they are actively undergoing DNA synthesis (Blow et al., 2011; 
Ge and Blow, 2010). 
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Figure 1.2. The replication timing programme. 
(A) The progress of DNA replication can be visualised in human HeLa cells stably expressing GFP-
tagged PCNA. Snapshots of a time-lapse confocal microscopy movie show that during early S 
phase, sites of active DNA replication are found in small foci distributed throughout the nucleus, 
mostly corresponding to euchromatic regions. The DNA replication machinery loads at perinuclear 
and perinucleolar heterochromatin regions in mid S phase and then at large constitutive 
heterochromatic chromosomal regions at the end of S phase. This temporal replication program is 
recapitulated at each cell cycle. SE: S early/ SM: S mid/ SL: S late. Adapted from (Chagin et al., 
2010). (B) Schematic of the establishment and execution of the timing programme in the cell cycle. 
Cell cycle phases are denoted in the inner circle while stages of DNA replication are shown on the 
outer circle; yellow and red arrows represent periods of licensing competence and inhibition 
respectively and the green arrow indicates execution of the replication timing programme; 
representative nuclear transitions are illustrated. During mitosis, paired sister chromatids align on 
the metaphase plate before separation to opposite poles of dividing cells at anaphase onset. 
Chromosome decondensation and nuclear envelope reformation takes place. In early G1, 
euchromatin (red) and heterochromatin (blue) are initially randomly dispersed but become localised 
to specific domains in the nucleus. Replication nuclei (green) are then activated according to the 
timing programme over the course of S phase. Post-replication, nuclei pass through G2 into 
mitosis. Chromosome condensation and nuclear envelope breakdown marks entry into mitosis for 
another round of sister chromatid separation. Adapted from (Gillespie and Blow, 2010). 
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1.3.3.1  Cdk and Cdc7 in replication timing programme regulation 
Since the firing of replication origins require phosphorylation events mediated by Cdk 
and Cdc7, it is likely that they are involved in regulating the replication timing 
programme.  
 
Cdk activity is required throughout S phase for origin initiation in S. cerevisiae, in which 
S phase Cdk activity is provided by Cdc28 (Cdk1) binding to the B-type cyclins, Clb5 
and Clb6. Earlier studies reported that in budding yeast cells lacking Clb5, S phase is 
lengthened and only early- but not late-firing origins are initiated (Donaldson et al., 
1998b; Epstein and Cross, 1992; Schwob and Nasmyth, 1993). It was later determined 
that while Clb5 and Clb6 can both drive S phase, Clb6 is the minor S phase cyclin that 
is only expressed early in S phase. The defect in clb5 mutants can be restored by the 
expression of a non-degradable Clb6 construct and S phase proceeded with a wild 
type temporal pattern (Gibson et al., 2004; Jackson et al., 2006; McCune et al., 2008). 
In Xenopus egg extracts, the execution of replication timing programme requires on-
going activity of S-Cdk. Addition of roscovitine at different times throughout S phase to 
inhibit Cdk activity rapidly prevented origin firing within 2.5 min of treatment (Luciani et 
al., 2004). However, elongation of nascent DNA strands from origins fired before 
roscovitine addition was not affected.  
 
Using the experimental system first developed by Gilbert et al., in which the replication 
of mammalian G1 nuclei is driven by incubation in Xenopus egg extracts (Dimitrova 
and Gilbert, 1999; Gilbert et al., 1995), it was demonstrated that Cdk activity is required 
throughout S phase for progression through the replication timing programme 
(Thomson et al., 2010). Activation of replication factories/clusters was found to be 
highly sensitive to Cdk activity, whereby reduction of Cdk activity was associated with a 
reduced number of active replication factories, while the number of forks within each 
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factory remained largely unchanged. Progression through different replication timing 
patterns was also not sensitive to modest changes to Cdk levels. This study provided 
evidence that Cdk drives progression through S phase in different ways, differentially 
affecting the timing program, factory activation, and replication initiation. A similar effect 
of Cdk activating replicon clusters was also reported when sperm nuclei were used as 
replication substrates in Xenopus egg extracts (Krasinska et al., 2008). In human cells, 
expression of a constitutively active mutant fusion construct of Cdk1-cyclin A resulted 
in the premature appearance of DNA replication at late origins in early S phase, again 
establishing a role for Cdk in regulating replication timing (Katsuno et al., 2009).  
 
Several lines of evidence implicate a role for Cdc7 in the regulation of replication timing 
as well. In budding yeast, Cdc7 was shown to be required early as well as late in S 
phase for the initiation of early- and late-firing origins respectively (Bousset and Diffley, 
1998; Donaldson et al., 1998a; Pasero et al., 1999). Patel et al. showed that Hsk1 is a 
rate-limiting factor for origin firing in fission yeast (Patel et al., 2008). Origin efficiency 
increased or decreased correspondingly with Hsk-Dfp1 levels and physically tethering 
the kinase near an origin increases its firing efficiency, indicating a possible effect of 
local concentration. These results are consistent with a study by Wu and Nurse who 
provided evidence that increased levels of Hsk1 or Dfp1 accelerated firing of both 
efficient and inefficient origins across the genome (Wu and Nurse, 2009). In a recent 
report, the association of the Sld3-Sld7-Cdc45 complex with origins, an event 
dependent on Cdc7 activity, was reported to be a key step in regulating origin firing in 
S. cerevisiae. Sld3, Sld7 and Cdc45 are normally present at low levels in budding yeast 
and increased levels of these proteins allow late firing origins to fire early in S phase. 
Increasing the levels of Cdc7 or Dbf4 also allowed late firing origins to fire early, 
suggesting that Cdc7 activity may be rate limiting for replication initiation (Tanaka et al., 
2011a). These findings are consistent with another report showing that Dbf4 is in low 
abundance in the budding yeast and over-expression of Dbf4, the two essential Cdk 
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substrates Sld3 and Sld2 plus their binding partner Dpb11 is sufficient to allow late 
firing origins of replication to initiate early (Mantiero et al., 2011). These studies in yeast 
suggest that Cdc7 plays a role in promoting initiation at individual replication origins to 
drive the replication timing programme. A possible hypothesis for the role of Cdc7 in 
regulating replication timing may be that Cdc7 preferentially associates with Mcm2-7 at 
early-replicating origins in early S phase, and is displaced to activate later firing origins 
only when early firing origins have replicated. As yet, the role of Cdc7 in regulating 
metazoan replication timing remains to be elucidated. 
 
1.3.4  Cdc7 in the intra-S phase checkpoint response 
For the successful completion of DNA replication, cells must possess ways to 
constantly monitor the integrity of on-going replication forks and be able to initiate a 
DNA damage response as required during the course of S phase. The progression of 
replication forks may be hindered in a number of ways including the presence of 
protein-DNA complexes, depletion of the nucleotide pool, collisions between the 
replisome and transcription machinery and external DNA damaging agents. These 
elements induce the pausing or completely block the progression of replication forks, 
thereby increasing the possibility of DNA breakage events. The intra-S checkpoint 
ensures completion of replication before cells enter mitosis by slowing the rate of 
replication in response to DNA damage (Finn et al., 2011) and regulating the firing of 
uninitiated replication origins, including late-firing and dormant origins (Blow et al., 
2011). The replication checkpoint is also involved in regulating subsequent steps 
related to fork restart processes (Branzei and Foiani, 2005, 2010). 
 
Checkpoint signalling occurs through a network of sensors and transducers that detect 
and amplify the DNA damage or replicative-stress signal. Members from the family of 
phosphoinositide 3-kinase (PI3K)-related protein kinases, including ATM (ataxia-
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telangiectasia mutated) and ATR (ATM and Rad3-related), act as major upstream 
regulators of the DNA damage response. ATR is activated in response to single-
stranded DNA (ssDNA) coated with multiple subunits of RPA (replication protein A) – 
ssDNA-RPA. ATR binds to RPA through ATRIP (ATR-interacting protein) at the same 
time that the 9-1-1 complex (Rad9-Rad1-Hus1) is independently recruited to ssDNA-
RPA. TopBP1 (topoisomerase-binding protein 1) then binds and activates ATR, 
causing phosphorylation of the downstream Chk1 kinase and other ATR effectors. ATR 
activation inhibits origin firing and replication factory activation, induces cell cycle arrest 
and stabilises and allows stalled forks to re-initiate. On the other hand, the ATM 
checkpoint kinase is recruited to sites of double-stranded DNA damage, binding to the 
MRN (Mre11-Rad50-Nbs1) complex and phosphorylating the histone variant H2AX. 
Activated ATM phosphorylates Chk2 and other downstream targets, leading to 
inhibition of origin firing, cell cycle arrest and repair of double strand breaks (Cimprich 
and Cortez, 2008; Masai et al., 2010).  
 
Under replicative stress, replication forks are first paused or slowed down. In S. 
cerevisiae, proteins such as Mrc1 (Claspin in metazoans) and Tof1 (Swi1/Timeless), 
which are conserved replication fork factors, limit progression of the replisome under 
such circumstances (Katou et al., 2003). It was shown in budding yeast that mec1 
(homologue of ATR) or rad53 (homologue of Chk2) mutations repress late origin firing 
in the presence of hydroxyurea (HU) (Santocanale et al., 1999; Shirahige et al., 1998). 
By analysing S. cerevisiae mutants, it was proposed that checkpoint proteins stabilise 
stalled forks and prevent disassembly of the replisome, thereby preventing replication 
fork collapse (Cobb et al., 2003; Katou et al., 2003; Lucca et al., 2004). However, this 
view is challenged by a recent study which revealed that the replisome remained stably 
associated with replication forks following replication stress, even in the absence of 
Mec1 and Rad53 (De Piccoli et al., 2012). The authors proposed the function of 
checkpoint kinases is to phosphorylate components of the stalled replisome, 
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maintaining it in a state competent for DNA synthesis. This explains why checkpoint-
deficient cells fail to resume replication despite the presence of intact replicative 
machinery at replication forks (Berens and Toczyski, 2012; De Piccoli et al., 2012). 
 
There is substantial evidence that Cdc7 kinase is a direct target of the S phase 
checkpoint. In budding yeast, checkpoint-dependent phosphorylation of Dbf4 by Rad53 
restricts origin firing (Lopez-Mosqueda et al., 2010; Zegerman and Diffley, 2010). Dfp1 
also undergoes Cds1 (homologue of Chk2)-dependent phosphorylation in fission yeast 
(Snaith et al., 2000). Chromatin association of Dbf4 is reduced in a Rad53-dependent 
manner after HU treatment (Pasero et al., 1999) and Rad53 phosphorylation of Dbf4 
was found to attenuate Cdc7 kinase activity (Weinreich and Stillman, 1999). Genetic 
studies also suggest that Cdc7 is important in preserving fork integrity and recovery 
from fork stalling (Matsumoto et al., 2005; Takeda et al., 1999). In Xenopus egg 
extracts, initial studies suggested that the Topoisomerase II (Topo II) inhibitor 
etoposide causes checkpoint-mediated inhibition of Cdc7-Dbf4 complex formation and 
kinase activity (Costanzo et al., 2003). Similar results were obtained with human 
leukemia cells treated with etoposide (Dierov et al., 2004). However, other studies in 
both Xenopus egg extracts and mammalian cells provided evidence that the 
expression, complex formation, chromatin association and kinase activity of Cdc7 and 
associated regulators remain intact in cells during S phase checkpoint responses 
(Heffernan et al., 2007; Silva et al., 2006; Takahashi and Walter, 2005; Tenca et al., 
2007; Tsuji et al., 2008), raising the possibility the Cdc7 may also play active roles in 
mediating checkpoint recovery. 
 
In metazoans, some studies indicate that Drf1 may be more important in the S phase 
checkpoint than Dbf4 (Silva et al., 2006; Takahashi and Walter, 2005). Drf1 
accumulates on chromatin in an ATR- and Claspin-dependent manner in Xenopus egg 
extracts during replication arrest (Yanow et al., 2003) and Cdc7 could phosphorylate 
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and interact with Claspin in extracts and human cells (Gold and Dunphy, 2010; Kim et 
al., 2008), suggesting a potential regulatory relationship during a perturbed S phase. 
Mammalian cells were defective in Chk1 and Claspin phosphorylation and became 
sensitive to replicative stress caused by HU when Cdc7 was knocked down with small 
interfering RNA (siRNA) (Kim et al., 2008). However, a recent report had described that 
Dbf4 is a direct downstream target of ATM and ATR upon checkpoint activation in 
human cell lines. ATM/ATR phosphorylation sites on Dbf4 were identified which are 
important in restricting origin firing without inactivating Cdc7 kinase activity, reconciling 
the apparent conflict broached by other studies. Indeed, Cdc7 kinase activity is 
required to prevent fork collapse and the formation of double stranded breaks upon 
replication stress (Lee et al., 2012). There is still much to be learnt about the role and 
mechanisms Cdc7 activity in the intra-S checkpoint response. 
 
1.3.5  Cdc7 in other chromosome transactions 
Cdc7 is an important regulatory molecule not only in DNA replication but also in 
chromosomal cohesion and meiosis. In S. pombe, Hsk-Dfp1 was found to function in 
the same pathway as Swi6 (fission yeast heterochromatin protein 1), required at 
centrosomes for cohesion between sister chromatids, to promote heterochromatin-
mediated cohesion. This role for Hsk-Dfp1 was proposed to be distinct from its 
replication initiation function (Bailis et al., 2003). However, a later study suggests that 
Swi6 stimulates Sld3 recruitment to origins, which in S. pombe is dependent on Hsk1-
Dfp1, and is required for early replication of two heterochromatic regions (Hayashi et 
al., 2009). In Xenopus egg extracts, Cdc7-Drf1 was found to be in a stable complex 
with Scc2-Scc4, a complex required for cohesin recruitment to chromosomes, and 
Scc2-Scc4 was unable to bind to chromatin in the absence of Cdc7 activity. Cdc7 
activity is required to tether Scc2-Scc4 to pre-RCs to establish functional cohesion 
between replicated sister chromatids (Takahashi et al., 2008); it is currently unclear 
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whether this is mediated by Cdc7 phosphorylating Mcm2-7 or other proteins.  
 
Cdc7 was found to play multiple roles in events that promote meiosis I segregation 
(Marston, 2009). While the bob5 mutant allele allows a bypass of Cdc7 deletion in 
budding yeast, it could not rescue a prophase I arrest due to the failure in inducing 
transcription of NDT80, a global meiotic transcriptional regulator that is required for exit 
from prophase I and progression into meiosis (Lo et al., 2012; Lo et al., 2008; 
Sasanuma et al., 2008). Cdc7-Dbf4 is also required for the initiation of meiotic 
recombination (Matos et al., 2008; Sasanuma et al., 2008; Wan et al., 2008; Wan et al., 
2006) and to localise the monopolin complex to kinetochores to specify mono-
orientation (Lo et al., 2008; Matos et al., 2008). As in replication, Cdc7 appears to 
coordinate with Cdk phosphorylation events to execute its meiotic functions (Lo et al., 
2012; Marston, 2009). 
 
1.3.6  Cdc7 in clinical and translation applications 
Given its essential function in regulating DNA replication, it is perhaps unsurprising that 
Cdc7 may be regulated differently in cancer cells, in which sustained proliferative 
signalling contributes towards tumour development. Cdc7 expression has been found 
to be up-regulated in several cancer cell lines and primary tumours while remaining 
relatively low or absent in healthy and/or non-proliferative cells (Bonte et al., 2008; 
Hess et al., 1998). Intriguingly, however, this does not correlate with the cellsʼ 
proliferative status. Over-expression of Cdc7/Dbf4 either has no significant effect on 
cell cycle progression (Sato et al., 2003), arrests cells in G1 or appreciably retards S 
phase progression for cells already in S phase (Guo et al., 2005). Increased Cdc7/Dbf4 
may instead confer a survival advantage for cancer cells through its functions in 
recovery or repair of stalled forks (Bonte et al., 2008; Hess et al., 1998).  
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The analysis of Cdc7 expression can provide prognostic information on malignant 
progression and is a powerful marker of clinical outcomes in cutaneous melanoma 
(Clarke et al., 2009) and epithelial ovarian carcinoma (Kulkarni et al., 2009). In several 
cancer types, Cdc7 over-expression correlated with advanced tumour stage and poor 
clinical prognosis. In breast cancer, Cdc7 deregulation leading to high expression 
levels has been associated with acquisition of a malignant, hyper-proliferative 
phenotype (Rodriguez-Acebes et al., 2010). Higher levels and an increased number of 
cells staining positive for Mcm2 phosphorylation, indicative of high Cdc7 kinase activity, 
were also found in many cancer cell types such as skin basalioma, laryngeal 
squamous cancer and colon adenomas and adenocarcinomas (Montagnoli et al., 
2010). These clinical observations argue for a role of Cdc7 in the pathology of cancer 
aside from serving as a biomarker.  
 
In addition to providing diagnostic information, the central role that the Cdc7 kinase 
plays in DNA replication identifies it as an attractive target in cancer therapy. Cdc7 
depletion using siRNA provided the first indications that cancer cells lines behave 
differently from normal cell in response to replicative stress. Loss of Cdc7 in tumour cell 
lines resulted in an abortive S phase, leading to aberrant mitosis or p53-independent 
apoptosis. In contrast, a robust p53-dependent checkpoint response actively prevented 
normal fibroblasts from entering a lethal S phase in the absence of Cdc7 (Montagnoli et 
al., 2004). These results are consistent with a later study showing that fibroblasts 
depleted of Cdc7 arrest before entry into S phase in a checkpoint-dependent manner. 
The nature of this proposed pre-S phase arrest is currently unknown. Subsequent 
recovery of proliferative capacity suggested that this G1 arrest in normal cells is 
reversible (Tudzarova et al., 2010). The apoptotic cell death observed in cancer cells 
following Cdc7 depletion was suggested to be mediated by ATR-dependent activation 
of the p38 MAP kinase signalling pathway (Im and Lee, 2008). This was confirmed in a 
recent study which demonstrated that even p53-positive cancer cells were susceptible 
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to cell death as a result of Cdc7 depletion. The authors propose that Cdc7 depletion-
dependent cell death can occur through multiple mechanisms and that p53 status 
affects the eventual mode of cell death in different cells (Ito et al., 2012). 
 
These studies support the notion that differential expression of Cdc7 and other 
checkpoint defects may cause cancer cells to be selectively sensitive to a new class of 
drugs that targets the initiation of DNA replication (Blow and Gillespie, 2008). In this 
regard, several small chemical molecules have recently been reported to be potent and 
selective inhibitors of Cdc7 kinase function and to possess anti-tumour activity (Ermoli 
et al., 2009; Koltun et al., 2012; Menichincheri et al., 2010; Menichincheri et al., 2009; 
Shafer et al., 2008; Vanotti et al., 2008; Woods et al., 2012; Zhao et al., 2009). These 
drugs represent a novel approach to cancer therapy by targeting mechanisms 
regulating replication initiation, upstream of traditional anti-cancer therapeutics that 
inhibit elongation. Montagnoli et al. first reported that a Cdc7 inhibitor prevented 
replication initiation but does not impede fork progression or trigger the DNA damage 
checkpoint in cancer cells (Montagnoli et al., 2008). Several years on, potential 
candidates NMS-1116354 (Nerviano) (Montagnoli et al., 2010) and XL-413/BMS-
863233 (Exelixis and Bristol Myers Squibb) (Koltun et al., 2012) are currently being 
tested in clinical trials. A better understanding of Cdc7 in vivo will undoubtedly be of 
great impact towards the development and utilisation of clinical applications targeting 
Cdc7 function in the cell cycle. 
 
1.4  Control of cell cycle events by Cdks 
A eukaryotic cell has to complete a series of physiological processes in a timely 
manner over the course of a cell cycle to successfully divide. Three distinct transitions 
mark the onset of S phase and the entry and exit of mitosis and the heterodimeric 
complexes of Cdks with their cyclin partners mediate progression through these 
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different events. An active Cdk complex functions as a serine/threonine kinase and is 
made up of a catalytic subunit from the Cdk family associated with a cyclin subunit, 
which confers periodicity and substrate specificity to the kinase (Bloom and Cross, 
2007; Malumbres, 2011; Morgan, 1995). Up to six conserved Cdks exists in the 
budding yeast S. cerevisiae, but only one of them, Cdc28 (Cdk1), is necessary and 
sufficient to drive the cell cycle. Cdc28 associates with the G1 cyclins, Cln1, Cln2, and 
Cln3 for activities required in G1 phase and the B-type cyclins, Clb5 and Clb6, for S 
phase functions. In the absence of Clb5 or Clb6, other B-type cyclins, Clb1-4, can drive 
initiation (Donaldson et al., 1998b). Clb1-4 are required for mitotic events but must be 
down-regulated for mitotic exit and the completion of the cell cycle (Bloom and Cross, 
2007). In mammals, 20 different Cdks exist (Malumbres et al., 2009), of which five are 
clearly associated with cell cycle control and have partners which are actual cyclins – 
proteins that are synthesised and degraded in cyclical manner every cell cycle. These 
are Cdk1, Cdk2, Cdk3, Cdk4 and Cdk6 (Malumbres, 2011; Malumbres and Barbacid, 
2005).  
 
Members of the Cdk and cyclin families combine to form different cyclin-Cdk 
complexes in mammalian cells. Of the five cell cycle-associated Cdks, Cdk1 is known 
as the mitotic Cdk for its essential roles in mitosis. Cdk1 associates with A- (G2) and B-
type (late G2 and M) cyclins. Recent studies have also shown that Cdk1 can bind to 
interphase (D- and E-type) cyclins. This interaction is more pronounced in cells lacking 
interphase Cdks such as Cdk2 and Cdk4, which are the normal binding partners for 
these cyclins (Aleem et al., 2005; Malumbres et al., 2004; Santamaria et al., 2007). 
Cdk2, 3, 4 and 6 are known as the interphase Cdks. Only D-type cyclins are known to 
bind to Cdk4 and Cdk6. Cdk4- or Cdk 6-cyclin D complexes are the major sensors for 
mitogenic signals, mediating cell cycle entry. Cdk2 and Cdk3 are very similar to Cdk1 
but do not possess its mitotic functions. Both Cdk2 and Cdk3 bind to E- and A-type 
cyclins and Cdk2-cyclin E and -cyclin A complexes play important roles in DNA 
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replication. Most laboratory mice do not have functional Cdk3 due to a spontaneous 
mutation that generate a premature stop codon in the Cdk3 allele (Ye et al., 2001). 
There is no phenotype associated with the loss of Cdk3 and the functions of Cdk3 
remains poorly studied (Malumbres, 2011; Malumbres and Barbacid, 2005). 
 
Earlier analysis of the cell cycle Cdks led to a widely accepted ʻclassicalʼ model of 
mammalian cell division in which specific Cdks are responsible for driving each of the 
cell cycle phases. Experiments in which kinase-dead mutants were expressed in 
human cells caused G1 arrest in CDK2-mutants and G2 arrest in CDK1-mutants (van 
den Heuvel and Harlow, 1993). Injection of antibodies and antisense oligonucleotides 
led to the interpretation that specific cyclin-Cdk combinations mediate particular cell 
cycle transitions (Pagano et al., 1993). Biochemical analysis revealed the preferred 
binding partners of various Cdks and cyclins at different stages of the cell cycle (Sherr, 
1993). In this ʻclassicalʼ model, cells may exit the cell cycle and become quiescent (G0) 
or enter G1 phase following cytokinesis. During G1 phase, D-type cyclin synthesis is 
induced by mitogenic signalling and active Cdk4-cyclin D and Cdk6-cyclin D complexes 
phosphorylate members of the retinoblastoma (Rb) protein family, which act as 
repressors of the E2F transcription factors when hypo-phosphorylated. Cdk 
phosphorylation of Rb proteins inactivate them, allowing transcription of E2F-regulated 
proteins required later in the cell cycle, including E-, A- and B-type cyclins (Dyson, 
1998). Irreversible inactivation of Rb proteins is then completed by the action of Cdk2-
cyclin E, through positive feedback (Harbour et al., 1999; Lundberg and Weinberg, 
1998). At this point, cells are committed to the cell cycle, becoming independent of 
mitogenic signals; this corresponds to the ʻrestrictionʼ or R point in the cell cycle. Cdk2-
cyclin E is required to promote S phase entry and Cdk2-cyclin A and Cdk1-cyclin A are 
then responsible for progression through and completion of S phase. A-type cyclins 
associate with Cdk1 at the end of S phase but are degraded by ubiquitin-mediated 
proteolysis in pro-metaphase during mitosis. B-type cyclins are synthesised during S 
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and G2 phase and Cdk1-cyclin B complexes are essential to trigger and mediate 
progress through mitosis, being involved in different regulatory and structural 
processes including chromosomal condensation and breakdown of nuclear lamina. 
Degradation of B-type cyclins by the anaphase-promoting complex finally inactivates 
Cdk1-cyclin B complexes, allowing mitotic exit (Hochegger et al., 2008; Malumbres and 
Barbacid, 2005). 
 
In the past decade or so, the advent of gene targeting techniques in mice has allowed 
a genetic approach in studying mammalian Cdks. Findings from these studies 
challenge the orderly scheme of the ʻclassicalʼ model and suggest that there may be 
more plasticity and evolutionary conservation of the cell cycle than previously thought. 
From Table 1.1, the systematic knockdown of Cdk loci in the mouse germline has 
shown that Cdk2, Cdk4 and Cdk6 are not essential for the cell cycle in most cell types. 
The loss of each Cdk resulted in developmental defects only in specific cell lineages. 
The dispensability of Cdk2 in the mitotic cell cycle came as a surprise to the cell cycle 
field as it was believed to be essential for G1/S transition. The redundant activity that 
controls essential S phase functions appears to be supplied by Cdk1, which can 
associate with cyclin A and cyclin E, and in some cells by Cdk4 (Aleem et al., 2005; 
Hochegger et al., 2007; Jablonska et al., 2007; Krasinska et al., 2008; Santamaria et 
al., 2007). Cdk4 null mice are viable but are diabetic and exhibit hypo-pituitarism due to 
defective proliferation of pancreatic β-cells and endocrine cells (Rane et al., 1999; 
Tsutsui et al., 1999) while Cdk6 ablation causes defects only in cells of the erythroid 
lineage (Malumbres et al., 2004). The lack of major cell cycle phenotypes in cells 
lacking individual interphase Cdks cannot be fully attributed to compensation by 
another interphase Cdk as loss of multiple combinations of interphase Cdks only 
enhanced the individual phenotype (Malumbres and Barbacid, 2009). Only the loss of 
Cdk1 had resulted in a lethal phenotype, despite the mutant cells carrying a full 
complement of the interphase Cdks (Diril et al., 2012). This clearly illustrates that 
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interphase Cdks cannot compensate for the absence of Cdk1. Cdk2 expressed from 
the Cdk1 locus also failed to rescue early embryonic lethality (Satyanarayana et al., 
2008). The importance of Cdk1 is underscored by the observation that mouse embryos 
can develop normally to mid-gestation in the absence of all interphase Cdks, indicating 
Cdk1 alone is sufficient to drive a functional cell cycle in most cell lineages (Santamaria 
et al., 2007). Cdk1 can bind to all cyclins, resulting in the phosphorylation of pRb and 
the expression of genes regulated by the E2F transcription factors. Embryonic lethality 
eventually occurred as a result of defective haematopoiesis (Santamaria et al., 2007).  
 
Cdk 
knockout Viability Phenotype References 
Cdk1 Early lethality 
before E3.5 
- (Diril et al., 2012) 
Cdk2 Viable Male and female sterility from 
meiotic defects 
(Berthet et al., 2003; 
Ortega et al., 2003) 
Cdk4 Viable Lack of proliferation of 
postnatal pancreatic β-cells 
and pituitary lactotrophs 
(Rane et al., 1999; 
Tsutsui et al., 1999) 
Cdk6 Viable Defective erythroid-lineage 
development 
(Hu et al., 2009; 
Malumbres et al., 2004) 
Cdk2 and 
Cdk4 
Embryonic lethality 
at E15.5 
Heart defects due to 
decreased numbers of 
cardiomyocytes 
(Berthet et al., 2006; 
Malumbres et al., 2004)  
Cdk2 and 
Cdk6 
Viable Similar phenotype to single 
mutants 
(Malumbres et al., 
2004) 
Cdk4 and 
Cdk6 
Late embryonic 
lethality at E14.5 – 
E18.5 
Reduced proliferation of 
committed haematopoietic 
precursors 
(Malumbres et al., 
2004) 
Cdk2, Cdk4 
and Cdk6 
Embryonic lethality 
at E12.5 – E15.5 
Similar to Cdk2 and Cdk4 
knockout with greater severity 
(Santamaria et al., 
2007) 
Table 1.1. Gene targeting of Cdks in mice.  
 
Altogether, these observations suggest that Cdks display significant plasticity, leading 
to the proposal of an ʻessentialʼ model of the cell cycle in which Cdk1 alone is sufficient 
to support proliferation of all cell types, similar to the yeast cell cycle (Malumbres and 
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Barbacid, 2009; Santamaria et al., 2007). Increased numbers of Cdks have evolved in 
metazoans to supply additional regulation and to control proliferation of a wide 
repertoire of cell types in accordance to requirements at the tissue or organism level. 
Although Cdk1 is sufficient to support a functional cell cycle during the embryonic 
development, a most active period of cell division, it is eventually unable to 
compensate in certain specialised cell types. Interphase Cdks may phosphorylate 
distinct substrates in this case. Emerging evidence suggests that tumour cells may also 
require specific interphase Cdks for proliferation. It is not clear if non-canonical Cdk-
cyclin pairings occur under physiological contexts (Merrick and Fisher, 2012). Multiple 
Cdks probably only evolved at a late stage of cell cycle evolution, which was then 
already characterised by considerable complexity (Malumbres, 2005; Malumbres and 
Barbacid, 2009). As such, greater understanding of the complex Cdk network in 
mammalian cells, with its high levels of compensatory and shared functions between 
the Cdks or with other proteins, is required. This is especially essential in order to apply 
this knowledge to therapeutic ends, in developing Cdks as druggable targets.  
 
1.5  Concluding remarks – this thesis 
In this thesis, various aspects of S phase entry and progression will be addressed in 
two model systems. In the first section, I have analysed aspects of Cdc7 function in 
Xenopus egg extracts using PHA-767491 (Montagnoli et al., 2008; Natoni et al., 2011), 
a small molecule inhibitor of Cdc7. The point in the cell cycle in which Cdc7 executes 
its function was investigated as well the requirement of Cdc7 activity through S phase 
in relation to progression through the replication timing programme. The role of 
Xenopus Cdc7 in a perturbed S phase was also analysed. Following the biochemical 
characterisation of Xenopus Cdc7 activity, I present the design for generating a 
conditional Cdc7 knockout mouse, which will be a useful tool to dissect mammalian 
regulation of Cdc7 function, and results from the screening process. Finally, preliminary 
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work in characterising Cdk1/Cdk2 double-knockout in mouse embryonic fibroblasts will 
be described in the last part of the this thesis, providing additional insights into the 
regulation of G1/S transition and S phase progression in mammalian cells. 
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Chapter 2 – The role of Cdc7 in DNA replication and the intra-S 
checkpoint in Xenopus egg extracts 
Introduction 
Cdc7 is an essential kinase required for the initiation of DNA replication. It has been 
found to be up-regulated in tumor cell lines, including colon, lung, ovary, breast, 
leukemia, and prostate cancers (Bonte et al., 2008; Montagnoli et al., 2010). Genetic 
and other studies employing the use of siRNAs to block Cdc7 activity report disruption 
of S phase progression, leading to cell cycle arrest and subsequent p53-independent 
cell death through apoptosis (Ito et al., 2012; Kim et al., 2008; Montagnoli et al., 2004). 
Consequently, Cdc7 presents an attractive target in the development of novel cancer 
therapeutics. With the aim of developing a drug useful in a clinical setting, several small 
molecules belonging to different chemical classes have been reported to be potent 
inhibitors of Cdc7 activity as a result of large scale screening of chemical compound 
libraries (Ermoli et al., 2009; Koltun et al., 2012; Menichincheri et al., 2010; 
Menichincheri et al., 2009; Shafer et al., 2008; Vanotti et al., 2008; Woods et al., 2012; 
Zhao et al., 2009).  
 
Pyrrolopyridinones and pyrido-thieno-pyrimidines are two classes of chemical 
compounds reported to be selective and potent inhibitors of Cdc7 activity. PHA-767491 
and Compound 6d are ATP-mimetic, competitive small molecule inhibitors from these 
two classes respectively (Vanotti et al., 2008; Zhao et al., 2009). PHA-767491 was the 
first potent and selective Cdc7 inhibitor to be reported and characterised. It has a low 
half-maximal inhibitory concentration (IC50) of 10 nM and exhibited 20-fold selectivity 
over other targets when tested in a panel of 38 human serine/threonine kinases. In cell-
based assays using numerous tumour cell lines, PHA-767491 was found to inhibit 
Mcm2 phosphorylation at specific Cdc7-dependent sites, impairing origin firing without 
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affecting fork progression. Also, consistent with siRNA knockdown of Cdc7 (Montagnoli 
et al., 2004), PHA-767491 did not result in DNA damage or trigger a DNA replication 
stress response. It was found to have anti-tumour properties in rodent models, marking 
it as a promising prototype anti-proliferative agent (Montagnoli et al., 2008). Similar to 
PHA-767491, Compound 6d was determined to have a low dissociation constant (Ki) of 
2 nM and an IC50 of 20 nM against Cdc7, indicating high substrate affinity and potency. 
It exhibited more than 500-fold selectivity over a panel of 11 kinases, including Cdk2-
cyclin E. Compound 6d also inhibited Mcm2 phosphorylation in experiments using 
proliferating HT116 colon cancer cells and inhibited proliferation in a dose-dependent 
manner when tested on the HCT116, RKO, and SW480 human colon cancer cell lines 
(Zhao et al., 2009). 
 
In this study, Compound 6d and PHA-767491 were synthesised in-house at the 
University of Dundee, based on published chemical structures (Vanotti et al., 2008; 
Zhao et al., 2009). I then tested these compounds in the Xenopus cell-free system in 
order to characterise and use them as molecular tools to probe Cdc7 function and 
regulation in the cell cycle. Cell-free extracts prepared from Xenopus eggs were used 
as an in vitro model to examine the molecular events occurring during DNA replication. 
This system takes advantage of cell cycle proteins and mRNA present in the Xenopus 
egg, which support 12 synchronous rounds of cell division in the absence of 
transcription and growth following fertilisation. Extracts can support all cell cycle 
activities occurring in the intact egg and are able to initiate and complete DNA 
replication of exogenous DNA templates in a manner consistent with that present in 
vivo. Biochemical manipulations can be readily performed and results obtained are 
applicable to other eukaryotic organisms as the basic mechanisms of the cell cycle 
appear to be highly conserved (Blow, 2001). As such, this is a suitable in vitro system 
for the purposes of this study. 
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Results 
2.1 Compound 6d did not inhibit DNA replication in Xenopus egg 
extracts 
Cell-free extracts were prepared from Xenopus eggs and activated by the addition of 
calcium to release them from meiotic metaphase II arrest, allowing them to proceed 
into interphase of the first embryonic cell cycle. When demembranated sperm nuclei 
are incubated in activated interphase egg extract, sperm chromatin first decondenses 
and is assembled into interphase nuclei. Licensing of replication origins occurs and S 
phase begins shortly after nuclear assembly (Blow, 2001). Figure 2.1 shows a typical 
replication profile. Little incorporation of [α-32P]-dATP was detected in the initial 30 
minutes of incubation during which time the sperm chromatin decondenses, becomes 
licensed for subsequent replication, and is assembled into a functional interphase 
nucleus. Replication starts at 30 minutes and DNA synthesis proceeds at a constant 
rate until 90 minutes, when almost all DNA template would be replicated. In these 
extracts, protein synthesis has been inhibited by the addition of cycloheximide, which 
prevents accumulation of cyclin B and progression from G2 into mitosis. Complete 
DNA replication is not perturbed by the inhibition of protein synthesis (Blow and 
Laskey, 1988). Cycloheximide-treated egg extracts therefore support a single complete 
round of DNA synthesis.  
 
Compound 6d (Figure 2.2A) was titrated into Xenopus egg extract and its effect on 
DNA replication was assessed by quantifying the amount of DNA synthesised at 90 
min. As shown in Figure 2.2B, no significant reduction in DNA replication was seen at 
any concentration of Compound 6d used, up to 200 μM, compared to the control 
sample. One possible explanation for this lack of effect is that Cdc7 may be active and 
able to phosphorylate essential substrates in solution prior to the addition of the 
inhibitor. To address this possibility, Xenopus egg extract was pre-incubated with 
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Compound 6d for varying intervals to inactivate Cdc7. Sperm nuclei were then added 
and DNA synthesis quantified. As shown in Figure 2.2C, DNA replication in samples 
pre-treated with Compound 6d also did not appear to be significantly different from 
control samples at both pre-incubation intervals tested. In delaying DNA template 
addition, there was a loss in replicative capacity as Cdt1 present in extracts become 
degraded, resulting in a decrease in total DNA synthesis with increased pre-incubation 
time (Li and Blow, 2005). As such, origin licensing and initiation were adversely 
affected and extracts were no longer efficient in supporting DNA replication in vitro. 
From these experiments, Compound 6d does not seem to be effective in inhibiting DNA 
replication in this system. The reason for this is not clear, but include the possibilities 
that the compound was incorrectly synthesised here or that Compound 6d is 
significantly less active against Xenopus Cdc7 than the mammalian Cdc7 it was 
developed against, perhaps due to sequence or structural differences in the ATP-
binding pocket. No further experiments were performed with Compound 6d in this 
study. 
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Figure 2.1. Replication time-course of demembranated sperm in Xenopus egg 
extract.  
Demembranated Xenopus sperm was incubated in activated egg extract supplemented with [α-
32P]-dATP. Samples were taken at specified time-points and the amount of [α-32P]-dATP 
incorporated into newly synthesised DNA was determined by scintillation counting. DNA synthesis 
was expressed as percentage of the amount synthesised by 120 min. The error bars represent 
S.E.M. from 14 experiments. 
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Figure 2.2. Compound 6d does not inhibit replication in Xenopus egg extract.  
(A) Chemical structure of Compound 6d (Zhao et al., 2009). (B) Compound 6d was titrated into 
Xenopus egg extracts supplemented with [α-32P]dATP, using demembranated sperm nuclei as 
DNA templates. The amount of DNA synthesised was determined by scintillation counting at 90 
minutes after sperm addition. DNA synthesis was expressed as percentage of the amount 
synthesised by 90 min in untreated extract. (B) Compound 6d was added to Xenopus egg extract 
and incubated for the indicated times before sperm addition. DNA synthesis was determined and 
percentage replication calculated as in (A). The error bars represent S.D. from 2 experiments. 
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2.2 PHA-767491 inhibits DNA replication by blocking an essential Cdc7 
activity 
2.2.1 PHA-767491 inhibits DNA replication 
As with Compound 6d, PHA-767491 was first titrated into Xenopus egg extracts and its 
effect on DNA synthesis measured. When extracts were treated with PHA-767491, 
DNA synthesis was inhibited when either demembranated Xenopus sperm or 
permeabilised CHO nuclei were used as DNA templates (Figures 2.3B and C). Since 
DNA replication cannot take place if initiation of DNA replication is inhibited, this 
observation is consistent with an inhibition of Cdc7 activity in Xenopus egg extracts. 
PHA-767491 appears to be slightly more potent when permeabilised CHO nuclei were 
used as templates as DNA synthesis was completely inhibited at 20 μM; a higher 
concentration above 50 μM was required for a similar inhibition with sperm nuclei.  
 
In Xenopus egg extracts, the assembly of an intact nuclear envelope is first required 
before initiation of replication can occur, after the recruitment of pre-RC components to 
origins (Blow and Laskey, 1986; Newport, 1987; Sheehan et al., 1988). To test if PHA-
767491 inhibition of DNA synthesis is due to non-specific effects on nuclear assembly, 
hence leading to a defect in DNA synthesis, sperm nuclei was incubated with 
interphase egg extract for 40 min and stained with Hoechst 33258 for visualisation. 
Nuclear envelope formation still occurred in the presence of PHA-767491, indicating 
that PHA-767491 does not affect nuclear assembly (Figure 2.4). Nuclei of comparable 
size and structure formed around sperm DNA in the presence of PHA-767491 and 
chromatin decondensation could be observed, similar to that of sperm incubated in 
control extract. PHA-767491 caused a reduction in the fine-scale dispersal of 
chromatin, which may be a consequence of inhibiting DNA replication (Blow, 1993).  
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Figure 2.3. PHA-767491 inhibits replication in Xenopus egg extract.  
(A) Chemical structure of PHA-767491 (Montagnoli et al., 2008). (B, C) PHA-767491 was titrated 
into Xenopus egg extracts supplemented with [α-32P]dATP. Demembranated sperm nuclei (B) or 
permeabilised somatic mammalian nuclei (C) were used as DNA templates. The amount of DNA 
synthesised was determined by scintillation counting at 90 minutes after sperm/nuclei addition. 
The error bars represent S.D. from 3 experiments. 
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Figure 2.4. PHA-767491 does not inhibit nuclear envelope formation in egg 
extracts.  
Sperm nuclei were incubated at 6 ng DNA/µl in egg extracts with (3 & 4) or without (1 & 2) 50 µM 
PHA-767491 for 40 min. Nuclei were stained with Hoechst 33258 and visualised by phase 
contrast (top) or fluorescence microscopy (bottom). The scale bar represents 10 µm. 
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2.2.2 PHA-767491 inhibits hyper-phosphorylation of chromatin-bound Mcm4 
Mcm4 is a Cdc7 substrate and becomes hyper-phosphorylated as DNA replication 
occurs (Sheu and Stillman, 2006, 2010; Takahashi and Walter, 2005). This can readily 
be observed as a mobility shift of Mcm4 with SDS-PAGE (Figures 2.5A and B, “control” 
lanes). The effect of PHA-767491 was tested using Mcm4 hyper-phosphorylation as 
read-out for Cdc7 activity. As shown in these figures, hyper-phosphorylation of 
chromatin-bound Mcm4 was inhibited when extracts were treated with 50 μM PHA-
767491. This suggests that PHA-767491 inhibits Cdc7 activity in Xenopus egg extracts. 
Mcm4 hyper-phosphorylation was not affected when Cdk activity was specifically 
blocked with 100 nM p27kip1. This result shows that a Cdc7-dependent event can be 
completed in the absence of Cdk activity and is consistent with previous reports that 
the essential replication function of Cdc7 is executed before that of Cdks (Heller et al., 
2011; Jares and Blow, 2000; Walter, 2000). Cdc45, a pre-initiation/replication fork 
protein which is recruited downstream of both Cdc7 and Cdk activities, was not 
detected on chromatin in both PHA- and p27kip1-treated samples, indicating initiation of 
replication origins was inhibited.  
 
When PHA-767491 was titrated into extract and chromatin was isolated in mid-S 
phase, phosphorylation of chromatin-bound Mcm4 was inhibited in a dose-dependent 
manner (Figures 2.5C and D). Cdc45 and PCNA, components of the replication fork, 
were also detected at lower levels with increasing PHA-767491 concentrations. 
Replication-dependent re-association of Cdc6 with chromatin was inhibited in a similar 
dose-dependent manner.  
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Figure 2.5. PHA-767491 inhibits hyper-phosphorylation of chromatin-bound 
Mcm4.  
(A, B) Chromatin was isolated from replicating extracts, which were untreated (Control) or treated 
with PHA-767691 or p27kip (KIP1), at the indicated time-points after DNA addition and immuno-
blotted for Mcm4 or Cdc45 to monitor S phase progression. 10 ng DNA/µl sperm nuclei and 50 
µM PHA-767491 (A) or 60 ng DNA/µl mammalian nuclei and 20 µM PHA-767491 (B) were used. 
100 nM p27kip1 was used for both experiments. (D, E) PHA-767491 was titrated into Xenopus egg 
extract containing 10 ng DNA/µl sperm nuclei (C) or 60 ng DNA/µl mammalian nuclei (D). 
Chromatin was extracted in mid-S phase and immuno-blotted for Mcm4, Cdc6, Cdc45 and 
PCNA. Histones were coomassie-stained and used as loading controls. 
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Using a recently characterised antibody against Xenopus Cdc7 (Poh et al., manuscript 
in preparation), Dr Gaganmeet Singh Chadha performed a follow-up experiment to 
determine if PHA-767491 treatment affected Cdc7 association with DNA. As shown in 
Figure 2.6, PHA-767491 did not inhibit Cdc7 recruitment to chromatin. Cdc7 is thought 
to be recruited to chromatin by direct interaction with the Mcm2-7 double hexamer 
(Jares and Blow, 2000; Jares et al., 2004) and so it did not associate with chromatin 
when licensing was blocked by geminin. In contrast, PHA-767491 appears to slightly 
increase Cdc7 chromatin association. In addition, PHA-767491 did not promote the 
association of Cdc6 with chromatin. Cdc6 binds to chromatin in Xenopus extracts only 
when Mcm2-7 is not present on DNA. In control extracts, this means that high levels of 
Cdc6 are seen on DNA in G2 when all Mcm2-7 have been displaced as a consequence 
of DNA replication having completed (Oehlmann et al., 2004; Rowles et al., 1999; 
Sonneville et al., 2012). Cdc6 also strongly associates with chromatin when licensing is 
blocked by addition of geminin. Taken together, these results indicate that PHA-767491 
does not affect licensing and Cdc7 recruitment to chromatin. The inhibition of DNA 
replication occurs by blocking an essential kinase activity of Cdc7 to phosphorylate 
Mcm4. 
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Figure 2.6. PHA-767491 does not inhibit Cdc7 binding to chromatin.  
Sperm nuclei were incubated in extracts optionally treated with geminin or 50 µM PHA-767491. 
Chromatin was isolated at the indicated times and immuno-blotted for Cdc7, Mcm4, Cdc6 or 
PCNA. This experiment was performed by Gaganmeet Singh Chadha. 
49 
2.3 PHA-767491 causes rapid loss of Mcm4 hyper-phosphorylation, 
which is reversed by protein phosphatase 1 
As PHA-767491 is a small molecule inhibitor, it is expected to act quickly on its target. 
This was tested using Mcm4 hyper-phosphorylation as a read-out. Sperm chromatin 
was incubated in Xenopus extract for 60 minutes in the presence of p27kip1. This time 
interval allows Mcm4 at licensed origins to become maximally hyper-phosphorylated 
while p27kip1 treatment causes hyper-phosphorylated Mcm4 to accumulate on 
chromatin since origin firing cannot occur. PHA-767491 was then added to the extract. 
Within 15 minutes of PHA-767491 addition, chromatin-bound Mcm4 had become 
largely dephosphorylated (Figure 2.7A, lanes 1-4). 
 
This rapid turnover of Mcm4 hyper-phosphorylation suggests that a phosphatase may 
be acting in close proximity to Cdc7 such that when Cdc7 activity is inhibited by PHA-
767491, equilibrium quickly shifts towards de-phosphorylation. In order to test this 
hypothesis and to identify the potential phosphatase, different phosphatase inhibitors 
were tested, each added at the same time as PHA-767491 treatment, while monitoring 
Mcm4 hyper-phosphorylation. When high concentrations (2 μM) of okadaic acid were 
added along with PHA-767491, Mcm4 dephosphorylation was largely abolished (Figure 
2.7A, lanes 11, 12); however, lower concentrations (0.25 - 1 μM) failed to block a major 
proportion of Mcm4 dephosphorylation (Figure 2.7A, lanes 5-10). Okadaic acid is an 
inhibitor of protein phosphatases in the PP1 and PP2A classes with a higher potency 
towards PP2A such that sub-micromolar concentrations typically inhibit PP2A but not 
PP1 (Cohen, 1989). Therefore these results suggest that PP1 may be responsible for 
the rapid dephosphorylation of Mcm4 observed here. 
 
To test this idea, extracts were pre-treated with Inhibitor-2 (I-2), a protein regulator that 
specifically inhibits PP1 activity (Huang and Glinsmann, 1976; Hurley et al., 2007). 
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Endogenous PP1 acts as a holo-enzyme. It is made up of a catalytic subunit which 
interacts with a regulatory subunit that modulates its substrate specificity and 
enzymatic activity (Cohen, 2002; Shi, 2009). Effective I-2-inhibition of PP1 activity is 
time-dependent, necessitating a 15-min pre-incubation of I-2 in Xenopus egg extract to 
allow for the formation of inactive PP1c•I-2 complexes. As seen in Figure 2.7B, I-2 pre-
treatment before PHA-767491 addition largely prevented the dephosphorylation of 
Mcm4 in the presence of PHA-767491, indicating that PP1 is the main phosphatase 
acting on hyper-phosphorylated Mcm4 in Xenopus extracts. Consistent with this 
conclusion, PP1 has recently been shown to physically interact with Mcm2-7 hexamers 
bound to chromatin in Xenopus egg extracts (Gambus et al., 2011). This suggests that 
PP1 is recruited to chromatin-bound Mcm2-7 to modulate the dephosphorylation of 
Mcm4, and potentially of other Mcm2-7 subunits. This may occur as part of a larger 
protein complex. 
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Figure 2.7. PP1 inhibition prevents Mcm4 dephosphorylation in the presence of 
PHA-767491. 
(A) 10 ng DNA/µl sperm nuclei were incubated for 60 min in extracts treated with p27kip1 to allow 
Mcm4 hyper-phosphorylation to occur. 50 µM PHA-767491 and okadaic acid (OA) at the indicated 
concentrations were added simultaneously and chromatin was isolated immediately (60 min) or 15 
minutes later (75 min) and immuno-blotted for Mcm4. (B) Similar to Fig 2.7A, sperm nuclei was 
incubated for 60 min in extracts treated with p27kip1. At 45 min after sperm addition, extracts were 
first pre-incubated for 15 min with 1.2 µM I-2, a protein inhibitor of PP1, before 50 µM PHA-
767491 was added at 60 min. Chromatin was isolated immediately (60 min), after 5 min (65 min) 
and after 10 min (70 min) and immuno-blotted for Mcm4. 
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2.4 PHA-767491 is a selective inhibitor of Cdc7 kinase 
2.4.1  Kinase profiling 
To determine the selectivity of PHA-767491, it was tested against a panel of 95 protein 
kinases, performed through the kinase profiling service available at the University of 
Dundee Protein Phosphorylation Unit. In this assay, 1 μM PHA-767491 gave more than 
90% inhibition of only 7 other protein kinases, namely DYRK1A, 2 and 3, PRK2, 
GSK3β, p38δ MAPK, and CK1 (Table 2.1), broadly in line with previous analyses of 
PHA-767491 specificity (Montagnoli et al., 2008; Natoni et al., 2011). None of these 
kinases have been implicated in the initiation of DNA replication and the use of specific 
inhibitors against these kinases did not significantly inhibit DNA replication in egg 
extracts (data not shown). The only kinase previously implicated in DNA replication that 
is affected by PHA-767491 is Cdk2-cyclin A, whose activity was inhibited by 72% under 
these assay conditions.  
 
2.4.2  Pre-incubated sperm nuclei can replicate in PHA-767491-treated extracts 
Since Cdk2 and Cdc7 are both required for the initiation of DNA replication, act at a 
similar time in this process and share common substrates, it is important to establish 
that PHA-767491 does not exert a significant cross-reactivity towards Cdk2 activity. In 
order to test the extent to which PHA-767491 inhibits DNA replication by inhibiting 
Cdk2 activity, a chromatin transfer experiment was designed based on the observation 
that Cdc7 acts before Cdks to promote DNA replication (Jares and Blow, 2000; Walter, 
2000). The schematic is outlined in Figure 2.8A. Sperm nuclei were incubated in extract 
containing p27kip1, which allows Mcm4 to be hyper-phosphorylated while preventing 
replication by inhibiting S phase Cdks. I-2 was added to this extract to minimise 
dephosphorylation of Mcm4. Chromatin was then isolated and transferred to fresh 
extract containing [α-32P]-dATP and optionally containing 20 μM PHA-767491 and/or I-
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2. The presence of PHA-767491 in the second extract prevents further Cdc7-
dependent Mcm4 phosphorylation so that replication is dependent on chromatin-bound 
Mcm4 phosphorylated prior to the time of transfer. Replication in the second extract 
requires functional Cdk activity since p27kip1 in the first extract had prevented Cdk-
dependent events from occurring. Therefore, if S phase Cdk activity were inhibited by 
20 μM PHA-767491, no replication will take place. 
 
Before this experiment could be carried out, conditions for isolating intact nuclei for 
replication were tested. When chromatin isolation is carried out for immuno-blotting of 
chromatin-bound proteins, extract containing sperm nuclei is diluted with buffer and 
under-laid with the same buffer containing sucrose. This is spun at low speed to 
separate soluble proteins from chromatin. Following the removal of soluble proteins in 
the supernatant and a cushion wash, chromatin is then compacted with high-speed 
centrifugation. For the purpose of isolating nuclei for replication in a second extract, 
however, the hard spin is omitted to avoid damaging the nuclei. Nuclei also have to be 
further cushioned in addition to the sucrose solution during centrifugation. As shown in 
Figure 2.8B, under-laying the sucrose cushion with 30% glycerol allowed for isolation of 
nuclei that replicated most efficiently in the second extract. This was thus used in all 
further experiments to isolate nuclei for replication. 
 
Figures 2.8C and D show that pre-incubated chromatin replicated efficiently to 
approximately 60% of control levels in extract treated with PHA-767491 whilst 
replication of naive sperm nuclei lacking hyper-phosphorylated Mcm4 was profoundly 
inhibited. This provides evidence that the Cdk-dependent step in DNA replication can 
be performed in the presence of PHA-767491 concentrations that inhibit replication. 
Consistent with Cdc7 being the key target of PHA-767491, addition of I-2 to the second 
extract enhanced the replication of pre-incubated chromatin. Taken together, these 
data strongly suggest that specific inhibition of Cdc7 kinase activity is the major reason 
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that PHA-767491 inhibits replication in the Xenopus system. This establishes PHA-
767491 as a reasonably selective inhibitor of Cdc7 in the initiation of DNA replication 
and is suitable for use in analysing Cdc7 function in Xenopus egg extracts. 
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Table 2.1. Kinase assay profile of PHA-767491.  
1 µM PHA-767491 dissolved in DMSO was tested against a panel of 95 kinases using a 
radioactive (33P-ATP) filter-binding assay, at an ATP concentration at or below the calculated KM for 
ATP of each kinase. The kinase activity detected was expressed as a percentage relative to 100% 
control activity and the S.D. calculated for duplicate values. This assay was carried out by the MRC 
Protein Phosphorylation Unit, University of Dundee. 
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Figure 2.8. Pre-incubated chromatin templates can replicate in the presence of 
PHA-767491. 
(A) Schematic of the chromatin transfer experiment: sperm nuclei were incubated in interphase 
extract with p27kip1 and the PP1 inhibitor, I-2. During early S phase, nuclei were isolated (“p27 
nuclei”) and transferred to a second extract. The second extract was untreated, treated with PHA-
767491 alone or treated with both PHA-767491 and I-2. DNA synthesis in the second extract was 
then measured and compared to DNA synthesis using naive sperm nuclei as templates. (B) Sperm 
nuclei were incubated in Xenopus egg extract. Nuclei isolation was carried out using different 
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buffers or egg extract to underlay the sucrose cushion. Extracted nuclei were transferred into a 
second extract containing [α-32P]dATP. and samples were taken at the indicated time-points to 
assay for total DNA synthesis. (C) Sperm nuclei were incubated at 20 ng DNA/µl in interphase 
extract with p27kip1. During early S phase (40 min), nuclei were isolated and transferred to 
untreated fresh extracts (filled circles) or fresh extracts treated with 20 µM PHA-767491 (filled 
squares) or 20 µM PHA-767491 and 1.2 µM I-2 (filled diamonds). Nuclei were added at a final 
concentration of 10 ng DNA/µl to the second extract and extracts were supplemented with [α-
32P]dATP. Total DNA synthesis was measured at the indicated times after transfer. Filled symbols 
represent replication of transferred “p27 nuclei” and the corresponding replication reactions in 
which naive sperm nuclei were used are represented by open symbols. Percentage replication was 
calculated by taking the amount of DNA synthesised at 90 minutes to be 100%. (D) At 40 minutes 
after DNA addition, nuclei that were pre-incubated had replicated DNA up to 50% of the untreated 
sample in the presence of PHA-767491 while naive sperm nuclei had barely synthesised any DNA. 
DNA synthesis expressed as percentage of the amount synthesised in control. The error bars 
represent S.D. from 3 experiments.  
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2.5 The execution point of Cdc7 activity in replication initiation 
2.5.1  Nuclear assembly is required for Cdc7 hyper-phosphorylation of Mcm4 
In Xenopus egg extracts and early embryos, origin licensing occurs only between 
anaphase onset and the completion of nuclear envelope assembly, while initiation of 
replication only occurs after nuclear assembly within a nucleoplasmic environment 
(Blow, 2001; Jares and Blow, 2000). To investigate the execution point of Cdc7 activity 
with respect to nuclear assembly and pre-RC formation, an experiment was performed 
to determine if Mcm4 hyper-phosphorylation occurs only on DNA-bound Mcm2-7 or 
whether it can also occur on soluble Mcm2-7 complexes. Figure 2.9A shows that unlike 
Mcm4 that was bound to DNA, soluble Mcm4 was not hyper-phosphorylated and its 
mobility on SDS-PAGE was not significantly changed when extracts were treated with 
PHA-767491, suggesting that Cdc7 only phosphorylated DNA-bound Mcm2-7.  
 
Although Cdc7 can be recruited to licensed chromatin prior to nuclear assembly (Jares 
and Blow, 2000), this may occur more efficiently after nuclear assembly has occurred 
when Cdc7 is enriched within the nucleoplasm (Walter, 2000). The degree of Mcm4 
hyper-phosphorylation in the absence of full nuclear assembly was therefore examined, 
using wheat germ agglutinin (WGA) to disrupt nuclear pore function (Finlay et al., 
1987). As previously reported, concentrations of WGA that inhibited nuclear import and 
nuclear envelope formation were also found to inhibit DNA replication (Figures 2.9B, C) 
(Cox, 1992). Increasing concentrations of WGA progressively inhibited Mcm4 hyper-
phosphorylation (Figure 2.9C). Taken together, these results indicate that Cdc7 does 
not phosphorylate its substrates in the cytoplasm and an intact nuclear envelope is 
required for maximal Mcm4 phosphorylation, possibly as a result of enhancing Cdc7 
nuclear import and subsequent binding and phosphorylation of chromatin-bound 
Mcm2-7. 
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Figure 2.9. Mcm4 hyper-phosphorylation does not occur in the absence of 
nuclear envelope formation. 
(A) Sperm nuclei were incubated at 10 ng DNA/µl in interphase extract in the absence or presence 
of 50 µM PHA-767491. At the indicated time-points, chromatin was isolated and immuno-blotted 
for Mcm4, Cdc45 and PCNA. 0.5% (v/v) of the supernatant was also loaded on the same SDS-
PAGE gel to blot for soluble proteins. (B) Sperm nuclei were incubated in interphase extract 
supplemented with 0.2 or 2 mg/ml WGA. At 40 minutes, nuclei were stained with Hoechst 33258 
and visualised by phase contrast for the nuclear envelope (top) or fluorescence microscopy for 
DNA (bottom). (C) Extracts were treated with WGA as in (B) and chromatin was isolated at the 
indicated time-points for immuno-blotting of Mcm4 and Cdc45. Extracts were optionally 
supplemented [α-32P]dATP and total DNA synthesis was determined at 90 minutes by scintillation 
counting. Error bars represent S.D. from 3 experiments.  
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2.5.2  Cdc7 acts very early in S phase to initiate replication 
Replication origins typically initiate at different times during S phase. When sperm 
nuclei replicate in Xenopus egg extracts, initiation occurs over the course of 20 to 30 
minutes (Blow, 2001; Labit et al., 2008; Luciani et al., 2004). In order to determine 
whether Cdc7 acts on all origins early in S phase, or whether it acts on late-firing 
origins only later in S phase, a ʻhybrid systemʼ where mammalian somatic nuclei from 
cells synchronised in G1 are incubated in Xenopus extracts was used (Dimitrova and 
Gilbert, 1999; Thomson et al., 2010). These nuclei replicate in egg extract according to 
the same overall timing programme as mammalian replication in vivo, though 
compressed into an interval of approximately 120 minutes. This system provides a 
longer S phase compared to sperm nuclei, making it easier to distinguish between 
different stages of S phase. Here, this ʻhybrid systemʼ was used to establish the 
execution point of Cdc7, to address whether Cdc7 acts on all origins very early leaving 
them competent for replication, or whether it is required to act on late-firing origins later 
in S phase.  
 
When nuclei from G1 CHO cells were added to Xenopus egg extract, chromatin-bound 
Mcm4 became maximally hyper-phosphorylated between 20 to 40 minutes from the 
start of the incubation, slightly slower than was seen with Xenopus sperm nuclei as 
substrate (Figure 2.10A). However, on both templates, maximal Mcm4 hyper-
phosphorylation occurs in early S phase, suggesting that by this time Cdc7 has acted 
on both early and late origins. To confirm this interpretation, PHA-767491 was added at 
different times after CHO nuclei addition. I-2 was present in all experiments to minimise 
Mcm4 dephosphorylation. Figure 2.10C shows that when PHA-767491 was added at 
30 minutes, before DNA replication had started, replication subsequently occurred to 
more than 60% of control levels. When PHA-767491 was added at 50 minutes, in very 
early S phase, subsequent DNA synthesis occurred to approximately 90% of control 
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levels. This supports the idea that the essential function of Cdc7 in replication is 
completed by early S phase and correlates well to the time of maximal Mcm4 hyper-
phosphorylation. 
 
These results are in contrast to experiments assessing the execution time of Cdks, 
which showed that even late in S phase, inhibition of Cdk activity promptly prevented 
further initiation (Luciani et al., 2004; Thomson et al., 2010). To verify this difference 
between Cdk and Cdc7 execution points, the effect of PHA-767491 was compared 
directly with a Cdk inhibitor, roscovitine, using the same approach outlined in Figure 
2.10B. When either PHA-767491 or roscovitine was added to extract at the same time 
as CHO nuclei, DNA replication was completely inhibited (Fig 2.10D, open symbols). 
However, when the inhibitors were added 35 min later in early S-phase, replication 
proceeded to more than 60% of control levels in the presence of PHA-767491 but only 
to less than 20% in the presence of roscovitine (Figure 2.10D, filled symbols). This 
indicates that Cdc7 executes its function before Cdk and suggests that once Cdc7 has 
completed its essential function, it is no longer the rate-limiting factor in driving the 
replication timing programme.  
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Figure 2.10. Cdc7 executes its essential function early in S phase, distinct from 
the Cdk execution point.  
(A) Permeabilised G1 nuclei from somatic Chinese Hamster Ovary (CHO) cells were incubated at 
60 ng DNA/µl in interphase Xenopus extract, supplemented with geminin to ensure that only 
origins licensed in vivo were used in replication. Sperm nuclei was incubated 10 ng DNA/µl in 
untreated interphase extract. Chromatin was isolated for immuno-blotting for Mcm4 and Cdc45 at 
the indicated times. (B) Schematic of time-of-addition experiments: Xenopus interphase extracts 
were first activated by the addition of CaCl2 before geminin and permeabilised CHO nuclei were 
added. 20 µM PHA-767491 was added at different times throughout S phase and aliquots were 
sampled for total DNA synthesis after that. I-2 was added from the beginning of the reaction to 
prevent any de-phosphorylation of Mcm4. (C) PHA-767491 was added at 0, 10, 20, 30, and 50 
minutes after the nuclei addition. At the indicated times, samples were removed and assayed for 
total DNA synthesis. (D) Nuclei were incubated as described in (A). At 0 or 35 minutes, extracts 
were supplemented with 20 µM PHA-767491 or 1 mM roscovitine and [α-32P]dATP. Samples were 
assayed for total DNA synthesis at the indicated times. The error bars represent S.D. from 3 
experiments.  
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2.6 The role of Cdc7 in the replication timing programme 
In order to study the role of Cdc7 in the progression through the replication timing 
programme, the different patterns formed by active replication factories/clusters as 
nuclei progress through S phase in vitro were analysed (Dimitrova and Gilbert, 1999; 
O'Keefe et al., 1992; Thomson et al., 2010). G1 CHO nuclei were incubated in extract 
and PHA-767491 or roscovitine were optionally added at 35 minutes. Extracts were 
pulsed with Cy-3 dUTP at 60 or 90 minutes to allow the visualisation of actively 
replicating factories/ clusters. Nuclei in each condition and timepoint were then scored 
according to the stage in S phase they were in (Figure 2.11A). 
 
When no inhibitor was present, most nuclei isolated at 60 minutes showed the Type 
III/IV replication pattern typical of mid – late S phase. This proportion subsequently 
increased to 60% at 90 minutes (Figure 2.11B). When roscovitine was added at 35 
minutes, the replication profile was significantly slowed relative to control, showing that 
continued Cdk activity is required for normal progression through the replication timing 
programme (Thomson et al., 2010). In contrast, when PHA-767491 was added at 35 
minutes, the overall replication pattern progression from 60 to 90 min was largely 
similar to controls. Continued Cdc7 activity therefore appears not to be required for 
progression through the replication timing programme once origins have been initiated, 
if Mcm dephosphorylation is prevented.  
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Figure 2.11. PHA-767491 does not affect progression through replication timing 
stages.  
(A) Permeabilised mammalian nuclei were incubated in interphase extracts as in Figure 2.10D. 
During early S phase (35 min), PHA-767491 or roscovitine was added to the replicating extract. At 
60 min or 90 min, extracts were supplemented with 25 µM Cy3-dUTP to label actively replicating 
origins. Nuclei were fixed and DNA stained with Hoechst 33258 for visualisation. (B) Nuclei were 
scored for the stage of replication based on the categories devised by Thomson et al (Thomson et 
al., 2010). The experiment was repeated 3 times and at least 20 nuclei were scored for each 
treatment at each timepoint. Similar trends were observed in all experiments; this bar chart 
represents data from one experiment. 
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2.7 Etoposide treatment and the role of Cdc7 in the checkpoint 
response 
2.7.1 Multiple proteins modulate Cdc7 activity upon etoposide treatment 
Previous studies have implicated Cdc7 in the intra-S checkpoint response to etoposide, 
an inhibitor of topoisomerase II (Topo II) that causes accumulation of covalently-linked 
protein-DNA complexes between Topo II and chromatin (Costanzo et al., 2003; Silva et 
al., 2006; Tsuji et al., 2008). However, the role of Cdc7 in this response remains 
controversial. To first establish if Cdc7 activity is regulated by checkpoint kinases in this 
system, Xenopus extract was treated with 300 μM etoposide prior to addition of 
Xenopus sperm chromatin. As shown in Figure 2.12A, the addition of etoposide caused 
a decrease in the levels of Mcm4 hyper-phosphorylation compared to controls. When 
caffeine was added to abolish ATM and ATR checkpoint kinase activities, Mcm4 hyper-
phosphorylation and DNA synthesis were restored to control levels in etoposide-treated 
extracts. The checkpoint response on Cdc7 activity is not dependent on on-going 
replication, as Mcm4 hyper-phosphorylation was still inhibited when etoposide was 
added to extracts in the presence of p27kip1 (Figure 2.12B).  
 
Because caffeine is a relatively non-specific inhibitor of ATM/ATR family kinases, 
specific inhibitors KU55993 and NU7441, were used to bypass the effect of the ATM 
and DNA-PK kinases respectively. From Figure 2.12C, KU55993 and NU7441 were 
able to restore high levels of Mcm4 hyper-phosphorylation. The total amount of DNA 
synthesised was also slightly rescued. This suggests that both ATM and DNA-PK play 
a role in etoposide-induced inhibition of Mcm4 hyper-phosphorylation. When PP1 was 
inhibited by pre-treatment of extract with the I-2 inhibitor, similar results were obtained, 
although the rescue of DNA synthesis was negligible in this case (Figure 2.12D). This 
implies etoposide-induced inhibition of Mcm4 hyper-phosphorylation is sensitive to PP1 
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activity levels. The lack of replication rescue could suggest that other checkpoint 
targets are involved in this response, for instance Cdk2 which had been shown to be 
targeted by ATM in Xenopus egg extracts to inhibit DNA replication (Costanzo et al., 
2000).  
 
Upon etoposide treatment, there appears to be some variation in the level of replication 
inhibition, which may reflect some biological variation between extract preparations. 
Comparing Figures 2.12A – D, replication was inhibited to 30 – 50% of control levels. 
Looking at the level of Mcm4 hyper-phosphorylation in Figure 2.12A, a distinct 
inhibition of phosphorylation could be observed, where the maximal level of 
phosphorylation was not attained at any timepoints assayed in etoposide-treated 
extracts. In contrast, the highest level of Mcm4 phosphorylation was attained in the 
presence of etoposide in the experiments shown in Figures 2.12B – D, although the 
overall level of phosphorylation was lower in all instances, as evident in the Mcm4 
smears, representing less phosphorylated protein complexes with higher mobility. This 
variation is also reflected in the Cdc45 blots: a marked decrease in chromatin-bound 
Cdc45 is perceptible in Figures 2.12A and D while differences in levels are subtler in 
Figures 2.12B and C. However in all experiments, there was a consistent delay in the 
Cdc45 recruitment to DNA in etoposide-treated extracts compared to controls, 
indicating delayed replication initiation and/or less efficient replication. 
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Figure 2.12. Etoposide treatment induces a checkpoint-dependent effect on DNA 
replication in Xenopus egg extracts. 
(A) 10 ng DNA/µl sperm nuclei were incubated in extracts treated with 300 µM etoposide or 300 
µM etoposide and 5 mM caffeine. Chromatin was isolated for immuno-blotting at the indicated 
timepoints. (B) Extracts were set up as described in (A), treated with 300 µM etoposide or 300 µM 
etoposide and 100 nM p27KIP1. Chromatin was isolated from immuno-blotting or extracts were 
supplemented with [α-32P]dATP to assay for total DNA synthesis. (C) Extracts were set up as 
described in (A) and the specific inhibitors of ATM (KU55933) and DNA-PK (NU7441) were used at 
final concentration of 10 µM. (D) Extracts were set up as described in (A) and PP1 I-2 was pre-
incubated for 15 min before sperm nuclei addition, at a final concentration of 1.2 µM. The error 
bars represent S.D. from 3 experiments in (A) and (D) and from 4 and 2 experiments respectively in 
(B) and (C).  
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2.7.2 Addressing the mechanism of the checkpoint response 
2.7.2.1 ATM signalling 
Etoposide can potentially induce extensive double strand breaks when replication forks 
encounter inhibited Topo II. To examine if ATM is the main checkpoint kinase 
responsible for this response, the restriction enzyme EcoRI was added to egg extracts 
to create double-stranded breaks in chromatin. ATM is primarily responsible for the 
signalling cascade in response to double-stranded lesions, involving phosphorylation of 
histone H2AX, whereas sensing of single-stranded breaks normally occurs through 
ATR. Figure 2.13A shows that etoposide treatment reduced Mcm4 hyper-
phosphorylation but did not recruit γ-H2AX to chromatin (Figure 2.13A). This is in 
contrast to EcoRI treatment, which resulted in high levels of chromatin-bound γ-H2AX 
but had little effect on Mcm4 hyper-phosphorylation. DNA synthesis was completely 
inhibited, unlike etoposide treatment, which had allowed some degree of DNA 
replication. When KU55933 and caffeine were used to bypass checkpoint signalling, 
both inhibitors caused a similar decrease in the levels of γ-H2AX in response to EcoRI 
treatment. However, while caffeine was able to rescue DNA replication to some extent, 
KU55933 addition did not reverse inhibition of DNA replication (Figure 2.13B). These 
results show that DSB generation with EcoRI clearly triggers a different checkpoint 
response compared to etoposide. As such, the checkpoint response to etoposide that 
inhibits Mcm4 hyper-phosphorylation is unlikely to be solely mediated through the 
formation of double stranded breaks and ATM signalling. 
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Figure 2.13. Etoposide does not cause a checkpoint response on Cdc7 activity 
solely through DSBs. 
(A) 10 ng DNA/µl sperm nuclei were incubated in extracts treated with 300 µM etoposide, EcoRI 
alone or EcoRI supplemented with either 5 mM caffeine or 10 µM KU55933. Chromatin was 
isolated for immuno-blotting at the indicated time-points. (B) DNA synthesis was quantified at 90 
min. 
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2.7.2.2 Addressing kinase down-regulation or phosphatase up-regulation 
It was shown in an earlier section (Section 2.3) that PP1 is involved in modulating 
Mcm4 hyper-phosphorylation in concert with Cdc7 activity and that inhibition of PP1 by 
I-2 pre-treatment was able to reverse the loss of hyper-phosphorylation upon etoposide 
treatment (Figure 2.7). It is thus possible that this checkpoint response may be 
executed through down-regulating Cdc7 activity, up-regulating PP1 function or a 
combination of both. An experiment was designed to distinguish between these 
possibilities by assessing the activity of one enzyme (PP1) in the absence or presence 
of caffeine while the activity of the counteracting enzyme (Cdc7) is acutely blocked by 
the addition of a specific inhibitor (PHA-767491), under conditions of checkpoint 
activation. If PP1 activity were the main target of this checkpoint response, a difference 
in Mcm4 dephosphorylation would be observed between extracts with or without 
caffeine treatment. As shown in Figure 2.14, extracts were set up that were untreated, 
treated with etoposide or etoposide plus caffeine and sperm nuclei were incubated for 
60 minutes with p27kip1 addition to allow accumulation of maximally phosphorylated 
Mcm4 on chromatin. In mid-S phase, PHA-767491 was added (Time = 0 min) and 
chromatin rapidly isolated to assess the loss of Mcm4 phosphorylation under different 
conditions. If the checkpoint response is mediated through Cdc7 down-regulation, no 
difference was expected between extracts treated with etoposide whether caffeine was 
present added or not.  
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Figure 2.14. Rate of loss of phosphorylation in etoposide-treated extract 
(A) 10 ng DNA/µl sperm nuclei were incubated in extracts treated with 300 µM etoposide or 
etoposide supplemented with 5 mM in the presence of p27kip1. At 60 min, 50 µM PHA-767491 
was added and an aliquot was immediately taken and diluted in cold isolation buffer. Aliquots were 
taken at the indicated time-points and chromatin was isolated and blotted for Mcm4. Whole 
extract was loaded in lane 1 as a control showing unphosphorylated Mcm4. (B) Mean 
phosphorylation (top row) was calculated by multiplying the densitometric quantification of Mcm4 
band intensity, measured from bottom to top (low to high phosphorylation), with pixel position 
number, also measured from bottom to top, to take into account phosphorylation state. The black 
line represents untreated samples, pink: etoposide-treated and orange: etoposide with caffeine. 
Dephosphorylation rate (bottom row) was calculated by the change of mean phosphorylation over 
time, normalised to each initial mean phosphorylation value, to take into account the availability of 
substrates for dephosphorylation at each timepoint. Quantification was carried out for 3 
experiments, as labelled above the graphs. The blot shown in (A) corresponds to Experiment 1. 
Julian Blow performed the densitometric quantification of blots and analyses shown in (B). 
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In control samples, Mcm4 was maximally phosphorylated at 0 min (Figure 2.14A). Over 
the course of the experiment, the major proportion of Mcm4 remained maximally hyper-
phosphorylated. Some smearing of Mcm4 could be observed from 1 – 3 min, indicating 
that some dephosphorylation may be occurring during chromatin isolation. When 
extracts were treated with etoposide, Mcm4 did not reach maximal phosphorylation, 
indicating that a checkpoint response had been induced. Mcm4 then became 
dephosphorylated upon Cdc7 inhibition by PHA-767491, so that the major proportion of 
chromatin-bound Mcm4 was already dephosphorylated by 2 min. In the presence of 
caffeine, Mcm4 was more highly phosphorylated at 0 min, as expected, and 
subsequently also became dephosphorylated when PHA-767491 was added, 
noticeable in the increased intensity of the non-phosphorylated lower Mcm4 band. 
 
The differences in the Mcm4 phosphorylation levels at 0 min of the experiment 
introduce considerable difficulty in determining the rate of dephosphorylation over the 
time-course. This is compounded by differently phosphorylated Mcm4 species 
presenting as a continuous smear in immuno-blotting. An attempt was made to 
measure the rate of dephosphoryation by quantifying the density of the Mcm4 bands in 
relation to the position of the band, which corresponds to the level of phosphorylation. 
This allows the derivation of a mean phosphorylation value for each band, as shown in 
Figure 2.14A. The rate of dephosphorylation is the decrease of this value from one 
time-point to the next. If this value were then normalised against the total 
phosphorylation of each sample, it would take into account substrate availability, that 
is, the amount of phosphorylated Mcm4, for PP1 to act on at the time of 
dephosphorylation. However, as shown in Figure 2.14B, no consistent trend can be 
observed over 3 independent experiments. A conclusive interpretation about the 
mechanism of checkpoint-mediated Mcm4 dephosphorylation could not be drawn from 
this quantification approach. An alternative approach using radio-active [γ-32P]ATP may 
prove to be more amenable to the quantification of phosphorylation levels and rates. 
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2.7.2.3 Etoposide affects nuclear envelope formation and Cdc7 
association to chromatin 
Thus far, attempts to delineate the etoposide-induced checkpoint response have been 
met with non-conclusive results. However, with the availability of a Cdc7 antibody, Dr 
Gaganmeet Singh Chadha was able to carry out further experiments to elucidate the 
mechanism of this checkpoint response in egg extracts. 
 
Consistent with the earlier report (Costanzo et al., 2003), the amount of Cdc7 
associated with chromatin was reduced in the presence of etoposide (Figure 2.15A). 
Although caffeine addition rescued both Mcm4 hyper-phosphorylation and DNA 
replication (Figure 2.12), abolishing ATM and ATR checkpoint kinase activity did not 
restore normal levels of Cdc7 on chromatin. Densitometric quantification confirms that 
etoposide has two effects on Cdc7 activity: a caffeine-dependent inhibition of Mcm4 
phosphorylation and a caffeine-insensitive inhibition of Cdc7 chromatin association. As 
such, inhibition of checkpoint kinases can restore Mcm4 hyper-phosphorylation even 
as levels of chromatin-associated Cdc7 remain low.  
 
In Xenopus egg extract, Topo II is rapidly loaded onto sperm chromatin as it undergoes 
decondensation and has been implicated in the process of nuclear envelope assembly 
(Khoudoli et al., 2008; Lucas et al., 2001; Takasuga et al., 1995). It is possible that 
etoposide, a topoisomerase II inhibitor, interferes with normal nuclear assembly, hence 
leading to inefficient loading of Cdc7 onto chromatin. As shown in Figure 2.15C, nuclei 
assembled in the presence of 300 μM etoposide (“ETO at 0 min”) were significantly 
smaller than control nuclei. However, when etoposide was added 30 min after sperm 
addition, after the bulk of DNA decondensation had already occurred, nuclei 
subsequently attained normal sizes (“ETO at 30 min”). Consistent with this, later 
additions of etoposide trapped less topo II on DNA, allowed more Cdc7 to bind to 
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chromatin and allowed normal levels of Mcm4 hyper-phosphorylation (Figure 2.16D). 
As mentioned earlier, Cdc7 is enriched within the nucleoplasm when nuclear assembly 
occurs (Walter, 2000), allowing efficient Mcm4 hyper-phosphorylation prior to initiation 
of DNA replication. Taken together, it appears that the checkpoint-independent 
response on Cdc7 binding due to etoposide treatment is the consequence of disruption 
to nuclear envelope assembly. Activation of checkpoint-mediated responses may then 
involve PP1, possibly through recruitment to chromatin, to further functionally suppress 
Cdc7 activity against chromatin-bound Mcm2-7. 
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Figure 2.15. Early addition of etoposide inhibits nuclear envelope assembly and 
reduces Cdc7 activity on chromatin. 
(A) 10 ng DNA/µl sperm nuclei were incubated in extracts treated with 300 µM etoposide or 300 
µM etoposide and 5 mM caffeine. Chromatin was isolated for immuno-blotting at the indicated 
time-points. (B) Cdc7 levels were quantified and expressed as a proportion of the peak value. 
Mean and S.E.M. for 6 independent experiments are shown. (C) Extracts were supplemented with 
300 µM etoposide at 0, 15 or 30 min following sperm nuclei addition. After 90 min, nuclei were 
stained with Hoechst 33258 and visualised by phase contrast (top) or fluorescence microscopy 
(bottom). Scale bars represent 25 µM. (D) Chromatin was isolated for immuno-blotting for Mcm4, 
Cdc7, PCNA and Topo II at the indicated time-points. Gaganmeet Singh Chadha performed the 
experiments presented in this figure. 
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Discussion 
Previous studies of Cdc7 function in the Xenopus system were carried out by immuno-
depleting Cdc7 and/or its regulatory subunits from egg extracts (Jares and Blow, 2000; 
Jares et al., 2004; Kundu et al., 2010; Pereverzeva et al., 2000; Silva et al., 2006; 
Takahashi et al., 2008; Takahashi and Walter, 2005; Yanow et al., 2003). This 
approach generally involves substantial incubation intervals with specific antibodies 
and result in the dilution of extracts used in the experiments. Non-specific protein 
absorption to beads may also occur that affects the amounts and types of protein 
removed from the extract (Silva et al., 2006). Using specific chemical inhibitors to block 
Cdc7 activity potentially introduces fewer disturbances into the biochemical 
environment for DNA replication, providing greater precision in defining Cdc7 activity 
and execution points in the cell cycle in this model system.  
 
The effect and specificity of PHA-767491 
PHA-767491 was reported to be a small molecule inhibitor that is specific for Cdc7 
(Montagnoli et al., 2008). In order to analyse its selectivity, PHA-767491 was 
characterised across a panel of 95 protein kinases, out of which 14 had been included 
in the assay in an earlier study (Montagnoli et al., 2008). Results from the two screens 
were reasonably consistent, in which higher significant cross-reactivity was detected 
with GSK3-b and Cdk2. While GSK3-b has not been reported to be required in the 
initiation of DNA replication, Cdk2-cyclin A and Cdk2-cyclin E can both induce initiation 
of DNA replication in Xenopus egg extracts. In interphase egg extracts treated with 
protein synthesis inhibitors, Cdc2 (Cdk1) is inactive and initiation of replication depends 
on Cdk2 activity (Strausfeld et al., 1996). Since S-Cdk and Cdc7 are both required for 
the initiation of DNA replication, it was important to establish that PHA-767491 did not 
inhibit DNA replication due to significant cross-reactivity towards S-Cdk activity. 
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Functional assays were thus carried out to test the specificity of PHA-767491 in the 
context of DNA replication in Xenopus egg extracts. 
 
Since nuclear assembly is required for DNA replication to occur, it was first established 
that PHA-767491 did not perturb nuclear envelope formation (Figure 2.4). Mcm4 hyper-
phosphorylation has been shown to be dependent on Cdc7 activity (Takahashi and 
Walter, 2005) and the essential function of Cdc7 may be to relieve an inhibitory activity 
in the amino terminal domain of Mcm4 (Sheu and Stillman, 2010). Looking at the effect 
on chromatin-bound proteins, it was observed that PHA-767491 inhibited Mcm4 hyper-
phosphorylation at concentrations where DNA replication was inhibited. This is 
consistent with PHA-767491 inhibition of an essential Cdc7 function, hence preventing 
chromosomal replication. PHA-767491 appears to inhibit the kinase activity of Cdc7 
without perturbing its association to chromatin, consistent with its chemical 
characterisation as an ATP-analogue (Vanotti et al., 2008). 
 
Chromatin containing hyper-phosphorylated Mcm4 but which has not undergone the 
essential Cdk-dependent step in initiation can replicate efficiently in extract treated with 
PHA-767491 whilst naive sperm nuclei could not (Figure 2.8). Since Cdc7 activity is 
required before Cdk for replication in egg extracts (Jares and Blow, 2000; Walter, 
2000), this experiment provided evidence that the Cdk-dependent step in DNA 
replication can take place in the presence of PHA-767491. While a full rescue of DNA 
replication did not take place, Cdk-dependent replication occurred in the presence of 
PHA-767491 to more than 60% of control levels, suggesting that even under the 
unlikely assumption that all residual inhibition of replication was due to inhibition of Cdk 
activity, this only accounts for less than half of the inhibitory activity of PHA-767491 
observed. The failure of a complete rescue could be attributed to several reasons. 
Firstly, phosphorylation of other Cdc7 substrates that are not present on chromatin at 
the time of transfer, such as Cdc45, may be required for efficient replication. Additional 
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or accessory Cdc7 phosphorylation events may also require the prior action of Cdk, 
which would not have occurred at the time of transfer. Previous studies have indicated 
that phosphorylation of Mcm2 on certain phospho-sites by S-Cdk may enhance Cdc7-
dependent kinase activity (Masai et al., 2000; Montagnoli et al., 2006). Second, weakly 
associated replication factors that could enhance replication efficiency may not be 
transferred under these experimental conditions. Although the omission of detergent 
during nuclei isolation preserves the integrity of the nuclear membrane, these isolated 
nuclei are ʻleakyʼ and soluble nucleoplasmic proteins will largely be lost when nuclei are 
removed from extract into buffer (Gillespie et al., 2012). Lastly, some degree of Mcm2-
7 dephosphorylation is inevitable even in the presence of I-2 in the extract and the 
possibility of PHA-767491 exerting an inhibitory effect on other targets cannot be 
completely ruled out.  
 
Comparing the effects of PHA-767491 and roscovitine (Figure 2.10D), a well-
characterised Cdk inhibitor, it is clear that both kinases act on targets with different 
execution times. Addition of PHA-767491 to extracts in early S phase allowed the 
majority of DNA synthesis to occur, in contrast to Cdk inhibition which almost 
completely blocked replication when added at this time. Also, since protein synthesis is 
inhibited by cycloheximide in these extracts, cyclin A is absent. All S phase promoting 
Cdk activity is dependent on Cdk2-cyclin E1 complexes (Strausfeld et al., 1996). This 
provides more evidence that cross-reactivity towards Cdk2-cyclin A is unlikely to be 
responsible for PHA-767491 inhibition of DNA replication. Looking at the kinetics of 
DNA synthesis (Figure 2.8C, compare whole and dashed lines), pre-incubated nuclei 
incorporated [α-32P]dATP at a higher rate than naive sperm. This is consistent with the 
interpretation that replication origins in pre-incubated nuclei were competent for 
initiation, with pre-RCs assembled on chromatin and the essential Cdc7-dependent 
activity already executed in the first extract. In contrast, a lag was initially observed in 
naive sperm before DNA synthesis proceeded more efficiently after 40 minutes. Taken 
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together, PHA-767491 largely inhibits DNA replication by acting specifically on Cdc7 
activity in Xenopus egg extracts.  
 
PP1 reverses Cdc7-dependent phosphorylation of Mcm4 
Protein phosphatase 1 (PP1) belongs to the phosphoprotein phosphatase superfamily 
of protein serine/threonine phosphatases, which also includes PP2A, PP2B and PP4-7. 
The specific activity and subcellular localisation of PP1 depend on the interaction of a 
PP1 catalytic subunit (PP1c) with one or sometimes two regulatory subunits. In 
mammalian tissues, four PP1 catalytic subunits, PP1α, PP1γ1, PP1γ2 and PP1β/δ, are 
encoded by three genes (Ceulemans and Bollen, 2004; Ceulemans et al., 2002; 
Cohen, 2002; Heroes et al., 2012). More than 200 PP1-interacting proteins (PIPs) have 
been identified in vertebrates (Heroes et al., 2012), thus allowing for the formation of a 
vast array of PP1 holo-enzymes with distinct substrate sets and differential regulation. 
This greatly contributes to and accounts for the diverse functions mediated by 
serine/threonine phosphatases, despite their relatively small number in the genome 
(~40) compared to serine/threonine kinases (~400) (Ceulemans and Bollen, 2004; 
Cohen, 2002; Moorhead et al., 2007). 
 
PIPs bind to PP1 through short docking motifs of four to eight residues in length. 
Through a unique combination of binding motifs, each PIP can interact with the surface 
grooves of a particular PP1 catalytic isoform in a highly specific manner (Bollen et al., 
2010; Heroes et al., 2012). Several docking motifs have been functionally 
characterised, of which RVxF is regarded to be the canonical PP1-binding motif. It is 
present in many but not all PIPs. Other PIPs that do not possess an RVxF motif can 
nevertheless interact with the same region of a PP1 catalytic subunit. Other docking 
motifs include the SILK-type binding motif and the myosin phosphatase N-terminal 
element (MyPhoNE) (Cohen, 2002; Heroes et al., 2012). 
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I-2 was the first protein phosphatase regulator to be identified (Huang and Glinsmann, 
1976). Its expression is conserved from yeast to human (Ceulemans et al., 2002) and 
the protein ranges from 25 – 32 kDa in size across different species (Li et al., 2007). 
Incubation of I-2 with PP1 results in a slow inactivation of PP1 catalytic activity (Bollen 
and Stalmans, 1992). The crystal structure of the PP1c•I-2 complex revealed that the 
interaction of I-2 with PP1cγ occurs at three major sites. While I-2 binding does not 
result in a conformational change in PP1cγ, amino acid residues 148-151 from I-2 are 
directly positioned across the active site of PP1c and I-2 Tyr149 occupies the 
phosphoamino acid binding site of PP1cγ such that one or more metal ions required for 
PP1 enzymatic function is displaced from the active site, thereby inhibiting PP1 activity 
(Hurley et al., 2007). 
 
Upon addition of PHA-767491, hyper-phosphorylation of chromatin-bound Mcm4 was 
lost very rapidly (Figure 2.7). This effect could be reversed using I-2, identifying PP1 to 
be responsible for Mcm4 dephosphorylation. Previous data have shown that a PP1 
catalytic subunit physically interacted with Mcm2-7 complexes that were immuno-
precipitated from chromatin assembled in Xenopus egg extracts (Gambus et al., 2011). 
Together, this is consistent with a scenario of PP1 being dynamically recruited to 
chromatin during S phase, thereby being ideally localised to modulate the kinase 
activity of chromatin-bound Cdc7. This is the first report of a phosphatase acting with 
Cdc7 to modulate an essential activity required for DNA replication. 
 
PP1 has been shown to be involved in cell cycle progression, regulating mitotic events 
such as chromosome condensation, spindle formation, chromosome separation and 
cytokinesis (Ceulemans and Bollen, 2004). PP1 also plays multiple roles in regulating 
the Xenopus early embryonic cell cycle including being required for chromatin 
decondensation before DNA replication (Walker et al., 1992). This report of a 
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phosphatase acting in concert with the Cdc7 kinase and its identification as PP1 has 
other implications for the regulation of Cdc7 activity in DNA replication, which would be 
discussed greater detail in later sections. 
 
Cdc7 acts early in S phase and is not rate-limiting for DNA replication  
In eukaryotic cells, DNA replication occurs through a series of ordered events leading 
to the loading of a double hexamer of the Mcm2-7 complex around origin DNA to form 
the pre-RC, thereby licensing the origin for replication in the subsequent S phase (Evrin 
et al., 2009; Gillespie et al., 2001; Remus et al., 2009; Remus and Diffley, 2009). In this 
study, I used PHA-767491 to define precisely when Cdc7 acts in the sequence of 
events leading to replication initiation in Xenopus egg extracts 
 
In egg extracts, decondensed chromatin becomes surrounded by a functional nuclear 
envelope, which is stimulated by licensed origins promoting the assembly of the 
nuclear pore precursor ELYS (Gillespie et al., 2007). Comparison of soluble and 
chromatin-bound Mcm4 showed that soluble Mcm4 was not hyper-phosphorylated 
(Figure 2.9A), consistent with observations from earlier studies (Masai et al., 2006; 
Pereverzeva et al., 2000; Sheu and Stillman, 2006). The association of Mcm3 (and by 
inference, the Mcm2-7 complex) with chromatin has been shown to be independent of 
nuclear envelope assembly (Chong et al., 1995; Jares and Blow, 2000) and consistent 
with this observation, Mcm4 was detected on chromatin in the absence of nuclear 
assembly (Figure 2.9C). In contrast, the recruitment of Cdc45 occurred only when 
Mcm4 was maximally hyper-phosphorylated (Figures 2.5A and 2.9A) and did not take 
place when WGA was present (Figure 2.9C). In vitro studies in Drosophila provided 
evidence that Mcm2-7 must be associated with Cdc45 and the GINS complex in order 
to be active as a helicase (Ilves et al., 2010; Moyer et al., 2006). Since Cdc45 
recruitment to chromatin is Cdc7-dependent and first requires nuclear envelope 
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formation (Jares and Blow, 2000), this is consistent with Cdc7 executing its essential 
function only after nuclear envelope formation in late M/early G1 phase. Although not 
strictly required, nuclear envelope assembly enhances Cdc7 association with 
chromatin (Silva et al., 2006; Walter, 2000). This is in line in vitro data from 
reconstituting replication initiation and elongation in yeast extracts, showing that Cdc7 
function is required in late G1 to drive the formation of a complex between Sld3 and 
Cdc45. This complex associates with early origins prior to S-Cdk-dependent 
recruitment of Sld2, Dpb11 and GINS, which is then stabilised upon S-Cdk action 
(Heller et al., 2011). Once Cdc7-dependent phosphorylation of the Mcm2-7 complex 
has occurred, S phase-Cdk activity can promote initiation by phosphorylating its 
substrates (Heller et al., 2011; Jares and Blow, 2000; Walter, 2000). 
 
Cdc7 phosphorylation of Mcm2-7 does not affect the stability of the double hexameric 
Mcm2-7 complex, believed to the active conformation of the helicase, before replication 
initiation (Gambus et al., 2011). This means that even if Cdc7 acts on all origins early, 
hyper-phosphorylated Mcm4 complexes may be maintained on chromatin throughout S 
phase, remaining primed for firing to occur according to the replication timing 
programme.  
 
The precise duplication of eukaryotic genomic DNA takes place over a replication 
timing programme with origins organised in spatially distinct clusters that fire at 
different times throughout S phase. Although origin usage within clusters may vary 
significantly from cell to cell, the stage of S phase when specific clusters replicate is 
reproducibly consistent between different cells. S phase progression can be followed 
by visualising these actively replicating clusters (Chagin et al., 2010; Gillespie and 
Blow, 2010; Zink, 2006). It has been proposed that the replication of genomic DNA may 
be organised into three levels of regulation, namely, at the level of individual origin 
firing, clusters of origins firing and progression through different timing stages 
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(Thomson et al., 2010), although the molecular basis of the hierarchical differences and 
regulatory mechanisms is currently poorly understood. 
 
A plausible model is that S phase Cdk acts as a global regulator to phosphorylate 
soluble replication factors while Cdc7 preferentially associates with Mcm2-7 at early-
replicating origins early in S phase until these origins fire, thereby displacing Cdc7 to 
initiate later-firing origins. Cdc7 acts to fine tune the timing programme at a local level. 
It has been reported that while activation of new replication factories is highly sensitive 
to Cdk activity, initiation of origins within factories and progress through new timing 
stages is not (Thomson et al., 2010). This fits with the idea that Cdk regulates origin 
firing at a global level, perhaps through phosphorylating soluble substrates, Sld2 and 
Sld3 in yeast (or their metazoan equivalent), while another regulator operates at the 
level of individual origins. As Cdc7 associates with chromatin through its interactions 
with the Mcm2-7 complex, it is ideally localised to exert a local effect on individual 
origins.  
 
However, the data in this study show that this is not how the replication timing 
programme is driven in Xenopus egg extracts. Here, Cdc7 phosphorylates and 
activates both early- and late-firing origins early in S phase. This is consistent with 
earlier work showing quantitative phosphorylation of Mcm2-7 in Xenopus egg extracts, 
which occurs even though only a fraction of these origins normally initiate in S phase 
(Edwards et al., 2002; Pereverzeva et al., 2000; Woodward et al., 2006). This 
conclusion appears to be inconsistent with studies in yeast which show that DDK 
activity is rate-limiting for origin initiation. Cdc7 was shown to be required throughout S 
phase for the initiation of early and late-firing origins in budding yeast (Donaldson et al., 
1998a). In fission yeast, Patel and co-workers showed that changing levels of Hsk-
Dfp1, the S. pombe homologue of Cdc7-Dbf4, corresponded with a change in origin 
efficiency. Physically tethering Hsk-Dfp1 near an origin also increased firing efficiency, 
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indicating that the effective local concentration of the kinase regulates origin firing 
(Patel et al., 2008). Recent reports examining temporal regulation of origin firing in 
budding yeast proposed that limited Cdc7 (DDK) activity regulates the timing of 
replication (Mantiero et al., 2011; Tanaka et al., 2011a), due to limited levels of Dbf4 
(Mantiero et al., 2011). Over-expression of Dbf4 facilitated late origin firing in both 
studies. 
 
Taking into account the observation Cdc7-dependent phosphorylation of Mcm4 is 
rapidly reversed by PP1, one interpretation that can reconcile these differences may be 
that although Cdc7 can execute its essential function early in S phase, sustained 
kinase activity is still required for normal S phase progression because of constant 
dephosphorylation. The requirement of Cdc7 in throughout S phase may be explained 
thus: in late G1/early S phase, Cdc7 executes its essential function to hyper-
phosphorylate Mcm4, relieving an inhibitory effect of the Mcm4 NSD on DNA 
replication and activating the Mcm2-7 through other phosphorylation events. PP1 is 
closely and dynamically associated to chromatin and constantly dephosphorylates 
Mcm4. In an unperturbed S phase, the equilibrium is maintained towards net (hyper-) 
phosphorylation of Mcm4. Origins thereby remain competent for replication throughout 
S phase as long as Cdc7 activity is present. If Cdc7 activity is inhibited during S phase, 
the equilibrium shifts towards dephosphorylation by PP1 and overall Mcm4 hyper-
phosphorylation is reduced. The NSD exerts its inhibitory function and origins that have 
not initiated can no longer be fired. This argument is consistent with the observation 
that inhibition of PP1 activity enhances rescue of replication in the chromatin transfer 
experiment (Figure 2.8).  
 
A direct comparison between the effects of PHA-767491 and roscovitine indicates that 
Cdk inhibition continued to inhibit DNA synthesis whereas replication could take place 
relatively efficiently in the presence of PHA-767491 when both inhibitors were added to 
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the extract in early S phase (Figure 2.10). Previous studies have shown that S phase-
Cdk activity (Cdk2-cyclin E and Cdk2-cyclin A) is needed throughout S phase for the 
initiation of replication when demembranated sperm nuclei were used as templates for 
replication but is not required for fork progression (Krasinska et al., 2008; Luciani et al., 
2004; Strausfeld et al., 1994). The data in this study show that Cdc7 executes its 
function before Cdk; this supports the argument that once it has executed its function, 
Cdc7 activity is not the rate-limiting step in initiating origins throughout S phase. When 
the progress of nuclei undergoing replication was examined, PHA-767491 addition in 
early S phase did not prevent the appearance of later stage temporal patterns. This is 
also in agreement with the hypothesis that progression through the timing programme 
can be uncoupled from absolute level of DNA synthesis (Thomson et al., 2010) and 
shows that Cdc7 activity is not required for the advancing through the timing 
programme. If Mcm dephosphorylation is prevented, the early activity of Cdc7 is 
sufficient to allow approximately normal progression through the replication timing 
programme. In contrast, Cdk activity is required throughout S phase for new initiation 
events to occur (Luciani et al., 2004) and for progression through the replication timing 
programme (Thomson et al., 2010). 
 
To sum up, while rate-limiting DDK activity contributes to the regulation of origin use 
during S phase in yeasts, the rapid phosphorylation of all replication origins by Cdc7 in 
Xenopus egg extracts may represent an adaption for the extremely short S phases that 
occur in an early embryonic environment. A residual timing programme may still be 
operative in Xenopus egg extracts and in this case, it appears to depend on rate-
limiting Cdk activity or on limiting availability of Cdk substrates required for replication 
initiation (Krasinska et al., 2008; Labit et al., 2008; Luciani et al., 2004; Thomson et al., 
2010). 
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Cdc7 in the intra-S checkpoint response 
Previous studies have been carried out to investigate the checkpoint response 
triggered by the topoisomerase II inhibitor etoposide in Xenopus egg extracts. 
However, results from these studies were not consistent. Costanzo and co-workers 
reported that etoposide treatment inhibited replication, which could be reversed by the 
addition of caffeine. This checkpoint response was attributed to ATR signalling and 
down-regulated Cdc7 kinase activity by impeding Cdc7 association with Dbf4. 
However, chromatin-bound Cdc7 was still detected in etoposide-treated extracts. The 
authors proposed that etoposide generated single-stranded DNA structures, which 
RPA bind to and subsequently recruit ATR, thus triggering the checkpoint response 
(Costanzo et al., 2003). In a different study, etoposide was found to induce an ATR-
dependent pathway through a similar mechanism as a result of slowed replication 
forks. However, etoposide treatment had no effect on the binding of the Drf1-Cdc7 or 
Dbf4-Cdc7 complexes to chromatin (Silva et al., 2006). Tsuji et al. also found that DNA 
replication was inhibited in the presence of etoposide and Chk1 phosphorylation was 
dramatically increased, indicating active ATR-Chk1 signalling. The authors showed that 
addition of Dbf4-Cdc7 to extracts treated with a low concentration of etoposide reduced 
Chk1 phosphorylation and restored DNA replication. They interpreted these results as 
Cdc7 playing an active role to attenuate the checkpoint response rather than being 
targeted for down-regulation (Tsuji et al., 2008). Studies in human cells also show that 
Cdc7 remains active in response to replicative stress and may be important in recovery 
functions (Heffernan et al., 2007; Silva et al., 2006; Takahashi and Walter, 2005; Tenca 
et al., 2007; Tsuji et al., 2008) 
 
In this study, it was observed that Mcm4 hyper-phosphorylation and DNA replication 
was reduced when extract was treated with etoposide. This response is checkpoint-
dependent as it is reversible upon caffeine treatment. When ATM or DNA-PK was 
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specifically inhibited using KU55933 or NU7441 respectively, some degree of rescue 
was evident at the level of Mcm4 phosphorylation, though not to the levels of the 
control sample. Also, since the reduction of hyper-phosphorylation did not depend on 
on-going replication, this checkpoint-dependent response is not majorly mediated by 
ATR (Figure 2.13). Taken together, ATM, ATR and DNA-PK signalling pathways may 
all be involved to some extent and it is likely that etoposide did not simply elicit a 
straightforward response through single- or double-stranded DNA breaks. This 
interpretation differs from previous studies where ATR/ATR-Chk1 signalling was found 
to be primarily responsible for etoposide inhibition of DNA replication (Costanzo et al., 
2003; Silva et al., 2006; Tsuji et al., 2008). It also differs from a previous study where 
Cdc7 was found not to play a role in the checkpoint response to double stranded 
breaks (Petersen et al., 2006). 
 
Looking at the levels of chromatin-bound Cdc7, two etoposide-dependent effects on 
Cdc7 were evident in the present study. There was a caffeine-insensitive inhibition of 
Cdc7 association to chromatin and a caffeine-dependent inhibition of Mcm4 
phosphorylation. This is consistent with the report from Costanzo et al. in that the 
etoposide checkpoint down-regulates Cdc7 kinase activity (Costanzo et al., 2003) but 
is not supported by studies by Silva et al. and Tsuji et al. who found that chromatin 
association, complex formation and kinase activities of both Dbf4-Cdc7 and Drf1-Cdc7 
were unaltered in etoposide-treated extract (Silva et al., 2006; Tsuji et al., 2008). Silva 
et al. also reported that Mcm4 phosphorylation was not affected (Silva et al., 2006). In 
the mammalian systems, neither Dbf4-Cdc7 nor Drf1-Cdc7 complexes were released 
from chromatin in human cells treated with etoposide. In fact, Mcm4 phosphorylation 
was induced upon drug treatment and was abolished by siRNA depletion of Cdc7 
(Tenca et al., 2007). 
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The differences in the response to etoposide observed in this study compared to 
previous studies could be due to variation in experimental conditions. While low speed 
supernatants which support nuclear envelope formation were used in all studies, the 
concentration of etoposide used in the other studies (30 μM) did not affect replication 
or reduce Mcm4 phosphorylation in this study (data not shown). In contrast, replication 
was reportedly inhibited up to 90% (Silva et al., 2006). It is possible that due to 
variations in extract preparation method, the low speed supernatant used in this study 
was more robust towards replicative insults. As such, there may be a different 
checkpoint response towards this comparatively lower-grade damage. In addition, 
while an inhibition to nuclear assembly was observed in this study, this was not directly 
addressed in the other reports. As previously mentioned, etoposide appears to be 
causing a complex response, possibly signalling through several pathways. The data 
presented here may describe a distinct mechanism of etoposide action from those 
investigated in other studies.  
 
Disparate observations may be the result of different signalling pathways in response 
to the intra-S disruption during the cell cycle. ATM and ATR are members of the 
phosphatidylinositol kinase-related family of protein kinases that function at or near the 
top of the signalling pathways of various checkpoint regulatory pathways in response to 
DNA damage (Zhou and Elledge, 2000). While ATM is mainly involved in the response 
to double-stranded breaks, ATR plays a key role in detecting lesions that generate 
single-stranded breaks, such as those arising from stalled replication forks (Harrison 
and Haber, 2006). In this signalling cascade, two other protein kinases, Chk1 and 
Chk2, act downstream of ATM and ATR respectively (Zhou and Elledge, 2000). While 
this describes the general response to DNA damage, ATM and ATR may also respond 
to common DNA lesions and exert their effects on downstream targets directly. In 
Xenopus egg extracts, it was reported that EcoRI treatment resulted in a major 
reduction of DNA replication which was completely reversible by the addition of 
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caffeine, in line with the data presented in Figure 2.13 (Yoo et al., 2004). Removal of 
either ATM or ATR by immuno-depletion allowed a restoration of DNA replication up to 
20 to 30% of control levels while depletion of both checkpoint kinases restored 
replication to approximately 70% of normal levels. Similar depletions of Chk1, Chk2 or 
both Chk1 and Chk2, however, had no effect on EcoRI inhibition of DNA replication. 
The authors concluded that ATM and ATR act cooperatively to inhibit DNA replication 
in response to double-stranded breaks and that the they exert their effects directly or 
through downstream effectors apart from the Chk1 and 2 kinases (Yoo et al., 2004). In 
another study, DNA replication in an extract depleted of Chk1 was still found to be 
sensitive to aphidicolin treatment and could be rescued by caffeine addition. This 
indicated that checkpoint signalling was still activated and that Chk1 was not an 
essential component in this response (Luciani et al., 2004). Given that chromosomal 
replication is a dynamic process involving the coordination of many proteins complexes 
over large stretches of DNA, impediments to replication fork progression may result in 
different physical intermediates, which trigger mixed checkpoint responses.  
 
On the other hand, different DNA damaging agents may also converge on a common 
mechanism to trigger checkpoint response through the formation of a common DNA 
structure. Lupardus and colleagues had showed that UV, MMS and aphidicolin 
treatment slowed down replication forks in Xenopus egg extracts, stalling DNA 
replication in a caffeine-insensitive manner. They proposed that slowed replication 
forks caused the formation of ssDNA structures which were insufficient to trigger a 
replication checkpoint response but necessary as templates for the association of 
additional proteins, like RPA and DNA polymerase α, to generate a checkpoint-
activating structure. On-going replication is required in this process (Lupardus et al., 
2002). This is consistent with the model in which the uncoupling of DNA unwinding by 
the Mcm helicase and DNA replication by replicative helicases in the presence of DNA 
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damage generates large regions of unwound ssDNA to allow accumulation of RPA and 
ATR on chromatin (Byun et al., 2005).   
 
Given the complex nature of the intra-S checkpoint signalling cascade, it is therefore 
important to consider the mode of action of etoposide in order to understand the Cdc7-
dependent response elicited. Etoposide is an anticancer agent that is used clinically in 
the treatment of human malignancies. In mammalian cells, it acts by poisoning 
topoisomerase II, stabilising covalent cleavage complexes that the enzyme transiently 
forms with double-stranded nicks to resolve DNA supercoils. This gradually increases 
the level of enzyme-mediated double-stranded breaks in the genome leading to cell 
death (Burden and Osheroff, 1998). Costanzo et al. had argued that while 
topoisomerase II is covalently bound to the 5ʼ terminus of cleaved DNA, the 3ʼ end 
remains free and is not equivalent to the conformation of a double-stranded break. 
Instead, they proposed that the intermediate is first processed into a single-stranded 
structure which loads RPA to activate an ATR-dependent checkpoint (Costanzo et al., 
2003). In the present study, a substantial amount of replication was still observed in the 
presence of etoposide (approximately 40% of control, see Figure 2.12), unlike previous 
reports (Costanzo et al., 2003; Silva et al., 2006; Tsuji et al., 2008). Here, in the 
presence of on-going replication, several checkpoint mechanisms may be active 
simultaneously, generating and responding to single-stranded intermediates and other 
double-stranded structures created, whether as a consequence of prior single-stranded 
processing or not. This means that ATM and ATR could both be involved in a complex 
signalling response. The involvement of Chk1 or 2 kinases has not been addressed yet 
by this present study, so the question of whether ATM/ATR signal through the Chk 
kinases or act directly on distinct downstream targets remains to be clarified. 
 
While the checkpoint signalling process remain ambiguous, it is clear that Cdc7 
function is restrained in response to etoposide treatment. In principle this could occur 
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either by inhibition of Cdc7 kinase activity or by promoting Mcm dephosphorylation. 
The observation that caffeine affects Cdc7 binding and Mcm4 phosphorylation 
differently shows that the amount of Cdc7 on chromatin is not limiting for DNA 
replication and implies that another factor may be regulating Mcm4 hyper-
phosphorylation in response to the checkpoint. Given that Mcm4 hyper-phosphorylation 
is reversed by PP1 (Figure 2.7) and I-2 addition can restore Mcm4 hyper-
phosphorylation in etoposide-treated extracts (Figure 2.12), an attractive explanation is 
that PP1 activity is up-regulated by the checkpoint response, thereby functionally 
lowering Cdc7 activity. Consistent with this hypothesis, unpublished experiments by Dr 
Gaganmeet Singh Chadha show that etoposide promotes the chromatin association of 
PP1α and PP1γ in a checkpoint-dependent manner (Poh et al., manuscript in 
preparation). 
 
Regulators of PP1 have been reported to be involved in modulating PP1 activity in 
response to DNA damage (Kuntziger et al., 2011). In Xenopus egg extracts, Peng et al. 
reported that one such regulator, Repo-Man (Recruits PP1 onto Mitotic chromatin at 
Anaphase), recruits PP1γ to chromatin. Repo-Man associates with ATM and PP1 
through distinct domains, targeting PP1γ to antagonise ATM activation and negatively 
regulate DNA damage-induced signal transduction. Inhibition of PP1 results in a 
sensitized response to DNA damage caused by double-stranded breaks and Repo-
Man dissociated from active ATM at sites of DNA damage, both on chromatin in extract 
or on DNA fibres prepared from mammalian cells. The authors propose that Repo-Man 
provides specificity and localisation to PP1, acting as an inhibitory mechanism to 
prevent checkpoint response activation by a sub-threshold level of DNA damage (Peng 
et al., 2010). While these results are different from the findings in this study, most likely 
because this specific PP1 regulator is mediating a distinct PP1 response, it 
demonstrates that PP1 can be mobilised to associate with DNA in response to 
checkpoint signalling and to modulate signal transduction. With PP1 being able to form 
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complexes with 50 or possibly more regulatory subunits in a mutually exclusive manner 
(Cohen, 2002), it is difficult to speculate on the identity of the regulator acting in the 
etoposide-induced response without more data. 
 
In this study, the inhibition of Cdc7 chromatin loading was dependent on etoposide 
being present in extract at the time of chromatin decondensation, and correlated with 
the ability of etoposide to trap Topo II on DNA and inhibit full chromatin decondensation 
(Figure 2.15). Taken together with observation that nuclear assembly is disrupted by 
etoposide treatment, a model of this checkpoint response involving Cdc7 and PP1 is 
proposed, as outlined in Figure 2.16. In this scheme, Mcm phosphorylation is the 
central event required for replication initiation to proceed. The net actions of a kinase 
(Cdc7) and phosphatase (PP1) regulate the equilibrium of Mcm phosphorylation status. 
Nuclear assembly and origin licensing occur before phosphorylation takes place. The 
introduction of etoposide results in the disruption of nuclear envelope assembly, which 
reduces Cdc7 recruitment and activity, triggering a checkpoint kinase-mediated 
recruitment of PP1 to chromatin via a specific regulator. Together, these events reduce 
total Mcm phosphorylation and inhibit replication initiation. While checkpoint bypass 
with caffeine cannot restore nuclear architecture to allow Cdc7 recruitment to 
chromatin, it is able to reverse the effect on PP1 recruitment. As such, etoposide-
induced inhibition of Mcm4 phosphorylation can be rescued without restoring normal 
levels of chromatin bound Cdc7. However, due to checkpoint effects on other targets, 
such as Cdk, the addition of I-2 alone cannot rescue the level of DNA synthesis.  
 
This model presents a novel mechanism through which Cdc7 activity is affected by 
etoposide. Unlike previous reports in the Xenopus system that position Cdc7 
downstream of and inactivated by checkpoint activity (Costanzo et al., 2003) or others 
which maintain that Cdc7 remains active to mediate a recovery response (Silva et al., 
2006; Tenca et al., 2007; Tsuji et al., 2008), this schematic places Cdc7 outside of the 
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direct effect of checkpoint kinases when Mcm4 activity is taken as a readout. Instead, 
PP1 is the proposed target of checkpoint activity while Cdc7 function is restricted by 
lack of nuclear formation. Checkpoint kinases counteract Cdc7 function at least in part 
by promoting PP1 chromatin association, thereby reducing Cdc7-mediated Mcm 
phosphorylation, which in turn affects recruitment of Cdc45 to chromatin and DNA 
replication. Prevention of hyper-phosphorylated Mcm4 from PP1 dephosphorylation 
with caffeine to bypass checkpoint kinase activity can therefore rescue the distinct 
delay in the recruitment of Cdc45 to DNA in etoposide-treated extract, allowing initiation 
of replication origins.  
94 
 
 
 
 
 
 
 
Figure 2.16. Proposed mechanism for the checkpoint-dependent response 
triggered by etoposide treatment in Xenopus egg extracts.  
In late M phase of the cell cycle, nuclear envelope reassembles following chromosome 
segregation. Origin licensing then takes place from late M to early G1 phase, when Mcm2-7 
complexes are recruited to chromatin to form pre-RCs. Nuclear assembly enhances recruitment of 
Cdc7 to chromatin-bound Mcm2-7, thereby promoting Cdc7 phosphorylation of Mcm2-7 at the 
onset of S-phase. Cdc7 and S-Cdk phosphorylation of the Mcm2-7 complex is required for the 
activation of the helicase. PP1 modulates the hyper-phosphorylation of Mcm4. When etoposide is 
added to Xenopus egg extracts, nuclear envelope assembly is disrupted. This reduces the amount 
of Cdc7 that can be recruited to chromatin and also triggers a checkpoint response through 
checkpoint kinase to recruit PP1γ to chromatin. The result is an overall decrease in Mcm2-7 
phosphorylation, which prevents initiation of replication from taking place. Caffeine can bypass the 
checkpoint kinase action on PP1, thus restoring Mcm4 hyper-phosphorylation, allowing rescue of 
DNA replication. 
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Concluding remarks 
Through the course of this chapter, I have presented data from the characterisation of 
the small molecule inhibitor, PHA-767491, on Cdc7 activity in Xenopus egg extracts 
and showed that it inhibits DNA replication largely by blocking an essential Cdc7 
activity. Making use of the rapid action of a chemical inhibitor, I have used PHA-767491 
in experiments to determine the time of execution of Cdc7 for its S phase functions and 
identified that Cdc7-dependent Mcm4 hyper-phosphorylation is quickly reversed by the 
action of PP1 phosphatase activity.  
 
I had examined whether Cdc7 is involved in the progression of the replication timing 
programme and my results indicate that in the absence of Mcm4 dephosphorylation, 
Cdc7 is not rate-limiting for the progress through the replication timing programme 
once it has executed its essential function for initiation early in S phase. To address the 
role of Cdc7 in the intra-S checkpoint, I used etoposide in Xenopus egg extracts and 
explored its effects and mechanism of action. Finally, based on my work and results 
from Dr Gaganmeet Singh Chadha (Poh et al., manuscript in preparation), I propose a 
novel intra-S checkpoint mechanism in which checkpoint regulated PP1 activity 
functionally restrains Cdc7 activity upon etoposide treatment in Xenopus egg extracts.  
 
While the present study has provided additional insight into Cdc7 function and 
regulation in Xenopus, more work remains to be done to address several aspects of 
the replication timing programme and of the intra-S checkpoint response. These 
include determining how Cdc7 or PP1 may be involved in the regulation of early- and 
late-origin firing, how this is affected by the intra-S checkpoint and also to look in 
greater detail how PP1 activity is regulated by checkpoint kinases. The biochemical 
evidences presented here may provide the starting points to begin answering these 
questions. 
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Chapter 3 – Generating a Cdc7 condition knockout mouse 
Introduction 
Many studies on the function of Cdc7 have been done using yeast or Xenopus cell free 
extracts as model systems. These systems are versatile and amenable to genetic or 
biochemical modifications, greatly facilitating experimental design. Also, since Cdc7 is 
conserved from yeast to human, findings from such model systems are likely to be 
relevant to mammalian studies. To complement data from in vitro models, genetic 
studies in a mammalian system can provide additional information about 
developmental roles and other in vivo functions of the protein at the level of tissues and 
the whole organism.  
 
The development of technologies enabling the introduction of any mutation into the 
mouse genome through gene targeting in embryonic stem (ES) cells offers a powerful 
approach to investigate gene function in the whole organism. However, in the case of 
essential genes, the complete absence of the gene product results in early embryonic 
lethality, preventing studies in later development or adult stages. From the perspective 
of clinical studies, the complete inactivation of a gene may not reflect the full spectrum 
of its function in a physiological context, as disease phenotypes may arise from genetic 
changes arising only in a subset of cells or during a certain temporally-specific stage 
(Lobe and Nagy, 1998).  
 
To address these issues, a conditional knockout (cko) strategy may thus be employed. 
The basic idea is to insert a pair of loxP sites flanking opposite ends of the gene of 
interest. The gene can then be inactivated by the expression of the Cre (Causes 
recombination) recombinase, which catalyses recombination of the loxP sites in 
animals carrying this cko allele. Another level of control can be achieved by placing the 
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Cre gene under the control of tissue-specific and/or inducible promoters (Hayashi and 
McMahon, 2002) or to selectively introduce the Cre gene via viral delivery systems (Liu 
et al., 2003; Lobe and Nagy, 1998). Conditional knockouts can also be generated using 
the Flp/FRT system in which the S. cerevisiae derived Flp (flippase) recombinase 
mediates excision between FRT recognition sites. However since the bacteriophage P1 
derived Cre is optimally functional at 37ºC, it is more widely used in conditional 
mutagenesis than the more thermolabile Flp enzyme (Buchholz et al., 1996). 
 
Genetic studies of Cdc7 in the mouse model have previously been published. Kim et al. 
reported that deletion of murine Cdc7 resulted in embryonic lethality between E3.5 and 
E6.5. This observation was not unexpected since Cdc7 is an essential gene. E3.5 
Cdc7-/- blastocysts that were isolated and cultured in vitro failed to form an inner cell 
mass. Using a plasmid construct encoding a functional Cdc7 gene flanked by loxP 
sites, the group then generated and characterised conditional Cdc7-deficient ES cells 
lines carrying this Cre-removable Cdc7 transgene (Cdc7-/-tg). Upon the loss of Cdc7, 
Cdc7-/- cells rapidly ceased DNA replication and arrested with G2/M DNA content. 
Rad51 foci were observed in these cells, indicating a G2/M checkpoint response and 
the cells death eventually occurred through p53-dependent apoptosis (Kim et al., 
2002). In a follow up study, mice generated with the Cdc7-/-tg genotype were found to 
be sterile due to a defect in spermatogenesis in males and abnormal oogenesis in 
females. These mice also developed at a slower rate than wild type mice and Cdc7-/-tg 
MEFs displayed decreased proliferative capacity with a smaller population of cells in S 
phase. These phenotypes were attributed to hypomorphic expression of the Cdc7 
protein, which was five times lower than in wild type mice. By introducing a second 
copy of the transgene (Cdc7-/-tg/tg), Cdc7 expression was increased to two-thirds of 
wild type levels and these defects were rescued. These mammalian genetic studies 
revealed that Cdc7 is essential for early embryogenesis, highlighting the importance of 
a critical level of Cdc7 expression in mammalian development and an essential role for 
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Cdc7 in germ cell development (Kim et al., 2003). A related study in which ASK, the 
mammalian homologue of the Cdc7 activator Dbf4, was deleted in a mouse ES cell line 
showed that murine ASK is required for Cdc7 kinase activation in vivo and confirmed 
the essential role of Cdc7 for cell proliferation and DNA synthesis in ES cells 
(Yamashita et al., 2005). 
 
In the present study, a Cdc7 cko allele was constructed to generate transgenic mice in 
which Cdc7 loss can be induced conditionally. These mice represent a comprehensive 
model in which the contribution of targeted Cdc7 loss can be examined in different 
tissues, cell types and developmental stages. They will be useful models in 
tumorigenesis and other translational studies. The strategy for conditional Cdc7 
knockout is outlined in the following sections and results from the screenings done to 
identify the transgenic founder will be presented. The design and construction of this 
targeting vector was done in collaboration with Dr Zheng Xinde. I was involved only in 
the very preliminary stages of the construction process. Xinde designed and initiated 
the Southern blot strategy subsequently used in the screening process. I carried out 
and completed the final stages of the screening. 
 
Method 
Creating a conditional knockout targeting vector requires the insertion of loxP/FRT sites 
and positive and negative selection markers into the DNA sequence of the gene of 
interest cloned into bacterial artificial chromosomes (BAC). A major drawback of using 
conventional cloning techniques to create gene-targeting constructs is the dependence 
on suitably located, unique restriction sites within or in the proximity of the gene of 
interest. The development of the recombineering method of chromosome engineering 
(Copeland et al., 2001) has greatly facilitated this process, offering the flexibility to 
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precisely modify BAC DNA and shortening the time required (Liu et al., 2003). The 
recombineering technique is used in creating this Cdc7 targeting vector. 
 
Recombineering is a tightly regulated homologous recombination-based system based 
in Escherichia coli (Copeland et al., 2001). Efficient homologous recombination can be 
achieved by three proteins (Exo, Bet and Gam) encoded by the Red genes of the 
bacteriophage λ, allowing linear double-stranded DNA (dsDNA) molecules to be 
integrated into DNA cloned in BACs. The exo gene encodes a 5ʼ – 3ʼ exonuclease 
which digests the ends of the dsDNA fragment to produce 3ʼ single stranded 
overhangs. A pairing protein encoded by bet then binds to these overhangs and 
promotes annealing to a complementary sequence on the cloned DNA. Since linear 
dsDNA is unstable in E. coli due to the activity of endogenous RecBCD, a third phage-
encoded protein Gam is required to inhibit the bacterial exonuclease (Poteete, 2001; 
Stahl, 1998). The λ-phage recombination genes can be expressed from a plasmid 
(Murphy et al., 2000) or from a defective prophage integrated into the bacteria genome 
(Yu et al., 2000).  
 
Design of the Cdc7 conditional knockout (cko) targeting vector  
The murine Cdc7 gene is located on the mouse chromosome 5E5 and consists of 12 
exons, encoding 564 amino acids (Figure 3.1A) (Kim et al., 1998). The first step in 
designing a targeting construct is to identify the sequence of interest. The targeting 
strategy is based on the genomic sequence of murine Cdc7 in the NCBI database 
(NC_000071, Region 107 393 341 – 107 413 450). In order to decide which exons to 
target for knockout, several considerations were taken into account. The loss of the 
floxed exons should (1) result in loss of a protein function, (2) generate a frame-shift 
mutation and (3) result in the expression of a truncated protein so that the protein 
product is functionally inactive. Attention was paid to minimise the distance between 
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loxP sites, as the efficiency of recombination decreases with increasing distance, that 
flanking introns should be large enough to accommodate loxP sites and facilitate 
genetic manipulation and promoter- and enhancer-rich introns are avoided (Bouvier 
and Cheng, 2009).  
 
In this study, exons 3 and 4, encoding kinase domains I and II of murine Cdc7 were 
chosen. These exons are relatively small, separated only by a 217-bp intron, and are 
flanked by two very large introns of 3743 and 3452 bp. This would allow positioning of 
the two loxP sites close to each other and also provide a large distance to work with for 
the insertion of targeting construct elements. Alternative splicing of exons 2 and 5 due 
to the loss of intervening exons 3 and 4 would not yield an in-frame variant protein, 
hence fulfilling the criterion of a frame-shift mutation. In the event that exon 2 splices to 
exons 6 through 12, only the exon 2-11 and 2-12 combination will result in a product in 
the same reading frame as the full-length protein. However, since these resulting 
peptides will be very small and missing important conserved domains, they are unlikely 
to be functional. 
 
In this targeting strategy, a gene trap in the form of the engrailed-2 splice acceptor 
(eng2SA) was introduced in the 5ʼ homology arm of the targeting construct. As 
illustrated in Figure 3.1B, the linear targeting vector consists of a 5ʼ homology arm 
containing the FRT-loxP-eng2SA-Neo-FRT-loxP cassette and a lonely loxP site after 
exon 4, followed by the 3ʼ homology arm. With the inclusion of a splice acceptor, exon 
2 will be aberrantly spliced into eng2SA, resulting in a truncated message and hence 
protein product. Mutant mice carrying one copy of the correctly targeted allele would be 
constitutively hypomorphic for Cdc7 expression while mice homozygous for the 
targeted allele are expected to be phenotypically equivalent to a Cdc7 null mouse, 
which would be lethal. The homology arms were selected so that they were from 
regions of the genome that are free from repetitive sequences and they should not 
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contain restriction sites for at least one unique restriction enzyme that cuts the vector 
backbone so that this enzyme can later be used to linearise the targeting vector for 
electroporation into ES cells. 
 
The targeting construct is introduced into the wild type Cdc7 locus by homologous 
recombination in a gene-targeting event, giving rise to the mutant allele (Figure 3.1C). 
The FRT-loxP-eng2SA-Neo-FRT-loxP cassette can subsequently be excised from the 
allele by FLP-mediated recombination between the two FRT sites. This generates a 
conditional knock-out allele with exons 3 and 4 flanked by loxP sites (Figure 3.1D) – 
this is the floxed allele. Expression of Cdc7 from this allele is expected to be 
comparable to that from a wild type locus. Mice carrying the floxed allele may be 
crossed with mouse strains carrying tissue-specific and/or inducible Cre recombinase. 
This then allows selective deletion of exons 3 and 4 by Cre-mediated recombination as 
required, resulting in the Cdc7-null knock-out allele (Figure 3.1E).  
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Figure 3.1. Schematic of the targeting strategy for creating the Cdc7 cko allele. 
(A) The Cdc7 gene is located on the mouse chromosome 5E5 and consists of 12 exons. Exons 3 
and 4 were selected for gene targeting. The positions of relevant restriction enzyme sites and the 
5’ and 3’ probes for Southern blotting are indicated. (B) The linearised targeting construct would 
be integrated into the genomic locus by homologous recombination. (C) The targeted allele results 
when the linear targeting construct is successfully integrated. Pr1, 2 and 3 indicate positions of 
PCR primers designed to differentiate wild type (A), floxed (C, D) and null (E) alleles for genotyping. 
(D) The engrailed-2 splice acceptor (Eng2) and the Neor cassette can be excised by recombination 
between the FRT sites to leave a floxed, conditional knockout allele. (E) Mice carrying the floxed 
allele may be crossed with mouse strains expressing tissue-specific and/or inducible Cre 
recombinase. Selective deletion of exons 3 and 4 by Cre-mediated recombination results in a 
Cdc7-null allele. 
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Construction of the targeting vector 
Figure 3.2 illustrates the schematic for constructing the targeting vector. The 
construction of the linear targeting vector begins with the retrieval of a suitable length of 
genomic sequence from a BAC in which modifications can be introduced. This is 
accomplished by gap repair recombination with a linearised retrieval vector, bearing 
homology arms to 5ʼ and 3ʼ regions flanking the desired genomic region, and a suitable 
BAC containing the region of interest (RP23-24K16) (Figure 3.2). The retrieval vector is 
constructed by modifying a pBlight-TK vector backbone (PKB782) (Warming et al., 
2006) to contain a 413-bp 5ʼ retrieval arm and a 397-bp 3ʼ retrieval arm. The 5ʼ arm 
was PCR amplified from the BAC template with the primers PKO1187 and PKO1188 
(see Material and methods for primer sequences), gel purified, digested with BamHI 
and XhoI and ligated into PKB782. The 3ʼ arm was PCR amplified from the BAC 
template with the primers PKO1185 and PKO1186, gel purified, digested with HindIII 
and SpeI and also ligated into PKB782. To retrieve the genomic 6527-bp fragment, 
recombineering-competent BAC clones harbouring pSim18-Hygro (Lee and Liu, 2009) 
were shifted from 32ºC to 42ºC for 15 min to induce expression of the genes required 
for recombination, namely exo, bet and gam. The retrieval vector, linerised with XhoI 
and HindIII, was introduced by electroporation. Ampicillin-resistant clones were 
selected and presence of the retrieved Cdc7 locus can be confirmed by restriction 
digest analysis. 
 
The retrieval vector backbone includes a herpes simplex virus-thymidine kinase (HSV-
TK) cassette, situated outside the homology arms. It encodes the enzyme thymidine 
kinase which converts ganciclovir into a toxic product and functions as a negative 
selection marker against random integration events during gene targeting. Only ES 
colonies that have correctly undergone homologous recombination, hence losing the 
HSV-TK gene, will survive in the presence of ganciclovir.  
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Figure 3.2. Schematic for constructing the retrieval vector. 
Homology arms (green, red) were amplified by PCR using the primer pairs PKO1187 and 
PKO1188 (5’), and PKO1185 and PKO1186 (3’) with the corresponding restriction enzyme sites. 
These were cloned into the pBlight plasmid PKB782, after which the plasmid was linerised and 
transformed into recombineering-competent BAC-containing bacteria. The BAC sequence 
between the homology arms was “retrieved” onto the retrieval vector by gap repair. ES cells in 
which the targeting vector is correctly integrated into the Cdc7 locus through homologous 
recombination will lose the HSV-TK gene carried on the plasmid backbone, enabling their positive 
selection with ganciclovir. 
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The next step is the introduction of the lonely loxP site into the retrieved locus. First, a 
plasmid bearing the loxP-Neo-loxP cassette (PKB781, pL452) (Liu et al., 2003) was 
modified to contain homologous regions flanking the targeted loxP insertion site within 
the intronic sequence between exons 4 and 5 (Figure 3.3A and C, pink segments). The 
397-bp 5ʼ arm was amplified from the BAC template with the primers PKO1197 and 
PKO1198, gel purified, digested with ApaI and EcoRI and ligated into PKB781. The 
263-bp 3ʼ arm was likewise generated and added using the primers PKO1202 and 
PKO1238 and enzymes BamHI and NotI. An MfeI restriction site was included in 
PKO1202 after the BamHI site for future Southern Blot analysis. Recombineering-
competent bacterial cells containing the retrieved sequence were heat-shocked at 42ºC 
for 15 min as before. The modified loxP-Neo-loxP cassette was released from its vector 
backbone with ApaI/NotI and introduced by electroporation. Antibiotic-resistant clones 
were again selected and insertion verified by restriction digest. The floxed Neo cassette 
could then be removed to leave a single loxP site by introducing this construct into Cre-
induced competent cells (StrataClone SoloPack competent cells, #200185-41) by heat-
shock at 42ºC for 15s.  Ampicillin resistant clones were selected and insertion verified 
by restriction digest. 
 
The final stage of the construction is then to introduce the FRT-loxP-eng2SA-Neo-FRT-
loxP cassette. Homology arms were cloned into PKB996 (pLTM330), generously 
provided by Dr Lino Tessarollo from the National Cancer Institute-Frederick (Figure 
3.3B and C, blue segments). The 253-bp 5ʼ homology arm was PCR amplified with 
PKO1193 and PKO1194, digested with SalI and EcoRV and ligated into PKB996. The 
3ʼ homology arm was amplified with PKO1201 and PKO1217, digested with SacII and 
ligated into PKB996. A ScaI restriction site was added to the 3ʼ end of this insert via 
PKO1217 for verifying that the insertion of this homology arm into the single SacII cut 
site occurred in the right direction. A SpeI site was also added inside the SacII site for 
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the purpose of future Southern Blot analysis. Recombineering-competent bacterial cells 
containing the retrieved sequence modified with the lonely loxP site were heat-shocked 
at 42ºC for 15 min as before. The modified FRT-loxP-eng2SA-Neo-FRT-loxP cassette 
was excised from its vector backbone with SalI and ScaI and introduced by 
electroporation. Kanamycin-resistant clones were selected and correct insertion 
verified by restriction digest. This completes the construction of the targeting vector 
(PKB1086). 
 
The ability to delete the loxP- and FRT-flanked sequences in this cassette was verified. 
The vector was sequenced on both strands at the loxP and FRT boundaries to ensure 
integrity of the targeting construct. Finally, the vector was linerised with PvuI and sent 
to Dr Lino Tessarollo at the National Cancer Institute-Frederick for electroporation into 
ES cells.  
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Figure 3.3. Schematic for constructing the targeting vector. 
(A) Homology arms (dark and light pink) corresponding to sequences within the retrieved BAC 
sequence (Figure C, regions A, B) were generated by PCR amplification using the primer pairs 
PKO1193 and PKO1194 (5’), and PKO1201 and PKO1217 (3’) with the indicated restriction 
enzyme sites. These were digested and ligated into PKB996. The plasmid was linearised with SalI 
and ScaI to yield the FRT-loxP-eng2SA-Neo-FRT-loxP cassette (Orange box: FRT; Red 
arrowhead: loxP). (B) Homology arms (dark and light blue) corresponding to sequences within the 
retrieved BAC sequence (Figure C, regions C, D) were likewise generated by PCR amplification 
using the primer pairs PKO1197 and PKO1198 (5’), and PKO1202 and PKO1238 (3’) with the 
indicated restriction enzyme sites. These were digested and ligated into PKB781. The loxP-Neo-
loxP cassette was released from the plasmid backbone with ApaI and NotI digestion. (C) loxP-
Neo-loxP was first inserted into between regions C and D. Following Cre recombination to leave 
the lonely loxP site, FRT-loxP-eng2SA-Neo-FRT-loxP was then inserted between regions A and B. 
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Results 
3.1  Screening for Cdc7-targeted mice 
A Southern blot strategy was designed to distinguish the correctly targeted allele from 
wild type in screens of electroporated ES cell and, subsequently, tail lysates from 
crosses between chimeric mice. The positions of the 5ʼ and 3ʼ probes are illustrated in 
Figure 3.1A. The 5ʼ probe recognises a fragment of 3.6 kb in wild type and 5.6 kb in 
targeted samples upon SpeI restriction digest. The 3ʼ probe identifies a fragment of 8.6 
kb in wild type and 5.7 kb in the targeted samples upon MfeI digest.  
 
Following the successful generation of mice carrying the targeted allele, an alternative 
PCR-based method also has to be available to rapidly establish the genotypes of mice 
from this colony. To this end, a set of 3 primers was designed (Figure 3.1, C – E). 
Primers 1 and 2 flank the lonely loxP site whereas Primer 3 is located much further 
upstream, before the FRT-loxP-eng2SA-Neo-FRT-loxP cassette. This arrangement 
allows a single PCR reaction to distinguish among wild type, targeted/floxed and null 
genotypes. Primers 1 and 2 will produce PCR products in wild type and targeted/floxed 
genotypes which differ by approximately 146 bp – the size of the loxP site plus residual 
nucleotides from the Cre/lox recombination. Primer 3 will not result in any PCR product, 
as the distance to Primer 2 is too large for efficient amplification by standard PCR 
techniques. In the null genotype however, a Cre/lox recombination would excise the 
intervening region up to the lonely loxP site, including the sequence recognised by 
Primer 1, bringing Primer 3 close enough to Primer 2 for efficient PCR amplification. 
Primer 3 is positioned such that the size of this PCR product is unique from the PCR 
product of Primers 1 and 2. 
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3.1.1  1st screening of mouse tail lysates 
Figure 3.4 shows results from the first screening of tail lysates that I carried out to 
check for germline transmission of the correctly targeted allele from chimeric mice to 
their first generation offspring. Chimeric mice had been derived from positive clones 
from an earlier Southern blot screen of ES cell lysate following electroporation (results 
unavailable). From the 33 tail lysate samples received, a preliminary screen was first 
carried by PCR on HotSHOT-extracted genomic DNA. This PCR reaction amplifies a 
region found in the neomycin resistance cassette, which in principle would identify 
samples in which the gene locus had been correctly targeted. 14 out of 33 samples 
were found to be positive for the Neo cassette and were followed up with Southern 
blotting to confirm correct targeting at both the 5ʼ and 3ʼ ends. 
 
Genomic DNA was first extracted using phenol-chloroform-isoamyl-alcohol and 
Southern blotting performed using non-radioactive using DIG-labelled probes following 
restriction digests using SpeI or MfeI. As shown in Figure 3.4B, all 14 samples were 
positive for the 5.6 kb band when probed at the 5ʼ end. The 3.6 kb wild type was also 
present in all samples as any mouse carrying the targeted allele would be 
heterozygous at this stage. However, looking at the results from the 3ʼ probe, although 
all samples were positive for the 8.6 kb wild type band, as expected, none of them 
tested positively for the 5.7 kb targeted band. Instead, a puzzling observation was that 
of a much larger band between 10 and 20 kb in size, present in all samples. This 
indicated that no sample was correctly targeted at both 5ʼ and 3ʼ ends. A likely 
explanation for the larger 3ʼ band was that homologous recombination at the 3ʼ end had 
occurred at an intervening region upstream of the lonely loxP site. Since the lonely loxP 
site spans only an extremely short interval of only 146 bp, there is a higher possibility of 
it being “lost” in this manner without a selectable marker to maintain it in transformed 
cells. To test this hypothesis, two sets of PCR were carried out. The top panel of Figure 
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3.4C shows the result from a genotyping PCR, which gives different PCR products for 
wild type and targeted alleles (WT: 329 bp/ Targeted: 444 bp). Only the wild type PCR 
product was observed in all tail lysate samples. The lower panel shows the result of 
PCR amplification using primers that overlap the lonely loxP site. Wild type sequences 
would not be amplified by this reaction. No PCR product was detected in all tail lysate 
samples. This confirms the hypothesis that the loxP site was not present in these 
genomic DNA samples. Accordingly, with only correct targeting at the 5ʼ end without a 
corresponding 3ʼ insertion of the lonely loxP sequence containing an engineered MfeI 
site, a restriction digest with MfeI would be expected to yield a fragment of 
approximately 13 kb. This is consistent with the Southern blot results observed. 
 
From this screen, it was decided that a new round of ES cell electroporation would be 
carried out.  
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Figure 3.4. The targeting construct was only correctly integrated at the 5ʼ end, 
losing the lonely loxP site in the 3ʼ homology arm. 
(A) Genomic DNA was extracted from tail lysate using the HotSHOT method and PCR amplification 
carried out to check for the presence of the Neor cassette using the primers PKO838 and 
PKO839. The expected PCR product is 458 bp. (B) For Southern blotting, genomic DNA was 
extracted with phenol-chloroform-isoamyl-alcohol and digested with SpeI for detection with the 5’ 
probe or MfeI for detection with the 3’ probe. The 5’ probe was PCR amplified with PKO1502 and 
PKO1503 and the 3’ probe with PKO1191 and PKO1192 and were DIG-labelled by random-
primed labelling. Sample A2 was included as a negative control and correctly targeted ES cells 
samples from a previous screen were used as positive controls (+ control). Expected fragment 
sizes are indicated. (C) PCR amplification to distinguish between wild type and targeted alleles was 
carried out with primers PKO2282 and PKO2285 (top). The primer pair PKO2284 and PKO2286 
was used to verify the presence of the lonely loxP site (bottom). The expected PCR product is 261 
bp. The faint band visible at ~500 bp is non-specific. 
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3.1.2  Screening of ES lysates 
Figure 3.5 shows the results the screening of a new set of ES cell lysates. 66 samples 
were received this time. Southern blotting with the 3ʼ probe following MfeI digestion was 
carried out for all samples. Four samples, samples 2639, 2640, 2654 and 2669 were 
positive for the targeted band. 17 samples were found to be positive for the 13 kb band 
which results when homologous recombination had occurred before the lonely loxP site 
(Figure 3.5A).  
 
Samples 2639, 2640 and 2650 – 2671 were also tested for positive targeting at the 5ʼ 
end following SpeI digestion (Figure 3.5B). Nine samples were found to be correctly 
targeted, including the samples 2639, 2640, 2654 and 2669. This indicates that ES 
clones 2639, 2640, 2654 and 2669 had correctly integrated the targeting construct into 
the Cdc7 locus at both 5ʼ and 3ʼ ends. Consequently, these were to be used in 
microinjections into blastocysts for the derivation of chimeric mice. 
 
Only Southern blotting can be reliably used in the screening of ES cell lysates, as these 
lysates may have been prepared from mixed colonies following electroporation. As 
such, even a few cells carrying correctly targeted construct would yield a positive PCR 
result. If a mixed colony were subsequently used to derive chimeric mice, the efficiency 
of generating a desired transgenic animal would be lowered. There is also the 
possibility of successful electroporation but no recombination in the ES cell. In this 
scenario, PCR would yield a false positive result. 
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Figure 3.5. ES clones 2639, 2640, 2654 and 2669 are correctly targeted. 
(A) Genomic DNA was extracted with phenol-chloroform-isoamyl-alcohol and digested with MfeI 
for detection with the 3’ probe. Samples highlighted with red boxes are correctly targeted. (B) 
Correctly targeted samples together with a subset of samples were digested with SpeI for 
detection with the 5’ probe. Samples highlighted with red boxes are correctly targeted at the 5’ 
end. Samples with additionally marked with an arrowhead are correctly targeted at both ends. 
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3.1.3  2nd screening of mouse-tail lysates 
Following ES cell injections into blastocysts, the chimeric mice born will be mated and 
their offspring have to be tested to identify animals carrying a germline transmission of 
the targeted allele. Nine samples were received for this second round of screening of 
mouse-tail lysates. As shown in Figure 3.6A, D5 tested positive for the targeted band at 
both the 5ʼ and 3ʼ end by Southern blotting. PCR analysis verified the presence of a 
floxed allele, the lonely loxP site and the Neo cassette, indicating that the targeting 
construct had indeed been correctly inserted. These positive results indicated a 
germline transmission of the cko allele in this mouse. From this screen, mouse D5 will 
be mated and the resulting embryos re-derived in order to establish a transgenic 
mouse colony under specific-pathogen-free conditions, in line with local animal facility 
requirements. 
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Figure 3.6. Mouse D5 is heterozygous for the Cdc7 cko allele. 
(A) Genomic DNA was extracted from mouse-tail lysates with phenol-chloroform-isoamyl-alcohol 
and digested with SpeI for detection with the 5’ probe or MfeI for detection with the 3’ probe. D5 is 
positively targeted when tested with both probes. ES cell lysate from sample 2640 (Figure 3.5) was 
used as a positive control. (B) PCR verification was done to confirm the presence of the targeted 
allele (PKO2282, PKO2285), the lonely loxP site (PKO2284, PKO2286) and the Neor cassette 
(PKO838, PKO839). The expected band sizes are indicated below each gel picture. The targeting 
vector (TC) was used as a positive control in these PCRs. 
117 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7. Workflow for creating the Cdc7 conditional knockout mouse using 
the recombineering method. 
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Discussion 
In this chapter, I have briefly outlined the design strategy for the generation of a 
conditional Cdc7 knockout mouse. Results from the screening performed to identify a 
transgenic founder were presented. One mouse was found to carry a germline 
transmission of the conditional knockout targeting construct. 
 
The recombineering technique for gene targeting 
The workflow for creating a Cdc7 cko mouse strain is summarised in Figure 3.7, 
making use the recombineering technique in various stages to construct the targeting 
vector. The use of recombineering simplifies the process compared to using traditional 
cloning methods which rely on restriction enzymes and DNA ligases for vector 
construction. Greater flexibility is afforded, as any region of the BAC is now amenable 
to modification (Copeland et al., 2001). The placement of genetic elements such as 
loxP/FRT sites and selection markers in the targeting vector can be precisely 
determined without being limited by having to make use of existing restriction sites in 
the regions of interest.  
 
In the retrieval step, a selected portion of the BAC vector is subcloned into a high copy 
plasmid for target vector construction. This relies on the gap repair mechanism to 
recombine free ends of the retrieval vector with homologous sequences carried on the 
BAC. The retrieval vector could have been generated by PCR amplification, using 
chimeric primers that have at their 5ʼ ends the BAC homology sequences (45 – 50 bp) 
and at their 3ʼ ends sequences to prime and amplify the high copy plasmid (Copeland 
et al., 2001). However in this study, the method of cloning and inserting longer 
homology arms of 300 – 400 bp into the retrieval plasmid was chosen to increase 
subcloning efficiency (Liu et al., 2003). By subcloning only a selected portion of the 
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BAC sequence, the potential problem of removing existing loxP sites in the BAC 
backbone before introducing the loxP-Neo-loxP and FRT-loxP-eng2SA-Neo-FRT-loxP 
into the regions flanking exons 3 and 4 is circumvented (Liu et al., 2003).  
 
The expression of the λ-phage genes exo, bet and gam for recombination can be 
placed under the control of a plasmid (Murphy et al., 2000) or from a defective 
prophage integrated into the E. coli chromosome (Yu et al., 2000). In the generation of 
the Cdc7 cko targeting vector, bacteria strains were made recombineering competent 
by transformation with the pSim18 plasmid (Lee and Liu, 2009). When λ-Red genes are 
expressed from a defective prophage system, gene expression is driven by the strong 
λ PL promoter, which in turn is under the control of the temperature-sensitive λ cI857 
repressor. At 32ºC, there are negligible levels of Exo, Bet and Gam proteins. 
Expression of exo, bet and gam can be rapidly induced to high levels simply by shifting 
the culture to 42ºC for 10 to 15 min (Liu et al., 2003). The pSim18 plasmid carried the 
Red genes under this heat-inducible control, combining the flexibility of tightly 
controlled gene expression with the ease of delivering recombineering functions into 
any BAC-containing bacteria strain by simple plasmid transformation (Lee and Liu, 
2009). 
 
Considerations in inserting the lonely loxP site 
An important feature of this conditional knockout is the presence of loxP sites flanking 
exons 3 and 4. Owing to the small size of the lonely loxP site in comparison to the 
length of homology on either side, care must be taken to ensure that the whole 
targeting vector had been correctly integrated at both the 5ʼ and 3ʼ ends. To this end, 
an MfeI site was engineered into the loxP-Neo-loxP cassette so that an MfeI digest 
followed by Southern blotting would give a 5.6 kb product in a correctly targeted 
genomic sample. As described in Sections 3.1.1 and 3.1.2, this also allowed the 
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identification of constructs that had only incorporated the 5ʼ end of the targeting vector 
correctly. Another precaution was to make use of PCR primers specific for the lonely 
loxP sequence to confirm its presence. As seen in Figure 3.5A, 17 out of 66 ES cell 
lysate samples did not integrate the lonely loxP, compared to 4 out of 66 samples 
which did so correctly, pointing to a low efficiency of introducing the small lonely loxP 
site into the gene locus. On hindsight, the efficiency of this recombination step could 
have been improved by having a longer 3ʼ homology arm, starting from the lonely loxP 
site, of approximately 5 kb up to 10 kb in length (Bouvier and Cheng, 2009). By having 
the lonely loxP far from the ends of the linear targeting vector, it would be “safely” 
located in the middle portion of the targeting vector, which is exchanged intact into the 
genomic locus, following homologous recombination occurring much further 
downstream in the 3ʼ direction. 
 
Future perspectives for the Cdc7 conditional knockout mouse 
The cellular effects of Cdc7 depletion have been characterised through siRNA 
knockdown models in various cancer cell lines. Experiments revealed that inhibition of 
origin firing through targeting Cdc7 triggers a tumour-cell specific, p53-independent 
apoptotic response following an abortive S phase, which is not observed in normal 
cells. In contrast, wild type p53 and intact checkpoint responses arrest normal cells 
reversibly in G1 following Cdc7 depletion, maintaining untransformed cells in a viable 
non-proliferative state (Montagnoli et al., 2004; Montagnoli et al., 2008; Tudzarova et 
al., 2010). The response of normal somatic cells to Cdc7 depletion appears to be 
similar to the response to licensing inhibition and it has been proposed that a licensing 
checkpoint may exist in G1 that senses an insufficient number of licensed origins prior 
to entry into S phase (Blow and Gillespie, 2008; Shreeram et al., 2002). This is different 
from an intra-S checkpoint response that arrests cells in S phase following replication 
fork stalling or DNA damage (Branzei and Foiani, 2009). However, Cdc7 depletion also 
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caused cell death in p53-positive cells, suggesting that p53 alone is insufficient to 
prevent cell death due to Cdc7 depletion in these cells. The authors investigated the 
mechanisms of cell death upon Cdc7 depletion and their results revealed that distinct 
cell-cycle responses were induced by Cdc7 depletion in p53-positive and -negative 
cells, with p53-negative cells arresting in G2 with an accumulation of mitotic regulators, 
followed by post-mitotic cell death after prolonged arrest, while p53-positive cells 
mostly die after entry into an aberrant S phase (Ito et al., 2012). The molecular 
mechanisms leading to cell death and the checkpoint response following Cdc7 
depletion remain to be characterised.  
 
Cells from this Cdc7 conditional-knockout mouse may be useful in delineating the 
molecular differences in the putative licensing checkpoint operating in G1 and the intra-
S checkpoint as cells expressing normal, low and no Cdc7 protein respectively may 
can be generated and characterised for experiments. Activation of the intra-S 
checkpoint requires that some origins be fired before insufficient initiation present as 
replicative stress, leading to fork stalling which may eventually result in cell death. This 
process may be recapitulated using cells with a low level of Cdc7 expression whose 
response may be expected to be different from cells in which Cdc7 knockout has been 
induced prior to S phase, leading to signalling through the putative licensing 
checkpoint. By crossing the Cdc7 conditional knockout strain with a p53-null mouse 
line, the role of p53 status in response to Cdc7 knockout can also be studied. 
Alternatively, mouse embryonic fibroblasts with a Cdc7flox/flox genotype may be infected 
with shRNA to generate a stable p53-knockout cell line, which may be used in 
experiments to delineate p53-dependent and -independent checkpoint signalling 
pathways upon Cdc7 abrogation. These experiments mirror those reported in an earlier 
study carried out with siRNA knockdown of Cdc7 in a human fibroblast cell line 
(Tudzarova et al., 2010). This will be a useful means to validate the findings presented 
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in that study using a different and potentially more thorough and specific approach to 
abrogate Cdc7 expression in cells.  
 
In the same way, cells expressing normal, low and no Cdc7 protein will also be useful 
to examine the role of Cdc7 in replication timing regulation. DDK in the fission yeast 
has been suggested to be a diffusible, catalytic, rate-limiting activator of origin firing 
(Patel et al., 2008). Through manipulating Hsk1-Dfp1 levels, it was demonstrated that 
increasing or decreasing origin firing rates caused increased genomic instability. The 
cells derived from this cko animal present an ideal model in which this hypothesis can 
be tested in mammalian cells. 
 
Cdc7 and its regulator Dbf4 have been found to be upregulated in multiple cancer cell 
lines and primary tumours, including ovarian cancer (Kulkarni et al., 2009), malignant 
melanoma (Clarke et al., 2009; Nambiar et al., 2007) and breast cancer (Choschzick et 
al.). It is not clear how Cdc7 expression levels contribute to tumourigenesis and cell 
survival, however. Higher levels of Cdc7 expression do not always correlate with the 
proliferative status of cells; indeed, overexpression of Cdc7 and Dbf4 have been shown 
to cause cell cycle arrest in S phase (Guo et al., 2005). At the level of a whole 
organism, the importance of Cdc7 protein abundance or activity to tumourigenesis and 
cell survival may be studied if mice with the Cdc7flox/flox genotype were used to generate 
models of different cancers. The effect of Cdc7 depletion may then be characterised in 
different tissues via the expression of the Cre recombinase driven by tissue specific 
promoters or at different stages of disease development. Results from these studies 
may complement work from ongoing clinical trials (Koltun et al., 2012; Montagnoli et al., 
2010) and other work using Cdc7 inhibitors as a potential anticancer treatments (Ermoli 
et al., 2009; Koltun et al., 2012; Menichincheri et al., 2010; Menichincheri et al., 2009; 
Shafer et al., 2008; Vanotti et al., 2008; Woods et al., 2012; Zhao et al., 2009). 
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Observations from such animal studies could have implications for how best to use 
Cdc7 inhibitors as anticancer agents in a physiological context. 
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Chapter 4 – Characterisation of Cdk1/Cdk2 double knockout 
mouse embryonic fibroblasts 
Introduction 
Cyclin-dependent kinases drive important transitions in the cell cycle. Highly conserved 
in metazoans and abundantly expressed in all dividing cells, Cdk2 was believed to be 
an essential regulator of mammalian S phase based on its activation timing, cyclin-
binding preferences and dominant negative (DN) phenotypes. In an early study, in vitro 
injection of Cdk2-specific antibodies into cells caused an arrest in G1 phase of the cell 
cycle (Tsai et al., 1993). Similar cell cycle arrests were also observed with antibodies 
against cyclin A and cyclin E, the cyclin partners of Cdk2 (Ohtsubo et al., 1995; Pagano 
et al., 1992). By overexpressing DN alleles in which the Cdk is catalytically inactive 
while still retaining its cyclin-binding functions, it was determined that Cdk1 and Cdk2 
regulate different processes in the cell cycle (Hu et al., 2001; Itzhaki et al., 1997; van 
den Heuvel and Harlow, 1993).  
 
Cdk2 was thought to drive the G1/S transition in association with E-type cyclins, 
phosphorylating pRb to complete its inactivation after the initial action of Cdk4 and 
Cdk6 (Lundberg and Weinberg, 1998), and then allow progression through S phase 
with A-type cyclins as binding partner. However, this notion was challenged when it 
was reported that knockdown of Cdk2 with antisense DNA or siRNA oligonucleotides 
did not cause a G1 arrest or block proliferation in human cancer cell lines (Tetsu and 
McCormick, 2003). This study was followed by the generation of viable mice in which 
Cdk2 has been disrupted by gene targeting, demonstrating that Cdk2 is genetically 
dispensable for cell proliferation and the mitotic cell cycle in vivo (Berthet et al., 2003; 
Ortega et al., 2003). These results raised questions about the presumed specialised 
functions of Cdks in cell cycle events and transitions and it was of major interest to 
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delineate the Cdk activities needed for S phase entry and progression. 
 
Primary mouse embryonic fibroblasts (MEFs) isolated from Cdk2-/- embryos proliferate 
in culture with similar kinetics to those derived from heterozygous or wild type embryos 
at low culture passages. These cells enter S phase with similar kinetics to wild type 
cells after release from serum starvation (Berthet et al., 2003; Ortega et al., 2003). 
Cells from later passages proliferate more slowly and exhibit a slight delay in S phase 
entry (Berthet et al., 2003; Ortega et al., 2003). In primary Cdk2-/- MEFs, immuno-
precipitates obtained with antibodies specific to cyclin A contained kinase activity 
(Berthet et al., 2003; Ortega et al., 2003) and pRb was phosphorylated on Thr821, a 
residue thought to be a specific Cdk2-cyclin E substrate, indicating that another kinase 
can phosphorylate Cdk2 substrates.  
 
In the absence of Cdk2, Cdk1-cyclin A was initially suggested to phosphorylate Cdk2-
cyclin A targets (Berthet et al., 2003; Ortega et al., 2003). It was subsequently 
demonstrated that Cdk1 is able to bind cyclin E1 and these Cdk1-cyclin E complexes 
are active and responsible for promotion of S phase entry in the absence of Cdk2 
(Aleem et al., 2005). In the study, proliferation of wild type MEFs was reduced following 
knockdown of Cdk1 with a short hairpin RNA (shRNA) construct. This effect was more 
pronounced in Cdk2-/- MEFs. The percentage of Cdk2-/- cells entering S phase following 
release from serum starvation was also reduced by a greater extent after Cdk1 
knockdown, compared to wild type MEFs. These findings indicate that Cdk1 plays a 
role in S phase entry, although Cdk1-cyclin E activity is normally very low in wild type 
cells, presumably due to regulation by p27 (Aleem et al., 2005). Consistent with these 
results, mouse embryos lacking all interphase Cdks can develop to mid-gestation 
(Santamaria et al., 2007), with cell cycle progression being mediated by Cdk1, which 
was able to bind all cyclins, phosphorylate pRb and allow the expression of genes 
regulated by E2F transcription factors. Cdk1 thus appeared to have a previously 
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unstudied role in mediating G1/S entry and progression that becomes more important 
in the absence of Cdk2. 
 
In order to study the importance of Cdk1 and Cdk2 activity in mammalian cells, in 
particular their roles in promoting S phase entry and progression, the loss of both Cdk1 
and Cdk2 was analysed in cells derived from a conditional Cdk1/Cdk2 double knockout 
mouse model. This is possible by taking advantage of the Cdk1 conditional knockout 
mouse recently generated (Diril et al., 2012). Cdk1 loss can be induced in cells carrying 
the targeted construct by expression of the Cre recombinase. Induction of 
recombination in the Cdk1 allele in a Cdk2 null background (Berthet et al., 2003) then 
allows for in vitro analysis of cell cycle events in the absence of both functional Cdk1 
and Cdk2 activities. In the following sections, results including cell cycle kinetics and 
biochemical characterisation are presented.  
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Results 
4.1 Cdk1 loss is induced upon 4-OHT treatment to generate double 
knockout cells 
Primary mouse embryonic fibroblasts (MEFs) were isolated from Cdk1flox/flox/Cdk2+/+ or 
Cdk1flox/flox/Cdk2-/- embryos carrying the allele for inducible Cre/ESR1 expression. 
Supplementation of cell culture media with 4-hydroxytamoxifen (4-OHT) causes nuclear 
translocation of the Cre recombinase, hence excising exon 3 of Cdk1 which is flanked 
by loxP sites (Figure 4.1) (Diril et al., 2012). Induction was carried out for 72 h, 
concurrent with serum starvation of the MEFs to synchronise them in G1 phase of the 
cell cycle (Figure 4.2A). 
 
After 72 h serum starvation and induction, cells were harvested and genotyping PCR 
revealed that the floxed Cdk1 allele was no longer detected at a significant level. The 
PCR product for the Cdk1 null (Cdk1 knockout; K1 KO) allele was observed instead 
(Figure 4.2B). qRT-PCR carried out using primers specific for regions spanning exons 
3 and 4 also confirmed a loss of Cdk1 transcript after 4-OHT treatment. As seen in 
Figure 4.2C, Cdk1 transcript could be detected upon release from induction and serum 
starvation in wild type and Cdk2 knockout (K2 KO) cells, which increased 2-fold by 24 
h after release into full serum. In contrast, no Cdk1 transcript was detected at both 
time-points in the Cdk1 KO and Cdk1/Cdk2 double knockout (DKO) cells that were 
exposed to 4-OHT during serum starvation. Together, this demonstrates that wild type 
Cdk1 allele and expression is lost following 4-OHT treatment. 
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Figure 4.1. Schematic of the conditional Cdk1 knockout construct. 
(A) In the floxed Cdk1 construct, exon 3 is flanked by a pair of loxP sites (red triangles). An FRT site 
(blue rectangle) is left behind after Flp-mediated recombination to remove a Neor selection 
cassette. (B) After Cre recombination, exon 3 will be excised, resulting in a frame-shift. Pr1, 2 and 
3 indicate positions of PCR primers for genotyping verification. Modified from (Diril et al., 2012).  
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Figure 4.2. Treatment with 4-OHT induced loss of Cdk1 in MEFs. 
(A) Schematic of experimental setup. MEFs homozygous for the floxed Cdk1 locus became Cdk1-
null upon 4-OHT induction. This occurred concurrently with 72 h serum starvation to synchronise 
cells in G1. (B) Cells were harvested upon release from serum starvation and DNA extracted for 
genotyping. (C) qRT-PCR was performed using primers specific for the floxed Cdk1 exon. (D) Cells 
were collected before serum starvation and induction (lanes 1,2), during serum starvation (24, 72 h) 
and after release into full serum (+24 h). Whole cell lysates were immuno-blotted for Cdk1 and 
Cdk2. Hsp90 served as loading control. 
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To monitor the loss of Cdk1 protein following 4-OHT induction, cells were harvested 
over the course of serum starvation and 4-OHT induction (Figure 4.2D, “24” and “72”) 
and after release into full serum (“+24”). Whole cell lysates were blotted with antibodies 
specific for Cdk1 and Cdk2. During serum starvation in the absence of 4-OHT, the 
amount of Cdk1 protein decreased slightly from 24 to 72 h after starvation in wild type 
cells and increased when cells were released into medium containing full serum. This 
profile was also observed in Cdk2 KO cells, although there was a smaller decrease in 
Cdk1 level from 24 to 72 h during serum starvation. This decrease likely represents a 
general down-regulation of protein expression as cells become quiescent, which is 
reversed upon serum stimulation. In MEFs treated with 4-OHT during the course of 
serum starvation (K1 KO and DKO), the amount of Cdk1 detected was drastically 
decreased from 24 to 72 h. Background levels of Cdk1 were detected at 72 h in Cdk1 
KO cells; however by 24 h after release into full serum Cdk1 was no longer detected in 
both Cdk1 KO and DKO cells by immuno-blotting. These results corroborate with Cdk1 
transcript levels, demonstrating that 4-OHT effectively induces the loss of the 
Cdk1flox/flox allele, leading to loss of Cdk1 protein in MEFs.  
 
Cdk2 levels remained constant during serum starvation in wild type cells and were 
increased in the presence of serum. Cdk2 levels decreased slightly during serum 
starvation in Cdk1 KO cells and increased upon release from starvation. However, the 
level of Cdk2 detected at 24 h after release was lower in Cdk1 KO cells than wild type. 
Cdk2 was not detected at all time-points in Cdk2 KO and DKO cells, as expected. 
 
132 
4.2 Cdk1/Cdk2 DKO cells can enter S phase but cannot progress 
through DNA synthesis efficiently 
Cdk1 was proposed to compensate for the loss of Cdk2 interphase functions in Cdk2 
knockout mice (Aleem et al., 2005). To determine if the loss of both Cdk1 and Cdk2 
would affect S phase entry and cell cycle progression in MEFs, BrdU was added to 
culture media for 30 min before cells were harvested at different time-points following 
release from serum starvation to monitor DNA synthesis (Figure 4.3A). As shown in 
Figure 4.3, at 18 h after release from serum starvation, 56.6% of wild type cells had 
incorporated BrdU and appear to be in early S phase, displaying a total DNA content 
between 2N and 4N. By 24 h, the S phase population had decreased to 43% as cells 
progress into late S phase. Cells in G2 phase have completed one round of DNA 
synthesis and have 4N DNA content. From 18 to 24 h, the G2 cell population increased 
from 5.2% to 22.6% while the G1 cell population did not change greatly. At 48 h, the 
percentage of cells incorporating BrdU had decreased to 29.6%, G2 cells had 
decreased to 9.3% and the population of cells with 2N DNA content but did not 
incorporate BrdU had increased to 50.7%. This indicates that wild type MEFs have 
completed one round of DNA replication, undergone mitosis and cycled back to G1 by 
48 h after release into full serum. 
 
When Cdk1 was absent in MEFs, cells were still able to enter S phase. At 18 h, 47.5% 
of cells had incorporated BrdU. This proportion decreased to 28.4 and 5.6% at 24 and 
48 h respectively, indicating that cells were largely not actively synthesising DNA by the 
end of the time-course. The G2 cell population steadily increased from 18.9 to 34.4 and 
finally to 61.7% at 48 h. At all time-points, the G1 population remained <20% of all 
cells. This indicates that Cdk1 KO cells were able to enter S phase and complete one 
round of DNA replication but then become arrested in G2 cells due to a mitotic defect. 
This is consistent with previously published results (Diril et al., 2012). Cdk1 KO cells 
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cannot initiate early events of mitotic entry such as cytoskeletal reorganization and 
rounding up of the cell body and therefore cannot divide following genome duplication. 
Also in agreement with the earlier report, a significant level of endo-reduplication was 
observed in Cdk1 KO cells compared to wild type cells, resulting in a population of cells 
with 8N DNA content, which can be observed as a distinct peak in total DNA content. 
Endo-reduplication in Cdk1 KO cells is attributed to unrestrained Cdk2-cyclin A2 
activity (Diril et al., 2012). 
 
Cdk2 KO cells behaved largely in a similar manner to wild type cells, entering and 
progressing through S phase from 18 h to 24 h and cycling back to G1 by 48 h. Cdk2 
KO cells were slightly delayed in S phase entry as only 37.9% was BrdU-positive at 18 
h compared to 56.6% of wild type cells. This is consistent with previous reports (Berthet 
et al., 2003; Ortega et al., 2003). However, no difference was observed at the 
subsequent time-point, indicating that there was largely no significant difference in cell 
cycle progression in wild type and Cdk2 KO MEFs. 
 
Surprisingly, a population of DKO cells cells (14%) had incorporated BrdU at 18 h. This 
percentage had increased to 27.9% at 24 h with a corresponding decrease in the G1 
cell population, suggesting that more cells had entered S phase by this time. Looking at 
the histogram of total DNA content, S phase entry was significantly delayed in DKO 
cells compared to wild type cells. The distribution of cells in G1, S and G2 phases 
subsequently remained relatively constant from 24 to 48 h, implying a lack of progress 
through the cell cycle. At 48 h, the intensity of BrdU incorporated had decreased by 
one order of magnitude compared to the intensity at 24 h, indicating that cells at this 
time were no longer incorporating nucleotides efficiently. Taken together, these results 
strongly suggest that while a small population of cells lacking Cdk1 and Cdk2 can enter 
S phase, the timing of entry is delayed, progress through S phase is inefficient and 
cells could not complete one round of DNA synthesis following synchronisation. 
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Figure 4.3. Cell cycle profile of MEFs following release from serum starvation. 
Following serum starvation with or without 4-OHT induction, MEFs were labelled with BrdU for 30 
min before harvest. Cells were also stained with PI for total DNA content and analysed by flow 
cytometry. This experiment has been performed 6 times and this is the cell cycle profile of one 
representative experiment. 
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From Figure 4.3, DKO cells that were able to enter S phase appeared to synthesise 
DNA inefficiently, as observed from the markedly reduced level of BrdU incorporated at 
48 h. This observation may also be attributed to the unlikely scenario that some DKO 
cells had completed a first S phase normally and had entered a second aberrant S 
phase. To distinguish between the two scenarios, a BrdU pulse experiment was carried 
out. In this experiment, instead of labelling cells at the time of collection, BrdU was 
added to culture medium at 18 h after serum starvation when cells are entering S 
phase. BrdU was then washed off and the cell cultures maintained for varying durations 
until they were harvested at indicated time-points (Figure 4.4B). This scheme allows all 
cells entering S phase at 18 h to be labelled with BrdU and follows the progress of 
these cells through the time-course. Cell division following mitosis would reduce the 
intensity of the incorporated BrdU label by approximately half. In contrast, labelling 
cells with BrdU just before harvest (Figure 4.4A), as in the previous experiment, only 
captures the distribution of cells in different phases at the time of collection but does 
not provide information about the progress a particular cell population with time. 
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Figure 4.4. Schematics of BrdU treatment of MEFs to analyse cell cycle profile 
and cell cycle progression. 
(A) To analyse the profile of different cell populations at individual time-points, MEFs were labelled 
with BrdU for 30 min before harvest, following release from serum starvation with or without 4-OHT 
induction. (B) In order to monitor the progress of one cell population through the time-course, cells 
were labelled for 30 min at 18 h following release from serum starvation with or without 4-OHT 
induction. BrdU was washed off and pulse-labelled cells allowed to progress through the cell cycle. 
Cells were collected at intervals following the BrdU addition. 
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The results from this pulse-labelling approach are presented in Figure 4.5. At 4 h after 
release from serum starvation, cells were well-synchronised in G1, with 57 – 69.9% 
cells displaying 2N DNA content, without BrdU label. At 18 h, cells in all genotypes 
entered S phase, with 59.4, 52.1, 35.2 and 10.6% from wild type, Cdk1 KO, Cdk2 KO 
and DKO respectively, having incorporated BrdU. This is consistent with results from 
Figure 4.3. 
 
In an unperturbed S phase, wild type cells that were labelled at 18 h began to 
synthesise DNA, with the total DNA content of the labelled population increasing from 
21 to 24 h. At 27 h, some cells have completed DNA synthesis and undergone cell 
division, resulting in the reappearance of cells with 2N DNA content and a lower 
intensity of BrdU labelling. This G1 population continued to increase till 29 h and then 
remained constant till 45 h, the final time-point in this experiment. The cell cycle 
progression of Cdk2 KO cells is largely similar to wild type cells, with BrdU labelled 
cells having completed DNA synthesis and cycled back to G1 largely from 27 h after 
release from serum starvation. Again, this is consistent with previous reports that loss 
of Cdk2 does not affect the mitotic cell cycle (Berthet et al., 2003; Ortega et al., 2003).  
 
A similar progression from S phase entry up to 27 h was observed in Cdk1 KO cells, 
after which the proportions of cells with 4N and 8N DNA content remained constant. 
The proportion of cells with 2N DNA content remained low while the level of BrdU 
incorporated in cells that have completed S phase remained high until the end of the 
time-course. Taken together, this indicates that Cdk1 KO cells did not undergo cell 
division to cycle back to G1.  
 
Unlike the cells of the other genotypes which largely entered S phase at 18 h and then 
(for wild type and Cdk2 KO) began to divide and cycle back to G1 by 27 h, DKO cells 
that had incorporated BrdU at 18 h only appeared to have substantially accumulated 
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4N DNA content by 29 h. There also appears to be a G2 arrest. These results suggest 
that the absence of both Cdk1 and Cdk2 prevented efficient DNA progression, leading 
to a defective S phase while the loss of Cdk1 then contributed to a subsequent mitotic 
defect and G2 arrest. 
 
Overall, these results are also in line with proliferation assays, where it was observed 
that loss of Cdk2 did not affect cell proliferation whereas loss of Cdk1 alone or together 
with Cdk2 led to senescence and non-proliferation in MEFs (Figure 4.6). Cdk2 KO cells 
proliferate like wild type cells. 
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Figure 4.5. DKO cells enter but progress very inefficiently through S phase. 
Following serum starvation and 4-OHT induction, cells were released into full serum. At 4 h and 18 
h, cells were labelled with BrdU for 30 min before they were harvested (grey box). As outlined in 
Figure 4.4B, cells were pulse-labelled with BrdU for 30 min at 18 h. BrdU was washed off and cells 
were collected at the indicated time-points after labelling to monitor the progress of one population 
of cells (green box). Following collection, BrdU-labelled cells were analysed with flow cytometry. 
The labels in the top row (green text) indicate the time after the BrdU pulse while the labels in 
bottom row (black text) indicate the time after release into full serum. This experiment was 
performed twice with similar results; this is a representative plot. 
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Figure 4.6. DKO cells do not proliferate. 
Following serum starvation with or without 4-OHT, cells were plated at low density. Proliferation of 
MEFs was analysed using the alamarBlue assay every 24 h over the course of 8 days. This 
experiment has been performed three times and a representative plot is shown. 
 
 
141 
4.3 Cyclin E and Cdc6 protein levels are elevated in DKO cells 
In order to explore the molecular basis for the cell cycle profiles observed, cells were 
collected at 24 h after release from serum starvation and whole cell lysates blotted for 
cell cycle regulators and components of the pre-RC. At this time-point, cells would be in 
mid-S phase. As shown in Figure 4.7A, Cdk1 was not detected in Cdk1 KO and DKO 
cells, indicating efficient 4-OHT induced loss, and Cdk2 was not detected in Cdk2 KO 
and DKO cells as expected. Cdk1 protein level appeared to be slightly lower in Cdk2 
KO cells. Cdk4 protein levels were relatively constant across cell types but may be 
slightly lower in Cdk1 KO cells, as was the case for Cdk6. p27, a member of the 
Cip/Kip family of Cdk inhibitors, appeared to be lower in Cdk1 KO and higher in cells 
lacking Cdk2 (Cdk2 KO and DKO). This is in agreement with the report that Cdk2-
cyclin E phosphorylation can down-regulate p27 (Sheaff et al., 1997). Asynchronous 
wild type and Cdk2 KO cells appeared to express higher levels of Cdk1; there was no 
significant difference in the levels of other proteins. 
 
Cyclin A2 was observed to be present in significantly higher levels in serum-released 
cells compared to asynchronous cells. This likely reflects the enrichment of S phase 
cells following synchronisation, compared to an asynchronous MEF population. 
Comparing across different genotypes, cyclin A2 was present at a lower level in cells 
lacking Cdk2: it was lower in Cdk2 KO compared to wild type asynchronous cells 
(lanes 1 and 2) and in Cdk2 KO and DKO compared to wild type and Cdk1 KO 
synchronised cells (lanes 5 – 6 and 3 – 4). DKO cells had a significantly lower level of 
cyclin A2 compared to all genotypes. Cyclin B1 appeared to be present at a higher 
level in Cdk2 KO and significantly lower in DKO, similar to cyclin A2. Cyclin D1 levels 
did not vary significantly across genotypes or between asynchronous and synchronous 
cells. In contrast, cyclin E1 was present in markedly increased levels in DKO cells 
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compared to the other genotypes. However, no significant difference was observed 
across the other cell types (Figures 4.7A and B). 
 
The protein levels of components of the pre-replicative complex were examined to 
determine if an absence or deficiency of any components might be impeding S phase 
onset or progression in DKO cells. As shown in Figure 4.7A, there was no difference in 
the levels of Mcm2, Mcm4 and Cdc45 present across all cell types. Mcm2 may be 
marginally higher in DKO cells. In contrast to other pre-RC proteins, Cdc6 was present 
at an appreciably elevated level in DKO cells. There appeared to be slightly increased 
levels of Cdc6 in synchronised cells than asynchronous cells. Again, this may be due to 
higher proportion of cells undergoing S phase cells following synchronisation compared 
to a typical asynchronous MEF population. 
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Figure 4.7. Cdc6 and cyclin E1 protein levels are upregulated in DKO. 
(A) Cells were collected before serum starvation and induction (lanes 1,2) or 24 h after release into 
full serum. Whole cell lysates were immuno-blotted for the indicated proteins. Hsp90 served as the 
loading control. (B) A blot with a longer exposure of cyclin E1 is presented from a different 
experiment, carried out as described in (A). (C) MEFs were treated and harvested as in (A). 
Immuno-precipitates for the indicated Cdks or cyclins were prepared from total cell lysate and 
subjected to a radioactive kinase assay using histone H1 as substrate. The panel presented for 
cyclin E1 kinase activity is taken from a single phospho-scan of samples that were run on the 
same gel. Lanes have been omitted where there are separating lines for side-by-side comparison 
of the lanes shown. The asterisk (*) indicates a non-specific band. 
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4.4 Cyclin E1-associated kinase activity is not detected in DKO 
Kinase assays were carried out to compare the kinase activities associated with Cdk1, 
Cdk2 and cyclins from MEFs of different genotypes. Lysates prepared from 
asynchronous cells and synchronised MEFs collected 24 h after serum starvation were 
used in this experiment. Overall, IPs from asynchronous wild type and Cdk2 KO cell 
lysates contained less kinase activity than synchronised MEFs of the same genotype. 
This is likely to be due to the enrichment of S phase cells by synchronisation.  
 
Histone H1 was phosphorylated by all IPs from wild type cell lysates while no kinase 
activity was detected with all IPs from DKO cell lysates (Figure 4.7B). As anticipated, 
there was no Cdk1 and cyclin B1 kinase activity from IPs from Cdk1 KO and no Cdk2 
activity from IPs prepared with Cdk2 KO cells. Significant background was detected in 
the Cdk1 kinase assay, even in the “No antibody” control. Despite this, a difference in 
Cdk1 kinase activity level could still be observed in cells that contained or lacked Cdk1 
protein. Cdk1-associated kinase activity appears to be elevated in Cdk2 KO cells, 
although no corresponding increase was detected in the cyclin B1-associated kinase 
activity. This is consistent with the previous report that Cdk1 kinase activity 
compensates for the loss of Cdk2 (Aleem et al., 2005), so that Cdk1 kinase activity 
increases in the absence of Cdk2 activity by binding to cyclin A2 molecules, thereby 
maintaining constant total kinase activity.  
 
A p13-suc1 IP could be used to verify this since both Cdk1 and Cdk2 bind to p13-suc1, 
representing the total Cdk activity associated with Cdk1 and Cdk2. According to this 
idea, little or no difference is expected between p13-suc1 IPs from both wild type and 
Cdk2 KO.  In wild type cells, cyclin A2 binds to Cdk2 predominantly in S phase (Diril et 
al., 2012), so p13-suc1 would mainly pull down Cdk1-cyclin B1 and Cdk2-cyclin A2 
complexes. However in the absence of Cdk2, previously free Cdk1 molecules that were 
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not binding cyclin B1 can form active complexes with unoccupied cyclin A2, resulting in 
more Cdk1 protein being engaged as active kinase complexes. Cdk1-cyclin B1 activity 
would be expected to remain unchanged. 
 
Cyclin A2 kinase activity appears slightly higher in Cdk1 KO compared to wild type 
cells. This is consistent with the idea that Cdk1-cyclin A2 complexes having lower 
specific kinase activity than Cdk2-cyclin A2 complexes (Diril et al., 2012). In a normal 
cell cycle, cyclin A2 initially forms complexes with Cdk2. Rising levels of Cdk1 protein 
from late S phase act to sequester cyclin A2 molecules from Cdk2, quenching cyclin 
A2-associated kinase. However in Cdk1 KO cells, the absence of Cdk1 allows cyclin 
A2 to remained bound within high activity Cdk2-cyclin A2 complexes. This then results 
in the detection of higher levels of H1 phosphorylation compared to wild type cells (Diril 
et al., 2012). 
 
In Cdk2 KO cells, kinase activity was still detected with cyclin A2 and cyclin E1, the 
major cyclin partners of Cdk2, likely due to complex formation with Cdk1, although the 
kinase activity detected was lower than wild type controls. Cdk1 is known to bind to 
both cyclins to form active complexes, with Cdk1-cyclin E complexes being shown to 
compensate for Cdk2 functions in the mitotic cell cycle in the absence of Cdk2 protein 
(Aleem et al., 2005). No cyclin E1 kinase activity was detected in DKO cells, indicating 
that the high levels of cyclin E1 proteins present in DKO cells are not part of active 
kinase complexes. Since Cdk1, Cdk2, cyclin A and cyclin B proteins are not detected 
or detected at very low levels in DKO cells at this time-point (Figure 4.7A), no kinase 
activity was detected in these IPs with DKO lysates.  
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4.5 Cdc6 transcript levels remain high in DKO cells throughout S phase 
Since high levels of Cdc6 were present in total cellular protein in DKO MEFs, it was of 
interest to determine if increased expression was the reason for this observation. Total 
RNA was extracted from cells at 0, 18, 24 and 28 h after release from serum starvation. 
Following reverse transcription, qRT-PCR was carried out for Cdc6 expression levels 
(Figure 4.8A). 
 
Looking at Cdc6 expression levels in wild type MEFs, transcript levels increased upon 
release from serum starvation, to three times of 0 h levels at the start of at 18 h, 
decreased to two-fold at 24 h and then increased to approximately 2.5-fold at 28 h. 
This is consistent with published data that expression of mammalian Cdc6 peaks in G1 
and is down-regulated during S phase (Hateboer et al., 1998). This trend was also 
observed in Cdk1 KO cells, though with slightly lower transcript levels at 24 and 28 h 
compared to wild type cells. In Cdk2 KO cells, transcript levels across the three 
timepoints were similar to 18 h wild type levels. This may be attributed to the slight cell 
cycle delay in Cdk2 KO MEFs (Figures 4.3 and 4.5). As such expression levels may 
not yet have been down-regulated from higher G1 levels. In DKO cells, there was a 
greater increase in transcript levels that was maintained over the course of S phase at 
24 and 28 h. It appears that the loss of Cdk1 or Cdk2 alone does not affect the pattern 
of Cdc6 expression greatly but the absence of both somehow resulted in an up-
regulation of Cdc6 mRNA through the S phase time-points surveyed. The reasons for 
this increase remains to be further investigated. 
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Figure 4.8. DKO Cdc6 expression remains high through S phase.  
Following serum starvation with or without 4-OHT induction, cells were harvested at the indicated 
time-points. Total RNA was extracted from cells and qRT-PCR performed with three primer pairs 
specific for Cdc6 (PKR 240, 241, 242) following reverse transcription reaction. Values were 
normalised to housekeeping genes (β-actin, hsp90 and cyclophilin A) and the wild type 0 h sample 
to derive fold difference. Error bars represent S.D. from two experiments. The asterisk (*) indicates 
where a sample was lost and represents the value from only one experiment. 
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4.6 Increased levels of chromatin-bound Cdc6 in DKO cells 
Cdc6 is a component of the pre-replicative complex that is loaded onto DNA during 
origin licensing from late M to G1 phase of the cell cycle. Together with Cdt1, it acts as 
a loading factor to recruit the Mcm2-7 helicase onto chromatin. Since the levels of Cdc6 
were found to be much higher in whole cell lysate in DKO cells, the amount of Cdc6 
bound to chromatin was also examined. Pre-RC components that have been 
assembled onto chromatin templates become resistant to extraction by detergents and 
can thus be fractionated from soluble cytosolic/nucleosolic proteins. Histone H3 or 
lamin A/C partition only with the insoluble/chromatin fraction and are used as loading 
controls.  
 
Cells were serum-starved, treated with 4-OHT and harvested at 24 and 72 h during 
serum starvation (Figure 4.9A, “24” and “72”) or at 24 h after release into full serum 
(Figure 4.9A, “+24”). Cdc6 was not detected during serum starvation but was 
subsequently present in levels comparable to asynchronous cells at 24 h after release 
into full serum. Mcm2 and Mcm4 were present at all time-points, but at lower levels 
during serum starvation. 
 
Both Mcm2 and 4 and Cdc6 were largely not detected on chromatin during serum 
starvation in MEFs from all genotypes. Upon release into full serum, both Mcm 
subunits and Cdc6 were detected on chromatin, as were seen in samples from 
asynchronous cells. These results indicate that origins are not licensed when cells are 
arrested in G0/G1 by serum withdrawal, consistent with previous results analysing 
licensing in quiescent cells. Pre-RC assembly subsequently takes place after release 
into full serum, an indication of the cellsʼ proliferative status (Stoeber et al., 2001). 
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The levels of chromatin-bound Cdc6 at 24 h after release appeared to be slightly 
decreased in Cdk1 KO compared to wild type and were markedly higher in DKO cells. 
Chromatin-bound Cdc6 in Cdk2 KO was similar to wild type amounts. Chromatin-bound 
Mcm4, on the other hand appeared to be present at lower levels in Cdk1 KO cells 
compared to wild type and was detected in Cdk2 KO and DKO cells at similar levels, 
higher than wild type. Since Cdk1 KO cells can enter and complete a normal S phase 
following release from serum starvation (Figure 4.3 and 4.5), these results suggest that 
the decreased level of Mcm4 detected on chromatin in Cdk1 KO MEFs was sufficient to 
support DNA synthesis and S phase progression. The distinctly higher level of Cdc6 
bound to chromatin in DKO cells did not lead to the recruitment of a correspondingly 
larger quantity of Mcm4 and Mcm2 protein. This indicates that the large excess of Cdc6 
protein may play a role independent of its pre-RC assembly function under these 
conditions. For instance, reports of Cdc6 involvement in delaying entry into mitosis 
upon S phase defect have been previously described (Liu et al., 2009a; Lu et al., 
2009). 
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Figure 4.9. Chromatin-bound Cdc6 is increased in DKO cells. 
Cells were collected before serum starvation (lanes 1,2), during serum starvation (24, 72 h) and 
after release into full serum (+24 h). Whole cell lysate was prepared from a fraction of the cells 
harvested and immuno-blotted for total cellular levels of Mcm2, Mcm4 and Cdc6, with β-tubulin as 
loading control (top panel). The remaining portion of cells collected was CSK-extracted and the 
insoluble chromatin-bound fraction was also blotted for the same proteins. Lamin A/C only 
partitions to the insoluble fraction and was used as loading control (lower panel). 
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4.7 Total and chromatin-bound Cdc6 protein levels remain high in DKO 
cells throughout S phase 
In Xenopus egg extracts, Cdc6 levels on chromatin changes over the course of S 
phase, being displaced from chromatin following licensing and then re-loaded again 
later in S phase (Oehlmann et al., 2004). Overexpression has also been previously 
shown to cause changes in Cdc6 subcellular localisation in mammalian cells (Coverley 
et al., 2000; Delmolino et al., 2001; Pelizon et al., 2000; Petersen et al., 1999; Petersen 
et al., 2000; Saha et al., 1998). Thus Cdc6 partitioning within the cellular environment 
is related to its protein function. A detailed time-course was therefore carried out to 
characterise the changes in Cdc6 protein levels in MEFs over G1 and S phase, to 
determine if the high levels of Cdc6 in DKO cells are differently regulated and thereby 
hint towards a possible function.  
 
Cdc6 was not detected at 12 h after release from serum starvation in cells of all 
genotypes (Figure 4.10A). In wild type and Cdk1 KO cells, Cdc6 was synthesised prior 
to G1/S transition and could be detected from 16 h, with levels remaining unchanged 
up to 24 h in wild type and 21 h in Cdk1 KO cells. Cdc6 levels were slightly lower at 24 
h in Cdk1 KO. Cdc6 was detected at much lower levels in both Cdk2 KO and DKO cells 
at 16 h and remained low in Cdk2 KO cells. This suggests that there may be slight 
delay in the onset of Cdc6 synthesis in the absence of Cdk2 activity or this may be an 
effect of a delay in cell cycle progression. However by 24 h, significantly more Cdc6 
was detected in total protein in DKO cells. In a separate time-course looking at later 
time points, Cdc6 levels remained relatively constant in wild type and Cdk2 KO cells. In 
Cdk1 KO cells, levels decreased at 24 and 27 h during S phase and appeared to 
increase slightly at later times until 43 h. In DKO cells, a dramatic increase in protein 
levels was observed at 24 and 27 h, decreasing slightly at 30 h and again at 43 h. 
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Overall Cdc6 levels remained significantly higher compared to cells of other genotypes 
at all time-points.  
 
The drastic increase in protein levels from 18 h after release from starvation is not in 
proportion to the increase in Cdc6 transcript levels in DKO MEFs. This suggests that 
while Cdc6 expression may be up-regulated in DKO cells, differences in degradation 
may also contribute to the accumulation of Cdc6 observed here. 
 
Cdc6 has been previously shown to be an APC/C substrate (Mailand and Diffley, 2005; 
Petersen et al., 2000). It was proposed that Cdc6 is stabilised in G1 by Cdk2-cyclin E 
phosphorylation so that Cdc6 can accumulate earlier than licensing inhibitors like 
geminin and cyclin A, which are also APC/C substrates. This allows for an interval 
during which Cdc6 is available for pre-RC assembly before APC/C inactivation later in 
G1, which allows cyclin accumulation and also prevents licensing from taking place in 
S phase (Mailand and Diffley, 2005). In line with this, cyclin A only began accumulating 
from 18 h in wild type, Cdk1 KO and Cdk2 KO cells, several hours later than Cdc6 was 
detected (Figure 4.10A and C). Cyclin A was not detected in DKO cells. From Figures 
4.9 and 4.10, it is clear that licensing can take place in cells from all genotypes. In 
Cdk2 KO cells, Cdk1 is probably able to compensate for the absence of Cdk2 to 
stabilise Cdc6 by forming complexes with cyclin E, which still contained kinase activity 
(Figure 4.7B). In DKO cells, since there is no detectable S phase Cdk activity, the 
cellular environment is conducive for licensing in this respect. 
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Figure 4.10. Chromatin-bound Cdc6 levels remained high throughout S phase. 
MEFs were serum starved with or without 4-OHT for 72 h. Following release into full serum, cells 
were harvested at the indicated time-points prior to or following S phase entry. Whole cell lysate 
(Total protein), the soluble fraction from CSK extraction (Soluble protein) and the chromatin-bound 
fraction were immuno-blotted for the Mcm2, Mcm4 and Cdc6. Hsp90 and histone H3 were used 
as loading controls. Total cyclin A2 was also blotted for in the second time-course. Panels 
represent: (A) G1/S, total and soluble protein; (B) G1/S, chromatin-bound protein; (C) S/G2 and 
after, total and soluble protein; and (D) S/G2 and after, chromatin-bound protein.  
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Cdc6 and Mcm proteins were detected on chromatin from 12 – 16 h in wild type cells 
(Figure 4.10), consistent with other studies in which pre-RC assembly was detected 
from late G1 in mammalian cell lines that have been synchronised by serum starvation 
(Mailand and Diffley, 2005; Mukherjee et al., 2009). In DKO cells, the amount of Cdc6 
on chromatin correlated closely with the total amount of protein detected in whole cell 
lysate over the entire time-course. The high levels of Cdc6 total protein in DKO 
corresponded with high levels chromatin-bound Cdc6 while the difference in soluble 
Cdc6 between cell types is less significant. This suggests that the excess Cdc6 is 
mostly bound to DNA in these MEFs. Cdc6 was loaded onto chromatin from 16 h after 
release into full serum and was detected at higher levels from 21 – 24 h. Cdc6 
remained bound on chromatin at high levels throughout the time-course until 43 h after 
release from serum starvation. Increased levels of Cdc6 in DKO did not recruit a 
corresponding level of Mcm2 and Mcm4 to chromatin. Levels of chromatin-bound 
Mcm4 in Cdk1 KO cells appear lower after 24 h although total protein levels remain 
comparable to other cells. The reason for this is not clear but this reduced level of Mcm 
was still sufficient for Cdk1 KO cells to complete one round of DNA synthesis. This is 
consistent with the idea that more origins are licensed than required for complete DNA 
replication in an unperturbed S phase in normal cells (Ge et al., 2007; Santocanale et 
al., 1999; Woodward et al., 2006). 
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4.8 Cdc6 degradation is impaired in DKO cells 
To characterise the contribution of degradation pathways to the high levels of Cdc6 
protein observed in DKO cells, cycloheximide (CHX) was added to cells to inhibit 
protein biosynthesis at the onset of S phase. Cells were treated with CHX over a time-
course followed by immuno-blotting for Cdc6 to determine its half-life. From Figure 
4.11A, Cdc6 was rapidly degraded upon inhibition of protein synthesis, indicating active 
protein turnover in MEFs. In wild type and Cdk2 KO cells, Cdc6 was no longer detected 
at 1 h after treatment while in Cdk1 KO, Cdc6 was not detected after 30 min. In 
contrast, Cdc6 was still detected at 1 h in DKO cells, indicating that Cdc6 is degraded 
less rapidly, hence having a longer half-life. Examining Cdc6 protein levels over CHX-
treatment of a shorter interval yielded similar results, with DKO cells having detectable 
levels of Cdc6 for the entire duration of the timecourse (Figure 4.11B). In contrast, 
Cdc6 was only stable up to 60, 20 and 45 min in wild type, Cdk1 KO and Cdk2 KO 
cells respectively.  
 
When protein degradation was inhibited by the addition of the proteasome inhibitor 
MG132, comparing the amount protein detected at the end of the time-course to the 
protein detected in cells treated with both CHX and MG132 would reflect the amount of 
protein synthesised within this interval (4.11A, lanes 8 and 7; B, lanes 9 and 8). In the 
absence of protein degradation, comparable levels of Cdc6 appears to have been 
synthesised in all cell types by 75 min; this may be slightly higher in wild type cells 
(4.11B, lanes 9 and 8). By 3 h, slightly more Cdc6 has been synthesised in Cdk2 KO 
cells than wild type and DKO cells while less protein has been synthesised in Cdk1 KO 
cells (4.11A, lanes 8 and 7).  
 
Having established this, a comparison of samples from DMSO-treated cells, in which 
synthesis and degradation processes were unperturbed, with those from cells treated 
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with both CHX and MG132, in which both synthesis and degradation were inhibited, 
would give an indication of the equilibrium between synthesis and degradation (4.11A, 
lanes 6 and 7; B, lanes 10 and 8). After 75 min, there were higher levels of Cdc6 in 
DKO cells treated with DMSO than cells treated with CHX and MG132 (Figure 4.11A). 
After 3 h, there were higher levels of Cdc6 in both Cdk2 KO and DKO cells treated with 
DMSO than cells treated with CHX and MG132 (Figure 4.11B). These observations 
indicate that in Cdk2 KO and DKO cells, degradation had proceeded less efficiently 
than synthesis, leading to an eventual accumulation of protein by 3 h. In DKO cells, the 
large accumulation can be clearly observed by mid S phase, 23 h after release into full 
serum (Figure 4.11B, lane 11). Taken together, these results suggest that Cdk2 plays a 
role in Cdc6 degradation while Cdk1 appears not to affect this process. From these 
experiments, it can be concluded that impaired degradation and increased expression 
both contributed to the high levels of Cdc6 protein in DKO cells. It is important to take 
into consideration that the differences in protein turnover observed in this experiment 
may reflect variations in cell cycle phases rather than an effect of Cdk loss per se, 
since cells of different genotypes progress through the cell cycle differently even when 
they have been synchronised by serum starvation. 
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Figure 4.11. Cdc6 degradation is impaired in DKO cells. 
(A, B) MEFs were serum starved with or without 4-OHT for 72 h. 18 h after release into full serum, 
cells were treated with cycloheximide (CHX) for the indicated intervals. Cells were also treated with 
DMSO, MG132 or both CHX and MG132 and harvested three hours (A) or 75 min (B) after 
treatment. (B) In addition, cells were harvested at 23 h after release into full serum (Untreated 5 h). 
All samples were lysed directly with sample buffer during collection and subsequently immuno-
blotted for Cdc6. Hsp90 served as loading control. 
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 4.9 Cyclin E1 transcript levels are increased in DKO cells 
Addressing the other observation that total cyclin E1 levels are also higher in DKO 
cells, RNA extraction and qRT-PCR analysis were also carried out to determine if 
increased expression might account for the increase. Three primer sets and RNA 
samples from two experiments were used. PKR 023 and PKR 277 were each used on 
one sample set while PKR 215 was used for both sample sets. Expression profiles of 
cyclin E1 generated from PKR 023 and PKR 277 were largely similar. The slight 
difference in the profiles obtained from using PKR 023 and PKR 277 is likely due to 
biological variation between experiments as this variation was also observed between 
the profiles generated using two sample sets and one primer pair, PKR 215. 
 
From Figure 4.12, cyclin E1 transcript levels were highest at 18 h in wild type cells, at 
approximately 2 times the level at 0 h. This coincided with entry into S phase. 
Transcript levels were reduced to close to 0 h levels at 24 h and 28 h. A similar profile 
was observed in Cdk1 KO cells. In Cdk2 KO cells, a greater increase from 0 to 18 h 
was observed, with transcript levels of approximately 2.5 times of 0 h levels. Transcript 
levels then decreased slightly at 24 and 28 h. In DKO cells, the transcript level at 0 h 
appears to be slightly higher than wild type. This was greatly increased to at 18 or 24 h 
and remained high at 3 to 4 times of wild type 0 h levels through 28 h.  
 
It appears that a slight increase in cyclin E1 transcript level correlated with the absence 
of Cdk2 while a greater increase correlated to the absence of both Cdk1 and Cdk2. 
This suggests that Cdk2 activity in late G1 may be involved in regulating cyclin E1 
expression. Increased transcript levels correlated to increased protein levels detected 
in DKO cells. A more detailed analysis of cyclin E1 protein level and also an 
examination of its degradation kinetics, similar to the experiment presented in Figure 
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4.11, would provide more data about how cyclin E1 is accumulating in DKO cells and 
suggest a possible function for this observation.  
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Figure 4.12. DKO cyclin E1 expression is upregulated. 
Following serum starvation with or without 4-OHT induction, cells were harvested at the indicated 
time-points. After total RNA extraction and reverse transcription, qRT-PCR was performed using 
primer pairs specific for cyclin E1. Three primer pairs (PKR 023, 215 and 277) were used with 
samples from two experiments: PKR 023 and PKR 277 were each used with one sample set while 
PKR 215 was used with both sample sets. Values were normalised to three housekeeping genes 
(β-actin, hsp90 and cyclophilin A) and the wild type 0 h sample to derive fold difference. Error bars 
represent S.D. 
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Discussion 
In this chapter, the loss of both Cdk1 and Cdk2 were studied in mouse embryonic 
fibroblasts. Since the loss of Cdk1 results in embryonic lethality at an early blastocyst 
stage which cannot be further characterised, an inducible Cdk1 knockout model was 
used to obtain MEFs lacking both Cdk1 and Cdk2 (Diril et al., 2012). Following release 
from serum starvation to synchronise cells in G1, a proportion of DKO cells was able to 
enter S phase although the cells subsequently failed to progress through and complete 
one round of DNA replication. Consistent with this observation, DKO MEFs do not 
proliferate. At the protein level, it was observed that Cdc6 and cyclin E1 levels were 
higher in DKO cells compared to wild type or Cdk1- or Cdk2-single knockout MEFs. 
Cdc6, a protein involved in pre-RC assembly, was also detected at higher levels on 
chromatin although Mcm2 and Mcm4 levels did not increase correspondingly. Impaired 
Cdc6 degradation related to the absence of Cdk2 appears to contribute to this 
observation. Cyclin E1 was also found to be up-regulated in DKO cells. No associated 
kinase activity was detected with cyclin E1 in DKO cells.  
 
Conditional loss of Cdk1 in DKO MEFs 
The loss of Cdk1 in the cells used this study is conditional upon 4-OHT treatment. 
While Cdk1 expression, protein and associated kinase activity were not detected in 
DKO cells, the possibility of some cells having residual kinase activity cannot be 
absolutely ruled out. It may be argued that this accounts for a small percentage of cells 
that are able to enter S phase since the overall level of kinase activity required for the 
events of S phase onset and progression is low compared to that required for mitotic 
entry. However, such cells will be expected to cycle with normal kinetics unlike the 
DKO cell cycle profile observed here. Nevertheless, an attempt was made to address 
this issue by making use of RO-3306, a selective chemical inhibitor of Cdk1 in human 
cells (Vassilev et al., 2006). MEFs were synchronised by serum starvation and induced 
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with 4-OHT after which cells were treated with RO-3306 and the vehicle control, 
DMSO. If 4-OHT had resulted in abrogation of Cdk1 activity, there should be no 
difference observed in the cell cycle profile in DKO cells treated with RO-3306 or 
DMSO. However, preliminary results indicate that RO-3306 is highly toxic and not 
sufficiently potent in MEFs (results not shown). As such further optimisation would be 
required to make use of this drug in this assay for a more conclusive outcome. 
 
G1/S transition in the absence of Cdk1 and Cdk2 activity 
Following 4-OHT treatment, recombination occurred efficiently in the targeted Cdk1 
locus and consequently, Cdk1 was not detected at the mRNA or protein level (Figure 
4.2). At the G1/S transition, Cdk2-associated kinase activity has important functions in 
activating the transcriptional programme that commits cells to divide. This is mediated 
by Cdk hyper-phosphorylation of pRb (Lundberg and Weinberg, 1998). Cdk activity is 
also required for initiation of replication origins for DNA replication at the onset of S 
phase. Both Cdk2-cyclin A and Cdk2-cyclin E complexes have been implicated in the 
processes of pre-RC assembly and activation (Coverley et al., 2002; Mailand and 
Diffley, 2005). In the absence of Cdk2, Cdk1 can take over the function of Cdk2 in the 
mitotic cell cycle and is sufficient to carry out most cell cycle activities (Aleem et al., 
2005; Santamaria et al., 2007). As such, it was expected that cells would arrest in G1 
in the absence of both Cdk2 and Cdk1. However, surprisingly, a fraction of DKO cells 
was able to enter S phase (Figures 4.3 and 4.5). 
 
In light of the apparent versatility of Cdk and cyclin functions, Cdk4 and Cdk6 most 
likely compensate for some of these functions in DKO cells in order to effect G1/S 
transition. One function that is likely to be adequately fulfilled by Cdk4 and Cdk6 is the 
phosphorylation and inactivation of pRb repression of E2F transcription factors. The 
accepted paradigm is that phosphorylation of pRb by D-type cyclin-Cdk4 or -Cdk6 
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complexes first causes partial inactivation to relieve transcriptional repression of E2F, 
allowing expression of a limited suite of genes needed to progress through G1, for 
instance the E-type cyclins. Cdk2-cyclin E activity then further phosphorylate pRb, 
completing its inactivation (Harbour et al., 1999; Lundberg and Weinberg, 1998). E2F-
regulated genes required for S phase include cyclins A2, B1, E and Mcm subunits 
(Ishida et al., 2001; Polager and Ginsberg, 2003; Ren et al., 2002). However, contrary 
to this orderly pathway of activation, mice lacking Cdk2 and mice lacking both E-type 
cyclins are viable and cycling MEFs from these mice can enter S phase normally 
(Berthet et al., 2003; Geng et al., 2003; Ortega et al., 2003). pRb was phosphorylated 
in Cdk2-/- (Ortega et al., 2003) and cyclin E1-/-/E2-/- MEFs (Geng et al., 2003) and 
known E2F targets such as Cdc6 and cyclin A2 were induced normally (Geng et al., 
2003). Indeed, Cdk4 was shown to phosphorylate Cdk2-specific pRb sites in colon 
cancer cells depleted of Cdk2 (Tetsu and McCormick, 2003) and pRb was efficiently 
phosphorylated on Thr821, a residue thought to be specifically phosphorylated by 
Cdk2-cyclin E (Zarkowska and Mittnacht, 1997) in Cdk2-/- cells (Ortega et al., 2003). 
Taken together, these results argue that there is no stringent requirement pRb to be 
specifically phosphorylated by Cdk2-ctclin E in order for cells to enter S phase.  
 
While Cdk1 can phosphorylate pRb in the absence of all interphase Cdks (Santamaria 
et al., 2007), the activity of just Cdk4 and Cdk6 may be sufficient to mediate this phase 
transition, even in the absence of Cdk2 kinase activity and the compensating Cdk1 
activity in DKO cells. Cdk4 may be the more important Cdk in fulfilling this this function 
since the loss of both Cdk2 and Cdk4 leads to embryonic lethality in mice and pRb was 
found to be hypo-phosphorylated (Berthet et al., 2006), whereas mice lacking one of 
these Cdks (Berthet et al., 2003; Malumbres et al., 2004; Ortega et al., 2003; Rane et 
al., 1999; Tsutsui et al., 1999) or both Cdk2 and Cdk6 (Malumbres et al., 2004) are 
viable. This hypothesis is also consistent with the report that ablation of Cdk2 in cyclin 
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D-null cells prevents proliferation and cell cycle re-entry, whilst either perturbation 
alone has little effect (Kozar et al., 2004).  
In the present study, Cdc6 and cyclin E expression were robustly detected (Figures 4.8 
and 4.12) in the absence of Cdk1 and Cdk2 activity in DKO cells. Since Cdc6 and 
cyclin E are E2F-regulated genes (Hateboer et al., 1998; Ohtani et al., 1995; Ohtani et 
al., 1998; Yan et al., 1998), this suggests that Rb mediated transcriptional repression 
may have been sufficiently relieved for a subset of DKO cells to enter S phase. 
Malumbres et al. reported that MEFs could cycle with normal kinetics even though pRb 
was hypo-phosphorylated due to the absence of Cdk4 and Cdk6 (Malumbres et al., 
2004). Compensation by non-cognate Cdks may thus be less efficient but still sufficient 
to promote G1/S entry. Alternative but not mutually exclusive to this interpretation, the 
gradual phosphorylation of pRb over G1 may represent a temporal or some other form 
of differential control of transcriptional de-repression, affecting functional subsets of 
E2F-controlled genes differently. In addition to gene products required for S phase, 
E2F-regulated genes also control events even later in the cell cycle, in mitosis (Henley 
and Dick, 2012). For instance, the mitotic checkpoint protein Mad2 is an E2F target and 
is aberrantly expressed in cells defective in the pRb pathway, being overexpressed in 
tumour cell types with high E2F activity (Hernando et al., 2004).  
 
Mukherjee et al. had demonstrated that ongoing de novo mRNA synthesis in late G1 is 
dispensable for G1/S transition in murine and CHO cells, suggesting that transcription 
only in early G1, prior to maximal Rb hyper-phosphorylation, is sufficient for S phase 
entry (Mukherjee et al., 2009). As such, a possible explanation for normal cell cycle 
progression in the absence of full pRb phosphorylation could be that genes required for 
progression through an unperturbed S and subsequent phases of the cell cycle may be 
sufficiently expressed by early G1, whereas full Rb inactivation would allow expression 
of a full complement of proteins which become necessary under conditions of 
replicative or other stresses to the cell cycle. Further work to examine the kinase 
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activity of D-type cyclins, Cdk4 and Cdk6 using pRb as substrate will be required to 
verify these suggestions. Monitoring the level and kinetics of pRb phosphorylation in 
DKO cells will also be informative. The timing and expression of S phase-related genes 
and other cell cycle regulators under the control of E2F transcription factors should also 
be closely examined to gain a better understanding of the relationship between pRb 
inactivation by phosphorylation leading up to and after the G1/S transition.  
 
Cdc6 regulation and function in DKO cells 
In this study, pre-RC assembly appears to be unperturbed in DKO cells as Cdc6, 
Mcm2 and Mcm4 were detected on chromatin following fractionation of total cell lysates 
(Figures 4.9 and 4.10). However, DKO cells that entered S phase did not progress 
through S phase efficiently (Figures 4.3 and 4.5). There was a conspicuous increase of 
Cdc6 protein levels in total cell lysate and also on chromatin. These observations 
raised questions about the mechanisms and functional significance of this Cdc6 
accumulation. 
 
The regulation of Cdc6 abundance and sub-cellular localisation have been proposed to 
be important in the regulation of cell cycle and licensing activities in metazoans. In 
mammalian cells, chromatin-bound Cdc6 persists through S phase and G2 once 
licensing has occurred in G1. Several studies had established that non-chromatin 
bound Cdc6 is exported from the nucleus in a Cdk-dependent manner, serving as a 
mechanism to prevent inappropriate pre-RC formation during S phase (Coverley et al., 
2000; Delmolino et al., 2001; Pelizon et al., 2000; Petersen et al., 1999; Petersen et al., 
2000; Saha et al., 1998). However, in contrast to these data derived from over-
expression studies, other studies demonstrated that a subpopulation of Cdc6 remains 
in the nucleus throughout this time despite not being associated with DNA (Alexandrow 
and Hamlin, 2004; Fujita et al., 1999; Mendez and Stillman, 2000; Okuno et al., 2001). 
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These apparently conflicting findings were resolved by the observation that 
endogenous Cdc6 is regulated in a different manner from exogenous proteins 
(Alexandrow and Hamlin, 2004). Native Cdc6 protein remains nuclear throughout the 
cell cycle while over-expressed proteins are subjected to nuclear-cytosolic 
translocation.   
  
Consistent with the behaviour described for endogenous Cdc6, chromatin-bound Cdc6 
was present at all time intervals leading up to and following entry into S phase in cells 
of all genotypes (Figure 4.10). The proportion of Cdc6 in soluble- and chromatin-bound 
pools appears to remain constant through the cell cycle and total protein levels 
correlated tightly with chromatin-bound protein. In wild type, Cdk1 KO and Cdk2 KO 
cells, levels of chromatin-bound Cdc6 may be slightly lower at 24 up to 30 h time-
points. This is reminiscent of the regulation Cdc6 in Xenopus egg extracts in which 
Cdc6 is displaced from DNA following origin licensing but regains high affinity for 
origins once replication forks have initiated. Cdc6 reloading during S phase in this in 
vitro system is required to activate the Chk1 kinase in response to inhibition replication 
elongation (Oehlmann et al., 2004).  
 
Phosphorylation by Cdk2-cyclin E was shown to be necessary to stabilise Cdc6 in G1, 
preventing its association with APC/C and protecting it from proteolysis (Mailand and 
Diffley, 2005). However, Cdc6 levels were unaffected in MEFs lacking type-E cyclins 
and Cdc6 was phosphorylated on Ser54 in these cells (Geng et al., 2007; Geng et al., 
2003), indicating that other Cdk-cyclin complexes can adequately compensate for this 
function. Cdk2-cyclin A is likely to confer this function and in the case of Cdk2-null cell 
types, Cdk1 may take over. Consistent with this, Cdc6 levels are not noticeably 
different in Cdk2 KO from wild type MEFs (Figure 4.7). According to this line of 
argument, it would be anticipated that Cdc6 could not be stabilised in DKO cells. 
Contrary to expectations, Cdc6 was detected in large excess in DKO MEFs and largely 
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localised to chromatin. Examining the profile of Cdc6 expression and protein turnover 
in DKO cells (Figures 4.8 and 4.11), the large accumulation of Cdc6 protein appears to 
be a combination of the effects of increased expression and decreased degradation, 
although the mechanism for Cdc6 stabilisation remains as yet unclear. In opposition to 
published work (Mailand and Diffley, 2005), it appears that Cdk activity is required to 
degrade Cdc6 in Cdk2 KO and DKO MEFs. It could be possible that this is an indirect 
effect of Cdk on another Cdc6 regulator. 
 
In a normal cell cycle, timely proteolysis of cyclins governs the periodic oscillation of 
Cdk activity. In particular, cyclins A and B are degraded through the action of the 
APC/C ubiquitin ligase during mitosis, resulting in the low Cdk activity throughout G1 
permissive for origin licensing. The activity of the APC/C requires interaction with either 
one of its activators, Cdc20 or Cdh1, and Cdh1 is primarily responsible for APC/C 
activity after mitotic exit up through G1 (Di Fiore and Pines, 2008; van Leuken et al., 
2008). In turn, Cdh1 function is antagonised by Emi1 (Di Fiore and Pines, 2007; Hsu et 
al., 2002; Machida and Dutta, 2007). In a recent study, the continuous activity of 
APC/CCdh1 as a result of Emi1 depletion resulted in the degradation of cyclin A and B in 
cells (Di Fiore and Pines, 2007). Cyclin E, which is not an APC/C substrate, was also 
found to accumulate to higher than normal levels in these cells. These findings are 
similar to those observed in DKO cells, in which cyclins A and B were found to be 
absent from total cell lysate (Figure 4.7). This suggests that Emi1 may be deregulated 
in DKO cells, a plausible explanation given that Emi1 gene expression is under the 
control of E2F transcription factors (Hsu et al., 2002). The absence of Cdk1 and Cdk2 
may have caused aberrant E2F regulation in these MEFs through effects on pRb. 
Monitoring the expression of Emi1 and probing for the protein in cells following release 
from serum depletion would provide more data required to substantiate this idea. In the 
study by Di Fiore and Pines, Cdc6 level was not significantly affected in the absence of 
Emi1 (Di Fiore and Pines, 2007), possibly due to (increased) protection from Cdk2-
168 
cyclin E mediated phosphorylation. However, this does not explain the accumulation of 
Cdc6 in DKO cells since there is no detectable Cdk1- and 2-associated kinase activity 
here. This suggests that an active mechanism involved in ensuring proper cell cycle 
progression is responsible for preventing Cdc6 proteolysis and its accumulation in 
these MEFs. 
 
In line with this notion, a previous study had reported that chromatin and total cellular 
levels of Cdc6 were markedly upregulated in cells when S phase arrest was induced by 
HU treatment (Liu et al., 2009a). While the exact mechanisms probably differ in 
mammalian cells, a function for Cdc6 and ATR interaction under conditions of 
perturbed S phase exists in yeasts. In both budding and fission yeast, cells lacking 
Cdc6 undergo mitosis despite failing to replicate their DNA (Kelly et al., 1993; Piatti et 
al., 1995), indicating that Cdc6 plays a role in coordinating successful S phase 
completion to entry into mitosis. Also in fission yeast, Cdc6 stabilised on chromatin 
acted as a receptor for the Rad3-Rad26 complex, homologues of mammalian 
ATR/ATRIP, which is required to maintain the block on mitosis for the interval of the 
arrest (Hermand and Nurse, 2007).  
 
Liu et al. found that increased Cdc6 levels in mammalian cells coincided with activation 
kinetics of ATR. Cdc6 was phosphorylated by ATR, which then stabilised Cdc6 by 
attenuating proteasomal degradation (Liu et al., 2009a). In DKO cells, Cdc6 in was also 
more stabilised against proteolysis (Figure 4.11). Liu and colleagues further 
demonstrated that increased levels of chromatin Cdc6 did not reflect its role in pre-RC 
assembly, again consistent with observations in DKO cells (Figures 4.9 and 4.10), but 
instead served a purpose in delaying mitotic entry following S phase arrest due to HU-
induced replicative stress (Liu et al., 2009a). This S/M checkpoint response is triggered 
when perturbed replication causes an accumulation of stalled replication forks in cells 
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(Borlado and Mendez, 2008). It may be possible that the accumulation of Cdc6 in DKO 
MEFs is a checkpoint response which may be regulated by ATR. 
 
In DKO cells, while G1/S transition may be accomplished by compensation by other 
Cdks so that licensing can occur, replication initiation and progression may be 
inadequately supported. Consequently, inefficient DNA replication in DKO cells could 
gradually constitute replicative stress to these cells, leading to up-regulation of Cdc6 in 
a checkpoint response. Inefficient replication may lead to slow-moving forks that stall 
and collapse soon after initiation, gradually accumulating single-stranded DNA or other 
intermediates that signal defective S phase progression. Increased Cdc6 as a result of 
checkpoint activation may also explain increased levels of cyclin E in DKO cells. It has 
been previously reported that cyclin E binds to replication origins and mediates Mcm 
loading in a kinase-independent manner (Geng et al., 2007). In cells treated with 
mitomycin C, a DNA-damaging agent, cyclin E and Cdc6 were retained on chromatin, 
slowing down S phase progression and activating the replication checkpoint (Lu et al., 
2009). If the accumulation of Cdc6 in DKO cells were due to a checkpoint response, 
perhaps a portion of the BrdU incorporation observed in DKO cells was due to DNA 
repair synthesis rather than replicative DNA synthesis. Nevertheless, this will only 
account for a small amount of incorporation and is unlikely to be at levels similar to 
BrdU incorporation via replicative DNA synthesis.  
 
If ATR were involved in this response, caffeine treatment would be expected to prevent 
Cdc6 accumulation above control levels. This would be a possible future experiment to 
do in continuing to define the mechanism(s) and function(s) underlying Cdc6 
accumulation in MEFs lacking Cdk1 and Cdk2. To check if Cdc6 accumulation is a 
general effect of inefficient replication, wild type MEFs may be subjected to other 
modes of replicative stress such as HU or aphidicolin treatment. Also, to determine if 
Cdc6 stabilisation were an effect of a loss of S phase-Cdk activity, MEFs may be 
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treated with other Cdk inhibitors such as roscovitine and purvalanol-a. In addition, 
further work is required to substantiate the proposal that APC/C functions are perturbed 
in DKO cells and that up-regulation of Cdc6 and cyclin E signify involvement in a 
checkpoint response. 
 
The role of Cdks in pre-RC initiation 
At this preliminary stage of investigation, many questions remain with regards to cell 
cycle progression in DKO cells. Cdk activity is essential for origin initiation during G1/S 
transition. Following pre-RC assembly at origin DNA, the inactive Mcm2-7 complex 
needs to be activated by the action of S phase-promoting kinases, Cdk and Cdc7, to 
recruit Cdc45 and GINS to generate the CMG complex. This is believed to be the 
active replicative helicase (Labib, 2010). In S. cerevisiae, Cdk phosphorylation of Sld2 
and Sld3 generates phosphosites on each protein that can interact with Dbp11 (Tanaka 
et al., 2007; Zegerman and Diffley, 2007). Sld3, together with Sld7, likely mediates 
Cdc45 association with the pre-RC while Sld2 chaperones the GINS complex to 
proteins at the origin (Muramatsu et al., 2010; Tanaka et al., 2011b). Less is known 
about this mechanism in vertebrates. Treslin/ticrr has been identified as the orthologue 
of Sld3, while the best candidate for Sld2 is RecQL4 (Kumagai et al., 2010; Matsuno et 
al., 2006; Sanchez-Pulido et al., 2010; Sangrithi et al., 2005). Functional analyses 
revealed Cdk-dependent regulation of Treslin/ticrr interaction with TopBP1, the human 
homologue of Dbp11, which mirrors Sld3-Dbp11 in yeast (Boos et al., 2011; Kumagai 
et al., 2011). Cdk phosphorylation of two conserved residues were identified to be 
important since non-phosphorylatable mutants at these sites could not rescue the 
inhibition of DNA replication in human cells when endogenous Treslin/ticrr was 
knocked down by siRNA (Boos et al., 2011; Kumagai et al., 2011). While RecQL4 is 
required for DNA replication, a requirement for Cdk phosphorylation in this function has 
not been identified. RecQL4 also appears to be dispensable for GINS recruitment, 
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suggesting that it is required for helicase initiation at a different step (Matsuno et al., 
2006; Sangrithi et al., 2005). 
 
Apart from BrdU incorporation as an indication of active DNA synthesis, there is little 
data at this point to verify that replication origins have initiated normally and that 
replication machinery are loaded and properly functioning. To address this, chromatin 
association of Cdc45, components of GINS and proteins forming the RPC can be 
probed for. Attempts to detect Cdc45 and cyclin E1 on chromatin by immuno-blotting 
have been unsuccessful so far, likely due to technical issues. Conditions used for 
protein fractionation and different antibodies would have to be tested to determine 
optimum conditions for detecting these proteins. DNA fibre analyses, examination of 
nascent strand synthesis and imaging of active sites of DNA replication could also be 
used to check that replication origins have initiated; the former two methods could also 
provide information about replication fork progression.  
 
Given that pre-RC components and processes are conserved from yeast to human, it is 
unlikely that the DNA replication observed in DKO cells in the present study had 
occurred independently of Cdk activity. One explanation for the ability of these MEFs to 
enter S phase could be that the Cdk targets required for replication initiation, might be 
pre-phosphorylated prior to the loss of Cdk1 activity and remain stable through 
quiescence and up to the G1/S transition. Since Cdk appears to be responsible for the 
phosphorylation of soluble targets, there may be no requirement for its activity in pre-
RC formation or other chromatin related functions. However, the pool of pre-
phosphorylated targets would likely become limiting in the absence of continued kinase 
activity, leading to inefficient replication which cannot be sustained over the course of S 
phase. In Xenopus egg extracts, Cdk activity is required throughout S phase for new 
initiation events to occur (Luciani et al., 2004) and for progression through the 
replication timing programme (Thomson et al., 2010). Without Cdk activity, late origins 
172 
may not fire, for instance, leaving stretches of the genome unreplicated. Origin initiation 
from fewer origins also mean that replication forks have to travel greater distances, 
increasing the chance of fork stalling and resulting DNA strand breaks (Ge and Blow, 
2009). As this stage, this hypothesis remains speculative and additional experiments 
and a better understanding of Cdk function in mammalian replication initiation at the 
molecular level will help resolve these outstanding issues.  
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Chapter 5 – Summary and concluding remarks  
 
The events of a cell cycle consist of a series of different and dynamic chromosome 
transactions that are tightly coupled to other cellular processes, with duplication of a 
cellʼs genetic contents occurring in S phase. Proper coordination of cell cycle 
transitions and regulation by checkpoint pathways ensure that genomic stability is 
maintained for cell survival. Cdks function as the engine to drive progression of cell 
cycle events by the successive activation of different Cdk-cyclin complexes. In 
particular, S phase onset, which involves initiation of DNA replication, is normally 
mediated by Cdk2 in metazoans together with Cdc7 activity. 
 
In this thesis, I have presented work relating to the role of S phase-promoting kinases 
in DNA replication and S phase regulation. Using the cell free system of Xenopus egg 
extract, I first characterised the activity of PHA-767491, a small molecule inhibitor of 
Cdc7, in a biochemical context. I provide evidence that Cdc7 executes its activity 
before Cdk early in S phase and is not rate-limiting in the progression of replication 
timing programme once Cdc7 has executed its essential function. The phosphatase 
PP1 was identified as a novel modulator of Cdc7 activity, rapidly reversing Cdc7-
dependent phosphorylation of chromatin-bound Mcm4. Finally, the role of Cdc7 in an 
etoposide-induced checkpoint response was investigated, uncovering a role for PP1 in 
checkpoint function.  
 
Moving on from a cell-free system into mouse genetics, I then outlined the design 
strategy and screening process for the generation of a conditional Cdc7-knockout 
mouse. A single mouse bearing germline transmission of the conditional knockout 
targeting construct was identified. This conditional knockout mouse will be useful in 
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delineating the effects of Cdc7 depletion in specific developmental and tissue contexts. 
Cells derived from these mice can also provide the basis to investigate molecular 
mechanisms of Cdc7 function, such as in the checkpoint response. In the last part of 
the thesis, I made use of another conditional knockout mouse to examine the effect of 
Cdk1 and Cdk2 double knockout in MEFs. Contrary to expectations, DKO cells enter S 
phase in the absence of S phase Cdk activity. I find that Cdc6 and cyclin E1 proteins 
accumulate at high levels in these cells, although the exact function(s) and 
mechanism(s) for these observations remain to be discovered. 
 
In this work, I have provided greater molecular detail about the regulation and function 
of Cdc7 in replication initiation, timing programme progression and checkpoint 
signalling in Xenopus and described a novel mechanism for PP1 in functionally 
lowering Cdc7 activity during an intra-S checkpoint response. As Cdc7 is believed to 
play key roles in these processes, it is hoped that these findings can contribute to a 
better understanding and provide fresh avenues for further investigation. On the other 
hand, the study of Cdk1 and Cdk2 knockout in mouse embryonic fibroblasts are still in 
the initial stages and primarily serves to identify the questions that need to be 
addressed. 
 
5.1  The kinase and the phosphatase: partners at the replication 
checkpoint 
It is clear from this and other studies in different model systems that Cdc7 has a role to 
play the intra-S checkpoint. However questions remain about the mechanisms of the 
signalling process. In this study, while total DNA synthesis is reduced upon etoposide-
induced checkpoint response, it is not known how origin firing is affected here. In 
budding yeast, inhibition of late origin firing is a major effect of the intra-S checkpoint 
response (Santocanale and Diffley, 1998). Slowing down ongoing replication forks can 
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also reduce the total rate of DNA synthesis (Kumar and Huberman, 2009; Seiler et al., 
2007). Yet another study proposed that the replication checkpoint retards S phase 
progression in a global manner rather than affecting a subset of origins, so that all 
origins are fired in the same order as in an unperturbed condition, only over a longer 
time interval (Alvino et al., 2007). Some experiments that may begin to address this 
issue include: (1) monitoring replication over time in the presence of etoposide to track 
overall rates of DNA synthesis through S phase, (2) nascent strand analysis or DNA 
fibre experiments to monitor new origin initiation and ongoing fork progression and (3) 
assessing the labelling patterns of active replication clusters in nuclei to determine if all 
characteristic S phase stages could be observed in the presence and absence of 
etoposide.  
 
From the present study and other unpublished data (Gaganmeet Chadha, Poh et al., 
manuscript in preparation), checkpoint-mediated enhancement of PP1 activity was 
found to functionally lower Cdc7 activity. In this regard, either scenario of local or global 
effects on origins may be borne out through checkpoint-mediated action on PP1. PP1 
localisation on chromatin presents the possibility that it can act locally at different 
origins to regulate origin initiation, hence allowing differential control over early- or late-
firing origins. On the other hand, its activity may also be globally upregulated during a 
checkpoint response, perhaps through degradation or nuclear export of an inhibitory 
subunit (or the reverse for an activating subunit), hence changing the overall rate of 
origin firing but not affecting the pattern of initiation. The interplay of a kinase and a 
counteracting phosphatase, especially a holo-enzyme administered by a repertoire of 
regulatory subunits, affords abundant possibilities in coordinating origin firing during S 
phase. In the same vein, uncovering the identity of the PP1 regulatory subunit 
responsible for the checkpoint-sensitive up-regulation is another issue of interest. It is 
also not clear now if ATR/ATM signal through the Chk kinases in this response. These 
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upstream components of this checkpoint response, too, merit consideration to further 
the understanding of how Cdc7 activity is regulated. 
 
5.2  The Cdk connection: same dance, different choreography 
The molecular basis of how Cdk activity mediates the initiation of replication has been 
extensively studied in S. cerevisiae, having essential Cdk targets and their 
mechanisms of action minutely defined. However, how the Cdk cycle is coordinated 
with replication initiation remains elusive in metazoans. Much research of metazoan 
Cdk requirements at the G1/S transition has been focused on the restriction point and 
how cells activate the transcriptional programme required for cell cycle commitment. 
One hurdle in addressing the role of Cdk in initiation has been the difficulty in 
identifying its physiological substrates for origin firing. Multiple Cdks have evolved to 
play different roles in controlling the cell cycle, which presumably also evolved greater 
complexity to coordinate the tasks of replicating larger genomes and to integrate 
intercellular and other regulatory inputs at the level of tissues and the organism (Diffley, 
2011; Malumbres, 2005).  
 
Fundamental processes of replication may have remained conserved through evolution 
but specific roles may be performed by different protein components with inter-species 
variation (Labib, 2010), such that differences exist even between the budding and 
fission yeasts. For instance, Cdk phosphorylation of Sld3 is essential in promoting its 
association with Dbp11 in the budding yeast (Tanaka et al., 2007; Zegerman and 
Diffley, 2007) whereas both Hsk1 (fission yeast Cdc7) and Cdk activity are required for 
fission yeast Sld3 function in mediating CMG complex formation (Nakajima and 
Masukata, 2002). Another example is that metazoans have evolved important Cdk-
independent mechanisms to prevent re-licensing unlike a major reliance on regulation 
through Cdk phosphorylation in S. cerevisiae (Arias and Walter, 2007). Besides Cdk 
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activity regulation of the initiation of replication, several studies have also uncovered a 
different relationship in that down-regulation of pre-RC components negatively 
regulates Cdk2-cyclin E activity in cells as a means to prevent S phase entry in the 
absence of sufficient numbers of licensed origins (Liu et al., 2009b; Machida et al., 
2005; Nevis et al., 2009). More work will be required to delineate the relationship 
between Cdks and replication initiation at the molecular level. In this respect, past and 
recent advances in detailing the players using the yeast model system will continue to 
serve as a framework to guide studies in metazoan systems. 
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Chapter 6 – Materials and methods 
6.1  Methods for working with Xenopus cell-free extracts 
6.1.1  Preparation and use of Xenopus egg extract 
Metaphase-arrested Xenopus laevis egg extract was prepared as previously described 
with modifications (Chong et al., 1997; Gillespie et al., 2012). Unfertilised eggs were 
rinsed with MMR (100 mM NaCl, 2 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 0.1 mM EDTA, 
5 mM HEPES-KOH at pH 7.8; final pH adjusted to 7.8) to remove non-egg debris and 
dejellied for 5-10 minutes with 2% cysteine solution (w/v). Visibly activated eggs and 
apoptotic eggs were removed throughout the washing and dejellying procedure. Fully 
dejellied eggs, which form a tightly packed mass, were washed twice with XBE2 (100 
mM KCl, 2 mM MgCl2, 0.1 mM CaCl2, 10 mM HEPES-KOH pH 7.8, 5 mM EGTA, 
17.1g/l sucrose) and once with XBE2 supplemented with protease inhibitors. Eggs 
were transferred to 14-ml Falcon tubes containing 1 ml of the same buffer but 
supplemented with 100 μg/ml cytochalasin D (Sigma, C8273) and packed by 
centrifuging at 3000 rpm in a swinging bucket rotor (Beckman Coulter, JS-13.1) for 1 
minute. Excess buffer and lysed eggs, which would be white and float to the surface, 
were removed with a Pasteur pipette at this point.  
 
The packed eggs were spin-crushed at 10 000 rpm for 10 minutes at 4ºC with the 
same rotor. The cytoplasmic fraction was extracted collected via side-puncture using a 
20-gauge needle and 1 ml syringe and supplemented with protease inhibitors (1 μg/ml 
each of leupeptin, pepstatin and aprotinin), cytochalasin D to a final concentration of 10 
μg/ml and 1 x ER mix [1 M phosphocreatine, 600 μg/ml creatine phosphokinase, 10 
mM Tris-Cl pH 7.6) and 15% (v/v) LFB1/50 (50 mM KCl, 40 mM HEPES-KOH pH 8.0, 
20 mM K2HPO4/KH2PO4 pH 8.0, 2 mM MgCl2, 1 mM EGTA, 10% sucrose (w/v), 2 mM 
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DTT, and 1 μg/ml each of leupeptin, pepstatin and aprotinin]. This was clarified by 
spinning at 30 000 rpm in a swing bucket rotor for 17 minutes at 4ºC (Beckman Coulter, 
SW 55 Ti). The clear golden cytoplasmic extract was collected and 2% glycerol (v/v) 
added before being snap-frozen in 20-μl beads in liquid nitrogen. 
 
All extracts were supplemented with 250 μg/ml cycloheximide, 25 mM phosphocreatine 
and 15 μg/ml creatine phosphokinase and incubated with 0.3 mM CaCl2 for 10 minutes 
to allow release from metaphase arrest before use. For DNA synthesis reactions, 
sperm nuclei (Gillespie et al., 2012) was incubated to a final concentration of 6–10 ng 
DNA/μl or CHO nuclei to a final concentration of 10 000 nuclei/μl extract. When CHO 
nuclei were used, extracts were further supplemented with 150 μg/ml geminin and 
incubated for 10 min after CaCl2 addition to prevent licensing from occurring.  
 
6.1.2  Analysis of DNA replication in Xenopus egg extracts 
DNA synthesis was assayed by measuring the incorporation of [α-32P]-dATP 
(PerkinElmer, NEG512H250UC) into acid-insoluble material followed by scintillation 
counting as previously described (Blow and Laskey, 1986; Chong et al., 1997). For 
each reaction, sperm nuclei were incubated to a final concentration of 6 ng DNA/μl in 5 
μl interphase extract supplemented with 50 μCi/ml [α-32P]-dATP. At pre-determined 
times, the reaction was terminated by the addition of 160 μl Stop-C (20mM Tris-Cl pH 
7.5, 5 mM EDTA, 0.5% SDS) containing 0.2 mg/ml Proteinase K and incubated at 37ºC 
for 30 minutes. This digested mixture was then precipitated with 4 ml of cold 10% 
trichloroacetic acid (w/v) (TCA)-2% Na4PO2O7.10H2O (w/v) at 4ºC for 30 minutes. 40 μl 
of the TCA-reaction mixture was spotted onto a filter disk for measurement of total 32P 
and the remainder of the sample was filtered under vacuum through a 25-mm-diameter 
glass microfibre filter (GF/C, Whatman). The GF/C filter was washed down once with 
5% trichloroacetic acid (w/v) (TCA)-0.5% Na4PO2O7.10H2O (w/v) and once with 70% 
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ethanol. The filter was dried under an infra-red lamp. 32P on the filters was measured 
by liquid scintillation. The amount of DNA synthesised can then be calculated by 
multiplying the percentage of total counts in acid precipitable material by a factor of 
0.654, assuming an endogenous dATP concentration of 50 μM in the extract. All 
incubations were carried out at 23ºC. 
 
6.1.3  Chromatin and nuclear templates 
For immunoblotting reactions, 12.5 μl of extract was diluted with 400 μl ice-cold NIB 
{50 mM KCl, 50 mM mM HEPES-KOH pH 7.6, 5 mM MgCl2, 0.5 mM spermidine, 0.15 
mM spermine, 2 mM DTT; supplemented with protease inhibitors, phosphatase 
inhibitors [25 mM β-glycerophosphate pH 7.6, 0.1 mM sodium orthovanadate and 0.1 
μM microcystine-LR (Enzo Life Sciences, ALX-350-012)] and 0.1% Triton X-100} and 
under-laid with the 100 μl of the same buffer containing 20% sucrose (w/v). This was 
centrifuged in a swing bucket rotor at 2100g for 5 minutes at 4ºC (Eppendorf, A-8-11). 
NIB was removed and the top of the cushion was washed once with NIB before the rest 
of the cushion was removed, leaving 15 μl above the pellet. Chromatin was then 
compacted by spinning at 13000g for 2 minutes in fixed angle rotor (Eppendorf, FA-45-
30-11). The remaining buffer was removed and the chromatin pellet was resuspended 
in SDS gel loading buffer for SDS-PAGE.  
 
In nuclear transfer experiments, where chromatin was isolated and incubated in a 
second extract for a further round of DNA synthesis, 45-μl aliquots of the first extract 
containing 20 ng/μl sperm nuclei was diluted in 800 μl ice-cold NIB supplemented with 
protease and phosphatase inhibitors but not containing Triton X-100. This was under-
laid with 100 μl of the same buffer plus 15% sucrose (w/v) and further under-laid with 5 
μl 30% glycerol (w/v). After spinning at 2100g for 5 minutes at 4ºC in a swing bucket 
rotor, the top of the sucrose cushion was washed once and the cushion removed. 
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Chromatin was gently resuspended in the glycerol cushion and then added to the 
second extract to a final concentration of 10 ng/μl. 
 
6.1.4  Immunoblotting and antibodies 
Immunoblotting was carried out as per standard techniques. Chromatin pellets were re-
suspended in SDS loading buffer and separated on 4-12% Bis-Tris gradient gels 
(Invitrogen). Proteins were transferred onto PVDF membranes (GE Healthcare, 
RPN303F) using a wet transfer system, blocked in PBS with 0.2% Tween-20 and 5% 
non-fat milk (Marvel). Membranes were incubated with appropriate primary and 
secondary antibodies before being developed using enhanced chemiluminescence 
detection (SuperSignal® West Pico Chemiluminescent; Thermo Scientific, 34087). To 
visualise histones as loading controls, the dye front was not allowed to run out of gels 
and the lower portion of gels were cut before transfer and stained with Coomassie 
Brilliant Blue. 
 
The sheep anti-Mcm4 and sheep anti-Cdc45 affinity-purified antibodies and sheep anti-
Cdc6 serum used in this study have been previously described (Gambus et al., 2011; 
Luciani et al., 2004; Oehlmann et al., 2004; Prokhorova and Blow, 2000). The PCNA 
(PC10) and PP1α and PP1γ antibodies are from Santa Cruz. The Cdc7 antibody was 
raised in sheep against a bacterially-expressed immunogen consisting of the C-
terminal 99 amino acids of Xenopus Cdc7 by Peter Gillespie (University of Dundee). 
The antiserum was affinity purified prior to use (Poh et al., manuscript in preparation). 
 
6.1.5  Recombinant proteins and other reagents 
Geminin was synthesised and purified as previously described (Ferenbach et al., 
2005). Briefly, Escherichia coli host strain BL21 carrying the His-tagged gemininDEL 
(McGarry and Kirschner, 1998) expression construct was cultured in Luria-Bertani 
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medium containing the appropriate antibiotics at 37ºC. 1 mM isopropyl-β-
thiogalactopyranoside was added when OD600 reached 0.4-0.5 and the culture was 
grown for a further 2 hours. Cells collected by centrifugation at 5500 rpm for 10 minutes 
at 4ºC and lysed using Bugbuster (Novagen, 70921) according to the manufacturerʼs 
instructions. The bacterial lysate was then incubated with Ni-NTA beads (Qiagen, 
36113), pre-washed and equilibrated with PBS containing 300 mM KCl and 20 mM 
imidazole, for 1 hour at room temperature. The mixture was transferred to a column 
and beads were washed 3 times with the same buffer. Protein elution was carried out 
with the same buffer but containing 250 mM or 500 mM imidazole. Protein fractions 
collected were quantified using the Quant-iT Protein Assay Kit (Molecular probes, 
Q33212) according to the manufacturerʼs instructions. Recombinant geminin was 
stored in 100 μl aliquots at -80ºC. To prepare a working stock of His-gemininDEL, the 
protein was diluted to 150 μg/ml with LFB1/50 supplemented with 2.5 mM Mg-ATP. 
 
Full length p27kip1 was synthesised by Gaganmeet Singh Chadha (University of 
Dundee) from a pGEX-p27-KIP1 plasmid (a gift of J. Walter, Harvard Medical School) 
and purified from RosettaTM(DE3)pLysS cells (Novagen) using Glutathione-
Sepharose. The PP1 I-2 protein inhibitor was generously provided by the DSTT, 
University of Dundee. I-2 was bacterially expressed, purified and initially solubilised in 
50 mM Tris-HCl pH 7.5, 0.1 mM EGTA, 150 mM NaCl, 0.1% β-mercaptoethanol, 270 
mM sucrose, 0.03% Brij-35, 1 mM Benzamidine and 0.2 mM PMSF. I-2 action is time-
dependent and it was typically pre-incubated with extracts for 15 min prior to 
sperm/nuclei addition (see individual figure legends for specific conditions). Compound 
6d (Zhao et al., 2009) and PHA-767491 (Montagnoli et al., 2008) were synthesised at 
the University of Dundee. Roscovitine was bought from Calbiochem (557360), caffeine 
from ICN Biochem (150114), NU7441 from Axon Medchem (1463) and KU55933 from 
Tocris (3544).  
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6.1.6  Protein Kinase Assay 
The MRC Protein Phosphorylation Unit, University of Dundee tested PHA-767491 
against a panel of 95 kinases. The assay was carried out using a radioactive (33P-ATP) 
filter-binding assay. 0.5 μl of PHA-767491 dissolved in DMSO was assayed in a total 
reaction volume of 25.5 μl at a final concentration of 1 μM. The 95 kinases used were 
divided into two groups and tested at 5 or 20 μM ATP so that the ATP concentration 
used was at or below the calculated KM for ATP for each kinase. The full panel of 
protein kinases tested in this assay can be accessed at http://www.kinase-
screen.mrc.ac.uk/kinase-protein-kinase-panel. 
 
6.1.7  Preparation of CHO nuclei  
CHOC-400 cells were cultured in Dulbeccoʼs modified Eagle medium (DMEM; Gibco, 
31885-023) supplemented with nonessential amino acids, 10% fetal calf serum (Gibco, 
10270-106), and 10 U/ml streptomycin/penicillin (Gibco, 15140) at 37°C in 5% CO2. G1 
cells were prepared as previously described (Gilbert et al., 1995; Thomson et al., 
2010). Briefly, cells were treated with 50 ng/ml nocodazole (Sigma-Aldrich, M1404) for 
4 h to block cells in metaphase before being released into G1 for 4 h in fresh medium 
to obtain post-origin decision (ODP) point cells.  
 
CHO nuclei used for DNA synthesis were prepared as previously described (Thomson 
et al., 2010). Post-ODP cells were harvested by trypsin treatment and resuspended in 
1 ml ice-cold transport buffer [20 mM HEPES, 110 mM K acetate, 5 mM Na acetate, 2 
mM Mg acetate, and 1 mM EGTA pH 7.6]. Cells were permeabilised with 50 μg/ml 
digitonin (Sigma, D141) for 5 minutes on ice and the reaction was stopped by adding 
3% BSA (w/v) in transport buffer. Nuclei were counted and the required number 
recovered by centrifugation at 1500 rpm for 5 minutes at 4ºC. 
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6.1.8  Replication pattern labeling and analysis  
As previously described (Thomson et al., 2010), somatic nuclei replication patterns 
were labelled by supplementing extracts with 25 μM Cy3-dUTP (GE Healthcare, 
PA53022) for 2.5 minutes. The reaction was stopped by resuspending extracts (20 μl) 
in 400 μl ice-cold Buffer A [60 mM KCl, 15 mM Tris-HCl, pH 7.4, 15 mM NaCl, 1 mM β-
mercaptoethanol, 0.5 mM spermidine, and 0.15 mM spermine] and under-laid with 1 ml 
Buffer A containing 10% sucrose (w/v). Nuclei were recovered by spinning at 1500 rpm 
for 5 minutes at 4ºC in a swing bucket rotor. Nuclei were resuspended in 200 μl 
paraformaldehyde (4%) and incubated for 10 minutes at 23ºC. After fixation, samples 
were carefully loaded into wells in a 24-well plate containing 12-mm poly-L-Lysine 
coverslips covered with 2 ml TBS (10 mM Tris-HCl, pH 7.5, and 0.15 M NaCl) plus 10% 
sucrose (w/v). Nuclei were spun down onto the coverslips on a swing plate rotor at 
1500 rpm for 5 minutes at 4ºC. Coverslips were retrieved and washed twice with TBS 
containing 0.1% TX-100 (v/v) and twice with TBS. Nuclei were stained with Hoechst 
33258 for 5 minutes at 23ºC. After 2 final washes with TBS, coverslips were mounted 
with Vectashield mounting medium and sealed for visualisation. 
 
Images were acquired using a cooled camera (CoolSNAP HQ; Photometrics) on a 
restoration microscope (DeltaVision Spectris; Applied Precision) built around a stand 
(Eclipse TE200; Nikon) with a 100× 1.4 NA Plan Apo lens (Nikon). Images were taken 
every 0.25 μm and 22 sections optical sections were recorded for every nucleus. 3-
dimensional datasets were deconvolved using the constrained iterative algorithm 
software (SoftWoRx; Applied Precision) and images were imported into the Open 
Microscopy Environment (OME) (Goldberg et al., 2005; Swedlow, 2003) for analysis. 
Timing patterns for this hybrid system of CHO nuclei in Xenopus extracts were 
analysed following the classification scheme detailed in a previous publication 
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(Thomson et al., 2010). Data was generated from 20 nuclei in each condition and time-
point for each experiment. 3 independent experiments were carried out. 
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6.2  Methods for generating a Cdc7 conditional knockout mouse 
6.2.1  Primers used for the construction of the targeting vector 
All PCRs were performed for 35 cycles under standard PCR conditions.  
 
Vector 
component Oligo no. 
RE site 
added Primer sequence 
5' retrieval 
miniarm F PKO1187 BamHI 5'- GCT GGA TCC GAC TTC TGG TGC ACA TT -3' 
5' retrieval 
miniarm R PKO1188 XhoI 5'- CGT CTC GAG CTG CTA AGA GCA CTG AC -3' 
3' retrieval 
miniarm F PKO1185 HindIII 5'- CGT AAG CTT GTC AGA GAT GGT CAA TG -3' 
3' retrieval 
miniarm R PKO1186 SpeI 5'- GCT ACT AGT CTC ATG TTC CAG ATA CG -3' 
Engrailed 5' 
miniarm F  PKO1193 SalI 5'- CGT GTC GAC TCA CCC AGC TTT AGT CC -3' 
Engrailed 5' 
miniarm R  PKO1194 EcoRV 5'- CGT GAT ATC GCC AGG GCT ATA CAG AG -3' 
Engrailed 3' 
miniarm F  PKO1201 
SacII, 
SpeI 
5'- CGT CCG CGG ACT AGT GCT CAC TTT GTA GAC 
CA -3' 
Engrailed 3' 
miniarm R  PKO1217 
SacII, 
ScaI 
5'- CGT CCG CGG AGT ACT GAA CTA ATG AGA TAC 
AGT CAG GG -3' 
Lonely loxP 
5' miniarm F PKO1197 ApaI 5'- CTA GGG CCC CTG ATA GTC TTG TCT CC -3' 
Lonely loxP 
5' miniarm R PKO1198 EcoRI 5'- CGT GAA TTC GTT AAG AGC ATC AAG GC -3' 
Lonely loxP 
3' miniarm F PKO1202 
BamHI, 
MfeI 
5'- CGT GGA TCC CAA TTG TAG TGC ATT TCC ATA 
GC -3' 
Lonely loxP 
3' miniarm R PKO1238 NotI 
5'- CGT GCG GCC GCA TGG TGG TAT CTT CTG TAC 
AC -3' 
Table 6.1. Primers for constructing the Cdc7 targeting vector  
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6.2.2  Genomic DNA isolation 
Genomic DNA was extracted from embryonic stem cell lysates or Proteinase K 
digested tail clips. Lysates were briefly centrifuged and 500 μl of phenol: chloroform: 
isoamyl-alcohol (Invitrogen, 15593-049) was added over the samples. This was gently 
vortexed for 15 min and then centrifuged at maximum speed in a microfuge for 5 min at 
room temperature. The upper aqueous phase was carefully removed into a fresh tube. 
500 μl chloroform was added over the aqueous solution. Samples were then vortexed 
and centrifuged as described above. The upper aqueous phase was collected into a 
fresh tube. 800 μl isopropyl-alcohol was added to these samples. Tubes were gently 
inverted repeatedly until white DNA precipitates become visible. Samples were 
centrifuged at maximum speed for 2 min and the supernatant carefully aspirated, 
leaving 10 μl over the DNA pellet. The pellet was washed once with 100% ethanol 
(DNA grade) and once with 70% ethanol. The pellet was then air-dried for 30 min at 
45°C. 50 to 100 μl nuclease-free water was added and the genomic DNA was 
resolubilised by shaking at 37°C at 1000 rpm in a thermoshaker. Total DNA was 
quantified with a spectrophotometer (Thermo Scientific, NanoDrop 8000). 
 
6.2.3  Non-radioactive Southern Hybridisation 
 
Probe preparation 
Analysis of genomic DNA by southern blotting was carried out using non-radioactive 
digoxigenin-dUTP (DIG) labelled probes. DIG-labelled DNA probes were generated by 
random primed labeling using the DIG DNA Labelling Mix (Roche, 11277065910) with 
the following PCR conditions and primer pairs: 
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Component Volume for 1 reaction (μl) 
Nuclease-free water 14.5 
10X Green Buffer for DreamTaq 
(Fermentas, B71) 2 
10X DIG DNA Labelling Mix 2 
DreamTaq DNA polymerase 
(Fermentas, EP0702) 1 
Forward Primer 0.2 
Reverse Primer 0.2 
BAC DNA template 1 
Total volume 20 
 
 
Probe Primers 
5ʼ  PKO1502: 5ʼ- ATG TGA CTC GCT GTG TTA G -3ʼ 
PKO1503: 5ʼ- CCT GTG ACA CTA AAC AGT GG -3ʼ 
3ʼ  PKO1191: 5ʼ- GTG TGG GTG CTG AGT TTT GC -3ʼ 
PKO1192: 5ʼ- GCT TGA AGC AGC AAT ACC TTC TG -3ʼ 
Table 6.2. Primers for generation of DIG-labelled probes. 
 
PCRs were run for 35 cycles with 61°C as the melting temperature. 
A dot-blot was used to verify the successful generation of DIG-labelled probes. 
 
Southern blotting 
2 μg genomic DNA was digested with restriction endonucleases for 6 hours at 37°C. 
Restriction digests were set up as follows: 
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For analysis with the 5ʼ probe: 
 
 
 
For analysis with the 3ʼ probe: 
Component Volume for 1 reaction (μl) 
Nuclease-free water 12 
10X NEBuffer 4 2 
Genomic DNA 2 μg 
MfeI (NEB, R0589) 1 
Total volume 20 
 
Digested DNA was resolved on 0.8% agarose gel overnight. The gel was briefly 
stained with ethidium bromide to visualise DNA and destained by washing with water. 
The gel was then treated with 0.25 M HCl for 15 min to depurinate DNA, rinsed with 
water for 15 min and treated with transfer buffer (0.5 M NaOH, 1.5 M NaCl) for 30 min. 
Gravity-aided transfer of DNA onto positively charged nylon membrane (GE 
Healthcare, RPN203B) was carried out for 6 h, following which the membrane was 
washed with 2X SSC (150 mM NaCl, 15 mM sodium citrate) for 5 min and allowed to 
air dry. DNA was cross-linked to the membrane with UV. The membrane was pre-
incubated with hybridisation buffer (Ambion, AM8670) for 1 hour at 42°C. It was then 
incubated with fresh hybridisation buffer containing 5 ng/ml of labelled probe, which 
had first been denatured at 95°C for 5 min and chilled on ice, with gentle rocking at 
42°C overnight. Following two washes with 2X SSC containing 0.1% SDS, 5 min each 
at room temperature, and two washes with 0.5X SSC containing 0.1% SDS, 15 min 
Component Volume for 1 reaction (μl) 
Nuclease-free water 11.8 
10X NEBuffer 4 2 
100X BSA (10 mg/ml) 0.2 
Genomic DNA 2 μg 
SpeI (NEB, R0133) 1 
Total volume 20 
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each at 68°C, the membrane was further washed once with Buffer 1 (100 mM maleic 
acid, 150 mM NaCl, pH 7.5) for 5 min at room temperature and blocked with Buffer 2 
[1% Blocking Reagent (Roche, 11096176001) in Buffer 1] for 45 min. Alkaline 
phosphatase conjugated antibody (Anti-DIG-AP, Fab Fragments, Roche, 
11093274910) was diluted 1: 10000 in buffer 2 and incubated with the membrane for 
30 min. The membrane was washed twice with Buffer 1 containing 0.3% Tween-20 for 
15 min and once with Buffer 3 (100 mM Tris-HCl, pH 9.5, 100 mM NaCl, 50 mM MgCl2) 
before hybridised probes were detected by chemiluminescence using CPD-Star Ready-
to-use substrate for alkaline phosphatase (Roche, 12041677001). 
 
6.2.4  Other PCR reactions 
Primers were designed to amplify specific regions as required during the screening 
process for positive gene targeting. The primers used are listed in the Table 6.3. PCRs 
were run for 35 cycles with melting temperatures of 61ºC, 62ºC and 59ºC for the Neo 
cassette, Lonely loxP and Cdc7FLOX/NULL amplifications respectively. 
 
PCR Primers 
Neo cassette PKO0838: 5ʼ- GTA TCC ATC ATG GCT GAT GC -3ʼ 
PKO0839: 5'- CAG AAG AAC TCG TCA AGA AGG C -3ʼ 
Lonely loxP PKO2284: 5ʼ- GCT ATA CGA AGT TAT TAG GTC CC -3ʼ 
PKO2286: 5ʼ- GGT GGT ATC TTC TGT ACA CAG -3ʼ 
Cdc7FLOX/NULL PKO2282: 5ʼ- CTC AGT GTG CCA TTT ACA GA -3ʼ 
PKO2285: 5ʼ- GTG AGG ATG CCA ATA AAG CT -3ʼ 
Table 6.3. Other primers used in the process of generating the Cdc7 cko mouse. 
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6.3  Methods for mouse work and mammalian cell culture 
6.3.1  Mouse strains and genotyping 
Conditional Cdk1 knockout mice with ER-CreEsr1 or Rosa26-CreERT2 (Cdk1flox/flox) 
(Diril et al., 2012) were bred with with Cdk2+/- mice (Berthet et al., 2003) to generate the 
Cdk1flox/flox Cdk2+/- mouse strain. Cdk1flox/flox Cdk2+/- mice were then crossed to generate 
Cdk1flox/flox Cdk2-/- 4-hydroxytamoxifen (4-OHT) conditional double mutant animals. 
Mice were routinely genotyped with genomic tail DNA isolated using the HotSHOT 
method (Truett et al., 2000). Briefly, animal tissue was lysed with alkaline lysis buffer 
(25 mM NaOH, 0.2 mM disodium EDTA, pH 12) at 95°C for 25 min. The alkaline pH 
was neutralised by addition of an equal volume of neutralisation buffer (40 mM Tris-
HCl). 1 μl of resultant genomic DNA was used in each 20-μl PCR reaction with primer 
sets as listed in Table 6.4. All PCRs were performed for 35 cycles with annealing 
temperatures of 68°C for Cdk1FLOX/NULL and 62°C for Cdk2NEO and Cre respectively.  
 
Strain Genotyping primers 
Cdk1FLOX/NULL PKO0844: 5ʼ- TTT GTC AAG AAA TGC AGC AGG ACA C -3ʼ 
PKO1006b: 5ʼ- GCG GTG GTT TAA ACC CAT AAT CCC GGC AC -3ʼ 
PKO1158: 5ʼ- GCT CAC ATG TTC CTG AAT GGT GGA -3ʼ 
Cdk2NEO PKO1640: 5ʼ- GTC TTC TTG TTC CCC AGG TG -3ʼ 
PKO1641: 5ʼ- CGC CTT CTA TCG CCT TCT TG -3ʼ 
PKO1642: 5ʼ- ATG GGT GGG CAG CAT AGA AC -3ʼ 
Cre PKO1628: 5ʼ- AGC ACT GGA AAT GTT ACC AAG GAA C -3ʼ 
PKO1629: 5ʼ- GGC TGG CTA AAC TCT GGC CCT ACA -3ʼ 
PKO2122: 5ʼ- CCA CCA GCC AGC TAT CAA CTC G -3ʼ  
PKO2123: 5ʼ- TAC ATT GGT CCA GCC ACC AGC -3ʼ 
Table 6.4. Primers used for genotyping. 
 
All mice used in this study were of mixed C57BL/6 x 129S1/SvlmJ background. Mice 
were group-housed under standard conditions with food and water available ad libitum 
and were maintained on a 12-hour light/dark cycle. Mice were fed a standard chow diet 
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containing 6% crude fat and were treated humanely in compliance with the Institutional 
Animal Care and Use Committee (IACUC) guidelines. 
 
6.3.2  Isolation and culture of mouse embryonic fibroblasts (MEFs) 
Primary MEFs were prepared from embryos as previously described (Berthet et al., 
2003). A female pregnant mouse was sacrificed at 13.5 days post coitum. The uterus 
was removed and washed in PBS after which the yolk sacs were separated and 
embryos isolated carefully. The head and organs were removed and a small amount of 
tissue was collected from the tail for genotyping. The remaining embryonic tissue was 
finely chopped with a razor blade and trypsinised for 20 min at 37°C. Finally, tissue and 
cell clumps were dissociated by pipetting. Isolated cells were plated in a 10-cm tissue 
culture dish (passage 0) and grown in DMEM (Prime; Invitrogen, 12701-017) 
supplemented with 10% FCS (Hyclone, SH30070.03) and 1% penicillin/streptomycin 
(PAA, P11-010). Primary MEFs were cultured in a humidified incubator at 37°C with 
5% CO2 and 3% O2. 
 
6.3.3  Synchronisation and induction of MEFs 
Synchronisation of MEFs at G1 phase of the cell cycle was carried out by serum 
starvation. MEFs were plated at high densities in 15-cm dishes and allowed to become 
confluent. Complete medium was replaced with starvation medium (DMEM containing 
0.3% serum and 0.2% penicillin/streptomycin). After 72 h, cells were trypsinised and re-
plated in complete medium to induce synchronous entry into cell cycle. 
 
To induce Cre-mediated recombination of the Cdk1-floxed locus to achieve Cdk1 
knockout, 50 ng/ml 4-OHT (Sigma, H7904) was added during the entire starvation 
period. Cells were genotyped at the end of the induction period using the Cdk1FLOX/NULL 
PCR protocol. 
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6.3.4  Proliferation assay 
Proliferation of MEFs was analysed using the alamarBlue assay (AbD Serotec, 
BUF012B). Cells were seeded in a 96-well plate at 1.5 x 103 cells/well, in triplicate per 
genotype per day. Complete medium with 10% alamarBlue was added to each well 
and fluorescent reading was carried out at 590 nm after 4 h.  
 
6.3.5  Bromo-deoxyuridine (BrdU) labelling and analysis 
To monitor S-phase progression, cells were labelled with BrdU and analysed by flow 
cytometry. 100 μM BrdU (BD Pharmingen, 550891) was added to the MEF culture 30 
min before collection at different time-points. At each time-point, cells were trypsinised 
and collected by centrifugation. The cell pellet was washed once in PBS and thoroughly 
dissociated into single cells before being fixed with ice-cold 70% ethanol by gentle 
vortexing. Fixed cells were incubated in blocking solution (PBS-1% BSA) for 5 min at 
room temperature. DNA was denatured by treating cells with 2N HCl/0.5% Triton X-100 
for 20 min at room temperature and neutralised with 0.1 M sodium tetraborate, pH 8.5. 
Cells were then washed with PBS-1% BSA-0.5% Triton X-100 and incubated with APC-
conjugated anti-BrdU antibody (BD Pharmingen, 623551) for at least 30 min. Cells 
were washed twice with PBS-1% BSA and stained for 15 min at room temperature in 
PBS containing 2.5 μg/ml propidium iodide (PI) (Merck, 537059) and 20 μg/ml 
RNase A (Sigma-Aldrich, R6513). Cells were filtered through a 40-μm cell strainer (BD 
Falcon, 352340) to dissociate any cell aggregates before analysis on the FACSCalibur 
flow cytometer (BD Biosciences). Cell cycle profile analysis was performed using the 
FlowJo 8 software. 
 
6.3.6  Protein extraction, chromatin fractionation and immuno-blotting 
To prepare total cell protein lysate from MEFs, cells were first collected by 
trypsinisation and washed with PBS. The cell pellet was resuspended in EB buffer (80 
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mM beta-glycero-phosphate, 15 mM MgCl2, 20 mM EGTA, pH 7.3) containing 0.5% 
NP-40, 150 mM NaCl and protease inhibitors [(10 μg/ml each of leupeptin, 
chymostatin, and pepstatin (Chemicon, EI8, EI6 and EI10)] and sonicated with using a 
sonicator bath (Diagenode Bioruptor; 15 s on/1 min off, total 10 min). The cell lysate 
was centrifuged at 14000g for 10 min at 4°C.  Protein concentration was measured 
using the BCA protein assay (Thermo Scientific, 23225). Protein Lysates were snap-
frozen in liquid nitrogen and stored at -80°C until required. 
 
Chromatin fractionation was carried out as previously described (Klotz-Noack et al., 
2012) with modifications. Briefly, cells were trypsinised and washed with PBS. The cell 
pellet was resuspended in CSK buffer (10 mM Hepes-KOH pH 7.4, 300 mM sucrose, 
100 mM NaCl, 3 mM MgCl2, 0.25% Triton-X100), freshly supplemented with 1 mM 
PMSF, 0.1 mM Na3VO4 and 10 μg/ml each of leupeptin, chymostatin and pepstatin. 
Samples were incubated on ice for 5 min and centrifuged at 5000g for 5 min at 4°C. 
The supernatant containing soluble cytoplasmic and nucleoplasmic proteins were 
snap-frozen in liquid nitrogen and stored at -80°C. The pellet containing chromatin-
bound proteins was resuspended and washed twice with CSK buffer and frozen in 
liquid nitrogen. To extract chromatin-bound proteins, the pellet was resuspended in 
RIPA buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% NP-40, 1 mM EDTA, 0.5% Na-
deoxychelate) supplemented with 1 mM PMSF, 0.1 mM Na3VO4, 0.1 mM NaF, 10 
μg/ml leupeptin, chymostatin, pepstatin) and processed as for total protein lysate. 
 
Immuno-blotting was carried out as follows: 5 to 10 ug of protein sample in SDS-
sample buffer was separated on 8% or 10% polyacrylamide gels, transferred onto 
PVDF membranes (Millipore, IPVH0010) using a semi-dry transfer system and blocked 
in Tris-buffered saline with 0.2% Tween 20 and 5% non-fat milk (Biorad, 1706404). 
Membranes were probed with appropriate primary antibodies, followed by anti-mouse, 
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anti-rabbit or anti-goat secondary antibodies conjugated to horseradish peroxidase 
(Pierce, 0031432) and developed using enhanced chemiluminescence (Millipore, 
WBKLS0500).  
 
Affinity purified antibodies against Cdk2 have been previously described (Berthet et al., 
2003). Other antibodies are bought commercially: mouse anti-Cdc6 (Santa Cruz, sc-
9964), rabbit anti-Mcm2 (Cell Signalling, 3619), goat anti-Mcm4 (Abcam, 3728), rabbit 
anti-Cdc45 (Cell Signalling, 3673), rabbit anti-Cdc2 (Cdk1) (Santa Cruz, sc-954), 
mouse anti-Cdk4 (Cell Signaling, 2906), mouse anti-Cdk6 (Cell Signaling, 3136), rabbit 
anti-cyclin A2 (Santa Cruz, sc-596), mouse anti-cyclin B1 (Cell Signaling, 4135), mouse 
anti-cyclin D1 (Cell Signaling, 2926), rabbit anti-cyclin E1 (eBioscience, 14-6714), 
mouse anti-p21 (Santa Cruz, sc-6246), mouse anti-p27 (BD Transduction, 610242), 
mouse anti-Hsp90 (BD Transduction, 610419), rabbit β-tubulin (Cell Signalling, 2128), 
rabbit anti-Lamin A/C (Cell Signalling, 4777) and rabbit anti-histone H3 (Cell Signalling, 
9715). 
 
6.3.7  Immunoprecipitation and kinase assays 
Immunoprecipitation (IP) and kinase assays were carried out as previously described 
(Berthet et al., 2003) with modifications. For immunoprecipitation, 50 to 500 ug of 
whole cell lysate was incubated with the respective antibody/peptide overnight at 4°C in 
buffer EB containing 0.5% NP-40, 150 mM NaCl, protease inhibitors and 1 mg/ml 
ovalbumin. IP for cyclin A2 was performed using antibody-conjugated sepharose beads 
(Santa Cruz, sc-751AC). Otherwise, IPs were carried out using antibodies against 
Cdk1 (Clontech, s1190), Cdk2 (Berthet et al., 2003) or cyclin E1 (eBioscience, 
14-6714) or serum against cyclin B1 (Berthet et al., 2003). Unconjugated antibodies 
were isolated with bound proteins by incubating with protein A beads (Roche, 
11719408001) for 1 h at 4°C. Beads were washed twice with EB containing 0.5% NP-
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40, 150 mM NaCl, protease inhibitors and 1 mg/ml ovalbumin and once with EB 
containing protease inhibitors and 1 mg/ml ovalbumin. Immunoprecipitated proteins 
were then eluted from beads with 1 x SDS-sample buffer and assessed for kinase 
activity using histone H1 (Roche, 11004875001) as substrate.  
 
For kinase assays, immunoprecipitated proteins on beads were incubated in EB buffer 
supplemented with 10 mM DTT, 15 μM ATP, 2.5 μCi [γ-32P]-ATP (PerkinElmer, 
NEG502A) and 1.6 μg of histone H1 for 30 min at room temperature. Reactions was 
stopped by adding SDS-sample buffer, heated at 80°C for 5 min and separated by 
SDS-PAGE. Proteins were fixed and stained with Bismarck Brown/Coomassie blue and 
quantification of incorporated radioactivity was done using a phosphoimager (Fujifilm, 
FLA-7000). 
 
6.3.8  RNA analysis 
Total RNA was extracted from cells using the Qiagen RNeasy mini kit according to the 
manufacturerʼs protocol. First-strand cDNA was synthesised from 0.2 μg total RNA for 
each quantitative real-time PCR (qRT-PCR) reaction using the SuperScript III reverse 
transcriptase (Invitrogen, 18080-051) following manufacturerʼs instructions. qRT-PCR 
was carried out with the Maxima SYBR Green qPCR Master Mix (Fermentas, K0252) 
and primers as listed in Table 6.5. The Rotor-Gene thermal cycler (Corbett Research) 
was used to monitor reactions with the following programme: 95°C for 10 min, followed 
by 40 cycles of 95°C for 15 sec, 55°C for 30 sec, and 72°C for 30 sec. All data were 
normalized to the expression levels of three housekeeping genes: β-actin, Hsp90 and 
cyclophilin A. 
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Gene Primers 
Cdk1 
(PKR196) 
F: 5ʼ- AGC GAG GAA GAA GGA GTG CC -3ʼ (PKO2004) 
R: 5ʼ- CAT GAG CAC ATC CTG CAG GC -3ʼ (PKO2005) 
Cyclin E1 
(PKR023) 
Commercial primer set (SABiosciences, PPM02891B) 
Cyclin E1 
(PKR215) 
F: 5ʼ- GAG CTT CTA GAC CTG TGC GT -3ʼ (PKO2316) 
R: 5ʼ- CGC ACC ACT GAT AAC CTG AG -3ʼ (PKO2317) 
Cyclin E1 
(PKR277) 
F: 5ʼ- ACA GCT TCG GGT CTG AGT TC -3ʼ (PKO2875) 
R: 5ʼ- CGG AGC CAC CTT CTT CTT TC -3ʼ (PKO2876) 
Cdc6 
(PKR240) 
F: 5ʼ- TGG GCG ATG ACA ACC TGT GC -3ʼ (PKO2689) 
R: 5ʼ- GGG GAA GCC TTA AAT GTC GG -3ʼ (PKO2690) 
Cdc6 
(PKR241) 
F: 5ʼ- GAT CGT GTT GGT GTT GGA CG -3ʼ (PKO2691) 
R: 5ʼ- GCT TCA AGT CUC GGC AGA AT -3ʼ (PKO2692) 
Cdc6 
(PKR242) 
F: 5ʼ- GCT GGA TGT TTG CAG GCG AG -3ʼ (PKO2693) 
R: 5ʼ- CAC CCT GTT CCC ATC AAC TT -3ʼ (PKO2694) 
β-actin 
(PKR143) 
F: 5ʼ- ACG GCT CCG GCA TGT GCA AA -3ʼ (PKO1630) 
R: 5ʼ- TTC CCA CCA TCA CAC CCT GG -3ʼ (PKO1631) 
Hsp90 
(PKR144) 
F: 5ʼ- ACT GCT CTG CTC TCC TCT GG -3ʼ (PKO1632) 
R: 5ʼ- CAT CGA TGC CCA GGC CTA GT -3ʼ (PKO1633) 
CypA 
(PKR195) 
F: 5ʼ- CCT TGG GCC GCG TCT CCT T -3ʼ (PKO2002) 
R: 5ʼ- CAC CCT GGC ACA TGA ATC CTG -3ʼ (PKO2003) 
Table 6.5. Primers used for qRT-PCR. 
 
6.3.9  Other chemicals used 
Cycloheximide (Sigma, C19988-1G) and MG132 (Calbiochem, 474790) were dissolved 
in DMSO as required. 
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